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Abstract
A variety of stressors cause hens to delay oviposition and this can result in
characteristic eggshell abnormalities which are commercially undesirable. This
project examined the duration of stress-induced oviposition delays in medium-hybrid
hens and investigated their underlying physiological causation. Social stress
(relocation of hens from individual to group cages) was used to induce the
oviposition delays.
From behavioural observations of stress-induced oviposition delays, it was
found that eggs were laid either before a threshold of approximately 3 h delay or
after at least 7 h delay. This distinction between short- and long-term delays
accounts for different types of eggshell abnormality.
Oviposition is caused by uterine contractions induced by release into the
circulation of ovarian prostaglandins and neurohypophysial arginine vasotocin
(AVT). Two possible physiological mechanisms which may account for the stress-
induced oviposition delays were examined. First, opioid peptides released in
response to stress may inhibit AVT release. Second, adrenaline released in response
to stress may directly suppress uterine contractions.
Plasma AVT concentration was elevated at the time of delayed oviposition,
but not during the delay, and AVT injection rapidly ended delays, thus supporting
the hypothesis that delays are caused by inhibition of AVT release. The possible
role of opioid release in causation of stress-induced oviposition delays was
investigated by treating hens with appropriate receptor antagonist and agonist
compounds. Nalmefene, a non-specific opioid receptor antagonist, significantly
reduced the duration of stress-induced oviposition delays. U50,488, a selective
kappa receptor agonist, induced oviposition delays, an effect prevented by nalmefene
and ended by AVT injection. U50,488 also increased the time from prostaglandin-
F2a injection to premature oviposition induction, and reduced the associated rise in
plasma AVT concentration. Morphine, a selective mu receptor agonist, induced
some ovipositions prematurely but may have delayed others. These findings support
the (first) hypothesis that opioids delay oviposition by inhibiting AVT release. The
frequency of headflicking in response to alerting stimuli, a putative index of hens'
opioid status, was significantly reduced by social stress. This evidence is consistent
with the assumption that opioids are released during social stress.
Propranolol, a (3-adrenergic receptor blocker, prevented stress-induced
oviposition delays, supporting the (second) hypothesis that these are caused by
adrenergic suppression of uterine contractions. Thus, the mechanisms underlying
stress-induced oviposition delays may involve both endogenous opioids, which
inhibit AVT release, and adrenaline, which directly suppresses uterine contractions.
As oviposition is associated with ovulation of the subsequent egg, it was of
interest to establish whether stress-induced oviposition delays were associated with
delays of the subsequent eggs ovulation. From investigations of the stage of
formation and position of the subsequent egg in the oviduct, it was concluded that
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CHAPTER 1: General Introduction
A variety of stressors cause hens to delay oviposition and this can result in
characteristic eggshell abnormalities which are commercially undesirable. This
thesis examines the duration of stress-induced oviposition delays in medium-hybrid
hens and investigates their underlying physiological causation.
In this Introduction, the production of eggs and their shells by hens is
summarised first (Section 1.1). The literature relating to stress-induced oviposition
delays is reviewed in Section 1.2 and then the consequences of these delays for
eggshell quality are described in Section 1.3. Physiological control of oviposition is
described in Section 1.4, then ways in which stress might disrupt this to delay
oviposition are hypothesised in Section 1.5. The possible roles of opioid peptides
and adrenaline in the mechanisms underlying stress-induced oviposition delays are
introduced in Sections 1.6 and 1.7. Finally, Section 1.8 outlines the experimental
approach followed in this thesis.
1.1 Egg Production by Laying Hens
There are two types of domestic hen used by the poultry industry: laying
hens, such as ISA Brown and Hisex, which have been selected for high egg yield,
and meat type chickens, broilers, which have been selected for high meat yield.
Hens of the modern egg laying strains examined in this thesis lay almost every day
once mature and individuals are expected to lay over 300 eggs in their productive
year (Appleby et al., 1992). This section summarises the daily cycle of egg laying
and the structure and formation of eggshells. For further information on the egg
laying cycle the reader is referred to reviews by Johnson (1986), Etches (1990) and
Bahr and Johnson (1991). The structure and formation of eggshells is reviewed by
Solomon (1991) and Roberts and Brackpool (1994).
The hen's reproductive system is comprised of a single ovary and a single
oviduct which is divided into functionally distinct regions, each concerned with
different aspects of egg formation. These organs and an indication of the time taken
for an egg to pass through each of the oviduct regions are shown Figure 1.1.
The ovary contains a large number of developing ova arranged in a follicular
hierarchy from which the largest is due to ovulate next. Progesterone released into










Figure 1.1 A diagrammatic representation of the reproductive organs of the laying
hen, with an egg in the uterus. The approximate times taken for the
developing egg to pass through each oviduct section are shown in brackets
(from Warren & Scott, 1935).
release lutenising hormone (LH), which then causes this follicle to ovulate about 5 h
later. The light-dark cycle affects the release of LH in such a way that ovulation is
restricted to an 8 h period in the morning (Etches, 1984). As oviposition occurs 24-
25 h after ovulation, oviposition is similarly restricted and most occur in the 12-18 h
after dusk, i.e. in the morning when conventional lighting patterns (14L:10D) are
used. Ruptured follicles from recent ovulations (post-ovulatory follicles) are also
present in the ovary and are involved in endocrine control of pre-laying behaviours
and possibly also timing of oviposition.
Once ovulated, the ovum is engulfed by the infundibulum and so enters the
oviduct. Occasionally the ovulated ovum is not picked up by the infundibulum and
remains in the body cavity where it is eventually reabsorbed. This is described as
'internal ovulation' and results in a day when no egg is laid (Wood-Gush & Gilbert,
1970). After the infundibulum, the egg passes through the magnum, where the
albumen layer is laid down, and then through the isthmus where the shell membrane
is formed. Finally, 4-5 h after ovulation, the egg enters the uterus (shell gland)
where eggshell formation occurs. Oviposition, the expulsion of the egg from the
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uterus through the uterovaginal sphincter, takes place 24-25 h after ovulation and is
accompanied by characteristic pre-laying behaviour patterns. The next day's egg is
usually ovulated 15-45 min after oviposition and the process of egg formation starts
again.
A group of eggs laid on consecutive days is described as a sequence.
Sequences are separated by days on which there is no oviposition. Oviposition time
is earliest for the first egg of a sequence, and is latest for the last egg. The change in
oviposition time between two consecutive days, the lag, is greatest at the start and
end of sequences and may be effectively zero in the middle of long sequences. This
pattern of oviposition times is a consequence of circadian rhythms which restrict the
period in which LH may be released and thus the times when ovulation can occur
(Etches, 1984). Examples of sequences of various lengths can be found in Lillpers
and Wilhelmson (1993b).
Oviposition is preceded by characteristic behaviour patterns associated with
the finding and preparation of a suitable nest site, and which are divided into two
phases: a searching phase and a nesting phase (Freire, 1994). During the searching
phase, cage-housed hens typically show restlessness and frantic pacing, while the
nesting phase is characterised by sitting and sometimes vigorous attempts to find
cover. Pre-laying behaviour is not controlled by the presence of an egg in the
oviduct but instead by the post-ovulatory follicles in the ovary, in particular that
which ovulated 24 h previously (Wood-Gush & Gilbert, 1964). Consequently pre-
laying behaviour occurs approximately 24 h after an internal ovulation even though
there is no egg to be laid (Wood-Gush, 1963). Food intake and gut motility are
suppressed during pre-laying behaviour but resume shortly after oviposition (Savory,
1977; Shimada, 1986; Shimada etal., 1987b).
Eggshells have two important functions: they protect the developing embryos
and, from a commercial perspective, provide packaging for their food contents. In
their capacity as incubation chambers eggshells must, in addition to providing the
embryo with physical protection and a source of calcium, allow movement of
respiratory gases. Artificial genetic selection has been used to improve the colour
and strength of eggshells.
The shell membrane is laid down as the egg passes through the isthmus and
becomes the foundation for the eggshell, providing centres for initiation of calcite
crystallisation. During the 18-20 h the egg spends in the uterus, calcium carbonate is
laid down, forming characteristic layers which provide the shell with most of its
strength. Under hormonal control linked to the egg's own ovulation, calcium
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mobilised from the skeleton and from increased intestinal absorption is transported
to the uterus in the blood. It is ovulation and not the presence of an egg in the uterus
that stimulates eggshell formation (Eastin & Spaziani, 1978). Finally, about 1.5 h
before oviposition, calcification stops and the cuticle is laid down. The cuticle is the
outermost layer of the eggshell and is an organic matrix that contains most of the
shell's pigmentation. It protects the egg from water penetration, water loss and
microbial invasion.
Some eggs carry an additional layer of calcification overlying the cuticle
which is visible as a chalky coating on the surface of brown eggshells. This feature,
described as eggshell dusting, is most common early in lay and may be unevenly
distributed over the eggshell (Mills etal., 1991).
1.2 Stress-Induced Oviposition Delays
It is known that environmental stress can cause hens to delay the time at
which their ovipositions occur. In one of the earliest reports, Patterson (1909)
describes how ovipositions were delayed for up to 20 h by disturbing hens every
time they attempted to lay. Scott (1940) observed that hens often delayed
oviposition when they were moved to unfamiliar environments shortly before they
were due to lay. Quail can also be induced to delay oviposition, for 1-28 h and
sometimes even longer, by frightening procedures such as dropping a metal drum
onto a hard surface (Opel, 1966).
The presence of unfamiliar birds and alterations to social group composition
also induce oviposition delays. Hughes (1979) found that replacing one hen from an
established group of four with an unfamiliar hen shortly before they were due to lay
increased the amount of aggressive behaviour and caused oviposition delays. The
replacement hens delayed oviposition longer than did the residents. Similarly, Watt
and Solomon (1988) and Watt (1989) reported that moving six individually housed
hens into a single cage shortly before they were due to lay also delayed oviposition.
Before oviposition time hens become highly motivated to find a suitable nest
site in which to lay their egg. Duncan (1970) reported that when hens which were
housed in deep litter pens and were used to laying in nest boxes were deprived of
access to these nest sites, either by closing the nests or by moving the birds to cages,
ovipositions were delayed. Moving hens to cages caused oviposition delays that
were, on average, 1 h longer than those caused by nest box closure, presumably
because relocation was an additional source of stress. Kite (1985) reported that
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some hens would regularly delay oviposition for over 24 h when deprived of a nest
site and would lay within a few minutes of being provided with a nest box. Hughes
et al. (1986) also found that excluding hens from regularly used nest sites induced
oviposition delays which often exceeded 13 h; they described how pre-laying
behaviours were present during the first few hours of the oviposition delay, but then
became interspersed with and finally replaced by other behaviours. Cooper and
Appleby (1994) found that partially obstructing access to a nest site, leaving only a
narrow gap through which the hen could pass with difficulty, delayed oviposition for
1-3 h.
It is not clear if motivational states such as hunger or thirst, which may
conflict with nesting motivation, can cause oviposition delays. Although the
distribution of oviposition times throughout the day may be influenced by daily
feeding time (Brake, 1985; Wilson & Keeling, 1991), it is not clear if these effects
are due to the food itself or the general disturbance associated with the food
presentation. Freire (1994) and Appleby and Freire (1995) found that the nesting
behaviour of hens housed in a row of cages was temporarily replaced by food
directed activity when their food was topped up at a time when most were soon due
to lay. Hens receiving this food within 15 min of the time when their oviposition
was due delayed oviposition for 9-42 min, and this was interpreted in terms of
conflicting motivations for feeding and egg laying.
From an evolutionary point of view, delaying oviposition in response to
stresses such as the absence of a nest site should ensure that birds do not lay their
eggs in places unsuitable for incubation. Furthermore, birds in natural habitats may
be vulnerable to predation during oviposition, and so delaying this process when
danger threatens would be a selective advantage.
1.3 Eggshell Abnormalities Associated with Oviposition Delays
1.3.1 Causation and Classification of Eggshell Abnormalities
When oviposition is delayed the egg is retained for longer than normal in the
uterus and, consequently, can acquire characteristic eggshell abnormalities. These
abnormal eggs are classified as either dusted or white-banded, the type of defect
being related to the duration of oviposition delay (Hughes et al., 1986). In the case
of white banding the subsequent egg is also defective and is described as slab-sided.
Examples of these three eggshell abnormalities are shown in Figure 1.2.
5
Figure 1.2 Eggshell abnormalities associated with delayed oviposition:
A, normal egg; B, dusted egg;
C, white-banded egg; D, slab-sided egg.
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Eggs laid after short oviposition delays tend to carry a coating of amorphous
calcium carbonate on top of the cuticle (Hughes et al., 1986). Although this
additional layer is visible as a chalky white coating on the surface of brown eggs,
and is described as eggshell dusting, it is difficult to detect on the white-shelled eggs
produced by some strains of hen (Mauldin, 1992). Eggshell dusting can also occur
in the absence of oviposition delays (Mills et al., 1991).
When oviposition is delayed for longer periods, the next day's egg eventually
arrives in the uterus and presses against the retained egg (Scott, 1940; van
Middelkoop, 1971). At this stage the newly arrived egg does not yet have a shell
and is therefore compressed where it touches the delayed egg. This deformation is
fixed by calcification as the eggshell is formed. When the delayed egg is eventually
laid it carries a prominent white band of additional calcification, indicating the area
of contact between the two eggs, and is described as being white-banded. The
subsequent egg is laid with a flattened area of eggshell and is described as slab-
sided. In addition to their defective shape, slab-sided eggs tend to have thinner
shells than normal eggs and may be laid prematurely without a shell (soft or shell-
less eggs). White-banded eggs are sometimes referred to as A eggs and slab-sided
eggs as B eggs, truncated eggs or compressed-side eggs (Romanoff & Romanoff,
1949; van Middelkoop, 1971; Carter, 1977). Hughes et al. (1986) observed that the
mean duration of oviposition delay was 1.35 h for dusted eggs and at least 13 h for
white-banded eggs.
Eggshell abnormalities similar to those resulting from oviposition delays can
result from diseases such as infectious bronchitis (Spackman, 1987).
1.3.2 Downgrading of Abnormal Eggs
Eggs intended for domestic consumption are downgraded if they have
eggshell abnormalities associated with oviposition delays and this results in a loss of
revenue for the poultry industry. Consumers tend to discriminate against these eggs
even though the contents are unaffected, and the slab-sided eggs are prone to
cracking on account of their thinner shells. Although these eggs can be marketed
through catering outlets or as liquid egg products, their value is much less than that
of top grade eggs.
Eggs produced by breeding flocks for incubation are also downgraded if they
have shell abnormalities associated with oviposition delays and this is because their
hatchability can be reduced in two ways. First, the additional calcium carbonate
deposits that form dusting and white-banding may block pores, thus reducing
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eggshell porosity (van Middelkoop, 1971; Hughes et al., 1986; Brake, 1987;
Mauldin, 1992). Embryos developing in low porosity eggshells have reduced
metabolic rates, reach low hatch weights and have a reduced chance of hatching
relative to those in high porosity eggshells (Tullett & Deeming, 1982; Burton &
Tullett, 1983; Peebles & Brake, 1987). Artificially reducing eggshell porosity by
covering areas with tape restricts the exchange of the embryo's respiratory gases,
thus leading to haematological and morphological changes which resemble those of
ascitic birds (Maxwell et al., 1987). Indeed, 88-98% of embryos incubated within
white-banded eggs die during incubation (van Middelkoop, 1972). Second, eggs
whose ovipositions have been delayed are kept at the hen's body temperature for
longer than eggs laid normally and, consequently, may be at an over-advanced stage
of development when laid. Patterson (1909) observed that eggs laid 20 h overdue
contained embryos that were at a developmental stage equivalent to normally laid
eggs that had been incubated for about 20 h. Storing eggs prior to incubation retards
the development of the embryos, this effect being greatest for embryos laid at more
advanced stages (Mather & Laughlin, 1979). Thus, by altering the stage of
embryonic development at oviposition, oviposition delays may lower egg
hatchability following storage.
From an animal welfare perspective, eggshell abnormalities associated with
oviposition delays might provide a useful indicator of stress experienced by flocks of
hens (Hughes et al., 1986; Mills et al., 1987b; Mills et al., 1991). In addition to
abnormalities resulting from oviposition delays, other eggshell defects indicate that
hens have been exposed to stress and can sometimes be used to pinpoint the time of
this disturbance (Coleman, 1988). For example equatorial bulges result from stress
in the afternoon (Hughes & Black, 1976; Hughes et al., 1986). A consideration of
all stress-related eggshell defects, including those associated with oviposition delays,
may be useful for assessing the welfare of commercial farmed hens.
1.3.3 Incidence of Abnormal Eggs
It is not clear what proportion of eggs laid by commercial flocks for
consumption are downgraded due to eggshell abnormalities associated with
oviposition delays. There are two reasons why this information is not available.
First, egg producers routinely remove many eggs which carry major downgrading
abnormalities before sending the better quality eggs to a packing station where
further grading takes place. Although detailed breakdowns of the downgrading at
grading stations is available, information on the downgrading carried out on farms is
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not and so the proportion of all eggs laid with specific abnormalities is usually not
known. The following surveys of downgrading considered all eggs laid. Second,
published analyses of eggshell quality and downgrading group shell faults into
categories which are not exclusively related to oviposition delays.
In a survey of more than 15 million eggs from 685 UK farms it was found
that 7.06% were downgraded and that 90.54% of these downgradings (6.39% of all
eggs) were due to shell faults (Maddison, 1970). Eggs with abnormalities associated
with delayed oviposition will be included in the 6.39% of eggs downgraded due to
shell faults. In a smaller but more detailed study, 500 eggs produced by ISA Brown
hens in several farms were graded (see Table 1.1). Dusted and white-banded eggs
would be classified as dusted or target eggs while slab-sided eggs would be included
in the poor shell, mis-shapen, soft-shell and liquid categories. Thus, the proportion
of eggs downgraded due to abnormalities associated with oviposition delays was less
than 2.39%.
Egg fault % of all eggs laid
Cracks 2.5







(dusting on one pole)
White (lack of pigment) 0.2





Table 1.1 The incidence of various categories of egg fault recorded in a study of
500 eggs from ISA Brown hens in several UK farms (information supplied in
confidence by a commercial egg producing firm). Eggshell abnormalities
associated with oviposition delays will contribute towards the categories
marked
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Carter (1977) found that the proportion of all eggs laid which were abnormal
was 8.3, 9.2 and 0.5 %, respectively, for a medium body weight commercial brown-
egg laying strain, a commercial White Leghorn strain and an experimental strain of
Brown Leghorn. In that study, more than two-thirds of the recorded abnormal
eggshells were white-banded or slab-sided. Ivy et al. (1972) reported that the
incidence of abnormal eggs was 1.6% in a commercial flock of White Leghorn hens
and 1-1.7% in two experimental strains of White Leghorn. These authors also noted
that individual hens which laid white-banded and slab-sided eggs regularly could be
identified, and suggested that removing a few of these birds would greatly reduce the
overall incidence of these abnormalities in the flock. Jaap and Muir (1968) reported
that 0.7-1.9% of eggs laid by two strains of Leghorn layer were abnormal and that a
higher proportion, 1.5-5.9%, of eggs from broiler fowls were abnormal.
Both the incidence of dusted eggs and the incidence of white-banded and
slab-sided eggs are heritable traits (Carter, 1977; Mills et al., 1991). However,
selection for production of these eggshells is limited by the low hatchability of
embryos developing within them (van Middelkoop, 1972).
1.4 Physiology of Oviposition
1.4.1 Introduction
Oviposition involves vigorous contractions of the uterine muscles and
relaxation of the uterovaginal sphincter, and is aided by the abdominal muscles (see
Shimada and Saito (1989) for a comprehensive review). Prostaglandins (PGs)
released into the circulation by ovarian follicles cause uterine muscles to contract
more frequently. These contractions stimulate the posterior pituitary to release
arginine vasotocin (AVT) into the circulation. AVT acts to further increase the
frequency of uterine contractions, both directly and by inducing production of PGs
by the uterine tissues themselves. The inter-relationships between PG and AVT
release form a positive feedback loop which has a cascading effect on the
development of uterine contractions. These contractions, aided by relaxation of the
utero-vaginal sphincter, expel the egg from the oviduct. A diagrammatic
representation of the mechanisms underlying oviposition is shown in Figure 1.3.
Uterine muscle contraction frequency varies during the laying cycle and this
can be devided into three phases (Figure 1.4): 1) little activity while the egg is in the




Figure 1.3 Diagrammatic representation of mechanisms involved in the control of
oviposition. 1) PGs, including PGF2a, released from the largest pre- and
post-ovulatory follicles stimulate uterine contractions. 2) These contractions
trigger AVT release from the posterior pituitary. 3) AVT further stimulates
uterine contractions, both directly and by stimulating PG production
in uterine tissues. These contractions, aided by PGE induced relaxation
of the uterovaginal sphincter, lead to expulsion of the egg.
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Hours after ovulation
Figure 1.4 Diagrammatic representation of the changes in uterine contraction
frequency associated with the formation and oviposition of an egg, with
oviposition occurring 24 h after ovulation (Shimada & Asai, 1978). See text
(p. 10 & 12) for description of phases 1-3.
presence of an egg in the uterus and eggshell formation, 3) high frequency
contractions at the time of oviposition (Shimada & Etches, 1986). These high
frequency contractions which expel the egg from the uterus begin only 3-5 min
before the egg is laid (Wechsung & Houvenaghel, 1988), and are likely to reflect the
release of PGF2a and AVT (Shimada & Asai, 1978; Saito et al., 1987). An increase
in uterine contractions similar to phase 3 occurs about 30 min before the ovulation of
first egg in a sequence, even though no egg is laid at that time (Shimada & Asai,
1978).
1.4.2 Prostaglandins
Plasma PG concentrations are elevated at the time of oviposition (Olson &
Hertelendy, 1981) and it is thought that release of ovarian PGs, including PGF2a, is
the initial event triggering a cascade of processes which lead to expulsion of the egg.
Although there are some inconsistencies between studies, it appears that PGF2a
accumulates in the largest pre- and post-ovulatory follicles of the ovary during the
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hours before oviposition (Day & Nalbandov, 1977; Hammond et al., 1980; Olson et
al., 1986; Saito et al., 1987). Although the pre-ovulatory changes in plasma LH
concentration are thought to influence oviposition time (Etches et al., 1990), the
mechanisms controlling ovarian PG release and the sequence of events linking the
LH surge to the oviposition which occurs 4-6 h later are not yet understood.
Circulating PGF2a acts via specific receptors in the uterus to increase the
contractile activity of the uterine muscles. The rise in plasma AVT concentration
that is stimulated by these contractions (see below) further enhances the uterine
contractions both directly and by stimulating the production of PGs, including PGE,
within the uterine tissues (Rzasa, 1984; Goto et al., 1985). In addition to promoting
uterine contractions, PGE stimulates relaxation of the uterovaginal sphincter to
facilitate the passage of the egg (Verma et al., 1976; Wechsung & Houvenaghel,
1976).
Supporting the view that PG release is a cause rather than a consequence of
oviposition, ovarian PG is not released in response to either intra-venous AVT
injection or intra-uterine PG injection, both of which induce uterine contractions and
premature oviposition (Olson & Hertelendy, 1981; Saito et al., 1987). Furthermore,
oviposition is induced by injection of PGs (Hertelendy et al., 1974; Goto et al.,
1985) and delayed by injection of indomethacin, an inhibitor of PG synthesis
(Shimada & Asai, 1979).
1.4.3 Arginine Vasotocin
AVT is a neurohormone synthesised in magnocellular neurones within the
supraoptic and the paraventricular nuclei of the hypothalamus, and released from
stores in the terminals of these nerves within the posterior pituitary (Goossens et al.,
1977). In addition to its role in oviposition, AVT is the avian anti-diuretic hormone
and is physiologically important in the regulation of fluid balance (Stallone & Braun,
1986, Grossmann et al., 1993). The physiological roles of mesotocin, an avian
neurohypophysial hormone structurally similar to AVT and found in similar
concentrations in the plasma, are largely unknown (Acher, 1993).
At the time of oviposition, the plasma AVT concentration rises to about 80
pg/ml and then rapidly declines, reaching basal levels of approximately 20 pg/ml
after 15-30 min (Tanaka et al., 1984). This rise in plasma AVT concentration is
associated with a 30% depletion of the posterior pituitary store (Tanaka & Nakajo,
1962). Although AVT is also present in the ovary, it is unlikely that this source
contributes to the rise in plasma AVT concentration at oviposition because the AVT
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concentration in peripheral plasma is higher than that in follicular venous plasma at
that time (Shimada et al., 1987a). The rise in plasma AVT concentration promotes
contractions of the uterus and thus assists with the expulsion of the egg. AVT acts
via specific receptors on the uterus whose binding characteristics are altered in
response to changes in PG and progesterone concentrations (Koike et al., 1981;
Takahashi et al., 1992, 1994). Injection of exogenous AVT causes contractions of
the uterine muscles and induces oviposition within a few minutes (Rzasa & Ewy,
1970).
Circulating AVT is rapidly degraded by an aminopeptidase, the plasma
concentration of this enzyme being lowest around the time of oviposition and rising
a few hours afterwards (Gilbert & Lake, 1964; Brzezinska et al., 1967). The AVT
inactivating activity of homogenates of various oviducal sections containing this
enzyme was found to be greatest for the uterus (Brzezinska-Slebodzinska & Rzasa,
1973; Brzezinska-Slebodzinska et al., 1979). There, it was also found to be lowest
at the time of oviposition, and to rise in the subsequent 4 hours (Brzezinska-
Slebodzinska etal., 1979).
Several lines of evidence suggest that the stimulus for the rise in plasma
AVT concentration at the time of oviposition is increased activity of uterine muscles.
First, plasma AVT concentration does not rise at normal oviposition time when the
oviposition is delayed by indomethacin, an inhibitor of PG synthesis, suggesting that
AVT release is a response to either elevated PG concentration or increased uterine
contractions. Second, when oviposition is induced prematurely by intra-uterine
injection of PG, acetylcholine or orthophosphate solution, plasma AVT
concentration increases but plasma PG concentration does not (Saito et al., 1987a;
Shimada et al., 1987; Murakami et al., 1991). Third, distension of the oviduct by
either digital palpation or inflation of an inserted balloon stimulates AVT release,
transiently doubling basal plasma levels (Rzasa et al., 1979; Shimada et al., 1987).
Although the mechanism by which uterine contractions stimulate AVT release has
not been described, a neural pathway similar to that which triggers oxytocin release
during parturition and lactation (Edqvist & Stabenfeldt, 1993) may be involved.
It is still unclear whether AVT is essential for oviposition, as hens which
have been neurohypophysectomised (surgical removal of the posterior pituitary) are
reported to lay normally even when this procedure is carried out only 1-2 hours
before oviposition, thus ruling out any possibility of neural regrowth (Shirley &
Nalbandov, 1956; Opel, 1965; Nakada et al., 1993, 1994). Furthermore, hens with
electrical lesions in the supraoptic nucleus show polydipsia, suggesting little anti¬
diuretic release of AVT, yet resume laying a few days after surgery (Ralph, 1960).
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However, in all these experiments, the possibility that AVT was still released in
association with oviposition, e.g. from cut nerve endings, cannot be ruled out. As
yet, no experiment measuring plasma AVT concentrations associated with
ovipositions of neurohypophysectomised hens has been reported. Nakada et al.
(1994) reported that injection of AVT antiserum, at a dose considered sufficient to
neutralise all circulating AVT, did not cause oviposition delays, further suggesting
that AVT may not be essential for oviposition. However, no measurements of
circulating AVT concentrations associated with oviposition, needed to confirm the
hypothesis, were made in that experiment.
An alternative approach to assessing the importance of AVT in the
oviposition process would be to use AVT analogues which block AVT receptors,
thus preventing any action of AVT. A similar approach using an appropriate
analogue has been used to demonstrate that oxytocin is essential for the normal
progression of parturition in rats (Antonijevic et al., 1995). Currently, the most
potent AVT analogues are able to block AVT induced contractions of isolated strips
of uterine muscle for only a few minutes, and so this approach is not yet able to
assess the importance of AVT in oviposition (Sudo et al., 1988).
1.5 Possible Mechanisms Underlying Stress-Induced Oviposition Delays
As described in the previous section, uterine contractions which expel the
egg at oviposition are initiated by ovarian PGs and then promoted further by
neurohypophysial AVT. Four ways in which stress may act to delay oviposition are
now hypothesised.
First, stress might delay the initiation of oviposition by preventing ovarian
PG release. The fact that either removal of the largest pre- or post-ovulatory follicle,
or treatment with a prostaglandin inhibitor delays oviposition (Rothchild & Fraps,
1944; Gilbert et al., 1982; Hertelendy & Biellier, 1978) suggests that ovarian PGs
are indeed essential for oviposition. Hence, any stress-related inhibition of PG
release (direct or indirect) could presumably delay oviposition.
Second, stress might inhibit neurohypophysial AVT release and so interrupt
the cascade of processes which cause oviposition. In mammals release of oxytocin,
a neurohypophysial hormone with functions similar to those of AVT, is inhibited by
endogenous opioids released in response to stress, resulting in interruptions to
parturition and lactation (see Petherick et al. (1993) for a review). By analogy, a
stress-related opioidergic inhibition of AVT release may be the cause of oviposition
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delays. The literature relating to this hypothesis is reviewed in Section 1.6.
Third, stress may directly suppress development of the uterine contractions
required to expel the egg. Adrenaline is released in response to various stressors
(Freeman, 1976; Harvey et al., 1984), and exogenous adrenaline relaxes uterine
muscles, both in vitro and in vivo, (e.g. Crossley et al., 1980; Wechsung &
Houvenaghel, 1987) and delays oviposition (e.g. Crossley, 1983). Hence,
oviposition delays could be due to stress-related adrenergic suppression of uterine
contractions. The literature relating to this hypothesis is reviewed in Section 1.7.
Fourth, stress may cause contractions of the utero-vaginal sphincter and so
prevent uterine contractions from expelling the egg. The sphincter is known to
posses musculature appropriate for this (Gilbert & Lake, 1963).
1.6 Opioids and Stress: Their Effect on Neurohypophysial Hormone Release
In this section the effects of opioids on neurohypophysial hormone release
and their possible role in mediating oviposition delays during stress are reviewed.
From this evidence, it is hypothesised that endogenous opioids released in response
to stress may induce oviposition delays by inhibiting neurohypophysial AVT release.
1.6.1 Opioids and Opioid Receptors
Opioid peptides are found in many organs where they are involved in various
physiological processes including responses to physical and psychological stress (see
Akil et al. (1984) and Millan and Herz (1985) for reviews on opioid biology). There
are three families of endogenous opioids: endorphins, enkephalins and dynorphins.
Within each family, opioids are derived in specific neurones by cleavage of one
precursor polypeptide.
From behavioural studies, radioligand binding assays and in vitro
pharmacological bio-assays, three major types of opioid receptor have been
identified (Mansour et al., 1988, Simon & Gioannini, 1993). Each of these receptor
types can be further classified into sub-types. These receptors show preferential
binding for particular opioids and have different anatomical distributions and
proposed physiological roles (Akil et al., 1988). When stimulated, opioid receptors
interact with G-proteins and so influence cell function by altering the permeability of
ion channels or by causing production of intracellular second messengers such as
cAMP (see North (1993) and Childers (1993) for reviews).
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For mammals, DNA cloning and expression techniques have been used to
describe the structure of each opioid receptor type and its interactions with ligands
(Knapp et al., 1995). Although avian opioid receptors are assumed to be similar to
those of mammals, their molecular biology has not yet been described by cloning
and the possibility that structural differences could cause them to interact differently
with ligands cannot be excluded. However, studies into the distribution of opioid
receptor types have found that ligands specific for mammalian mu, kappa and delta
sites have similar binding characteristics and selectivity in avian tissues, suggesting
that there is structural similarity between mammalian and avian receptors (Reiner et
al., 1989; Csillag etal., 1990; Deviche et al., 1993).
Various agonists and antagonists which respectively stimulate and block
opioid receptors are available and can be used to manipulate opioid pathways
experimentally (Zimmerman & Leander, 1990; McKnight & Rees, 1991). The
selectivity of these compounds for specific types of opioid receptor is assessed from
binding assays, a technique which determines their abilities to displace specific
radio-labelled ligands from each of the receptor types, usually in rat brain
Relative affinity for specific receptor type
mu delta kappa Reference
Antagonists
Nalmefene 1 0.16 0.19 Michel etal., (1985)
MR2266 0.7 0.12 1 Magnan et al. (1982)
norBNI 0.02 0.01 1 Traynor etal. (1989)
Agonists
Morphine 1 0.03 <0.01 Corbett etal. (1993)
U50,488 <0.01 <0.01 1 Corbett etal. (1993)
Table 1.2 Relative abilities of three antagonists and two agonists to displace
specific ligands from each of the three opioid receptor types. For each
compound, the receptor type at which the ligand was most readily displaced
has a relative affinity of 1. Binding affinity information was calculated from
data in the references provided. Note that different ligands were used in




Figure 1.5 Diagrammatic representation of the mammalian and avian magnocellular
neurones showing the distribution of specific opioid receptors which may
influence hormone release. Note that the hypothalamus (indicated by
light shading), but not the pituitary, is contained within the blood brain
barrier. Where information on the distribution of opioid receptors in hens is
not available this is indicated by a '?'. The literature relating to this figure is
reviewed in the text (p. 19 & 20). PP, posterior pituitary; AP, anterior
pituitary; |Lt, mu receptor; k, kappa receptor; 8, delta receptor.
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preparations (Corbett et al., 1993). The agonistic or antagonistic nature of these
compounds is usually identified from their effects in peripheral tissue bioassays
(Corbett et al., 1993; Smith & Leslie, 1993). Table 1.2 shows the opioid receptor
selectivities of three antagonists and two agonists used in this project.
1.6.2 Neurohypophysial Hormones and Opioids
In mammals, the neurohypophysial peptides oxytocin and vasopressin (AVP)
have evolved from mesotocin and AVT respectively, and functionally assume both
of the physiological roles of AVT (Archer, 1993). Oxytocin promotes milk ejection
in response to suckling and uterine contractions during parturition, while AVP, the
mammalian anti-diuretic hormone, is important in the regulation of water balance
and in the maintainence of cardiovascular function during haemorrhage. In addition
to its osmoregulatory functions, AVP has a role in controlling physiological
responses to stressors - in particular it facilitates the release of adrenocorticotrophic
hormone (ACTH) from the anterior pituitary (Krishnan et al., 1991). In hens, AVT
is released in response to challenges where plasma osmolality is not affected, such as
hatching (Kisliuk & Grossmann, 1994), and its role in the physiological stress
response may be similar to that of AVP in mammals (Kuenzel & Blahser, 1989).
These peptides are synthesised in separate groups of magnocellular neurones
within the paraventricular and supraoptic nuclei of the hypothalamus, and are passed
down the axons arising from these cells to be stored in their nerve terminals in the
neurohypophysis (posterior pituitary). Nerve impulses travelling down this
hypothalamo-hypophysial pathway trigger release, by exocytocis, of oxytocin and
AVP from these stores into the circulation.
Opioids can block the secretion of oxytocin and AVP both by acting to
reduce the electrical discharge activity of the magnocellular cell bodies in the
hypothalamus (centrally) and by inhibiting the exocytosis of storage vesicles in the
nerve terminals in the neurohypophysis (peripherally) (see Bicknell (1985) for a
review). Opioid agonists and antagonists which alter the release of
neurohypophysial hormones may only be assumed to act peripherally if it can be
shown that the firing rate of the magnocellular neurones is unchanged.
The opioidergic control of magnocellular neurones has been investigated by
describing the distributions of specific opioid receptor types and by characterising
the effects of specific opioid agonists and antagonists on peptide release. In
mammals both mu and kappa receptors in the hypothalamus modulate
neurohypophysial peptide release, while in the pituitary only kappa receptors are
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involved (Bicknell, 1985, 1993). In birds, opioidergic control of the
neurohypophysial system has not been fully described. Although the avian
paraventricular nucleus contains mu, kappa and delta receptors, it is not known if
these are associated with the cell bodies of the magnocellular neurones (Deviche et
al., 1993). Kawashima et al. (1995) found that the neurohypophysis of the laying
hen contained a single type of opioid receptor (type not identified) and suggested
that it may be involved in regulating peptide release. Martin et al. (1992) found that
specific opioid binding sites in the hen were associated with the terminals of
mesotocin neurones but not with those of AVT neurones. Presumably these binding
sites were the single opioid receptor type identified by Kawashima et al. (1995) and,
by analogy with the mammalian neurohypophysial system, it seems likely that they
will be kappa type.
Figure 1.5 shows diagrammatic representations of mammalian and avian
neurohypophyses and indicates the distribution of specific opioid receptors which
may influence hormone release.
1.6.3 Opioid Modulation of Oxytocin and Vasopressin Release
Centrally, endogenous opioids act via both mu and kappa receptors to
modulate electrical activity in the hypothalamo-neurohypophysial pathway and
hence oxytocin release from the neurohypophysis. Both morphine and U50,488,
selective mu and kappa opioid receptor agonists respectively, reduce the
spontaneous firing rate of putative oxytocin neurones in the rat hypothalamus both in
vitro (Wakerley et al., 1983; Pumford et al., 1992) and in vivo, following intra¬
venous administration, (Pumford et al., 1991, 1992, 1993).
Peripheral opioidergic inhibition of oxytocin release is mediated by kappa
receptors, with U50,488 inhibiting oxytocin secretion from the electrically
stimulated rat neurohypophysis in vitro (Zhao et al., 1988a) and in vivo (Russell,
1993). Mu receptor agonists such as morphine do not inhibit the release of oxytocin
caused by electrical stimulation of the neural stalk (Russell et al., 1993).
Endogenous opioids can also inhibit the release of neurohypophysial noradrenaline
and thus, as noradrenaline facilitates oxytocin secretion from the nerve terminals,
can suppress oxytocin release indirectly at the level of the neurohypophysis (Dyer
1988, Zhao et al. 1988b).
Injections of morphine or U50,488 depress circulating oxytocin
concentration, causing prolonged labour in rats. This disruption of parturition can be
ended by intravenous infusions of exogenous oxytocin or prevented by treatment
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with naloxone (Gosden et al., 1985; Russell et al., 1989; Douglas et al., 1993).
Similarly, morphine blocks suckling induced milk ejection in rats and mice in a
naloxone reversible manner (Haldar & Sawyer, 1978; Russell & Spears, 1983).
During normal parturition, modulation of oxytocin release by endogenous opioids
may play a role in spacing the deliveries of successive births (Leng et al., 1985).
AVP and oxytocin neurones themselves also release opioids which may be
involved in regulation of neurohypophysial hormone release (van Wimersma
Greidanus & van de Heijning, 1993). For example, dynorphin is co-released with
oxytocin and can act via peripheral kappa opioid receptors to inhibit oxytocin release
(Leng etal., 1994).
1.6.4 Opioids, Oxytocin and Stress-Induced Disruption of Parturition and Lactation
Disturbing rats or pigs in mid-parturition by moving them to an unfamiliar
environment increases the inter-birth interval, thus prolonging labour. This
disruption is reduced by the non-selective opioid receptor antagonist naloxone, thus
indicating a role of opioids in the mechanisms underlying this response (Leng et al.,
1987; Leng et al., 1988; Lawrence et al., 1992). The drop in plasma oxytocin
concentration which is associated with the stress-induced increase in inter-birth
interval does not occur in naloxone treated animals. Furthermore, administration of
exogenous oxytocin to rats or pigs that are exposed to disturbance causes labour to
resume. These observations indicate that stress prolongs parturition in mammals by
inhibiting oxytocin release in an opioidergic manner. Similarly, stress-related
inhibition of suckling-induced milk ejection in mice is reversed by oxytocin or
naltrexone treatments, again suggesting that opioidergic inhibition of oxytocin
release is involved (Haldar & Bade, 1981).
1.6.5 Opioids and Arginine Vasotocin Release
In both day-old chicks and laying hens, the rise in plasma AVT concentration
associated with elevated plasma osmolality following hypertonic saline injection is
completely prevented by morphine and is enhanced by naloxone (Xu et al., 1991;
Dublecz et al., 1992). It has also been reported that the peak in plasma AVT
concentration accompanying oviposition is increased almost two-fold by treatment
with naloxone (F.Ellendorff, personal communication).
Given that stress inhibits oxytocin release via opioidergic pathways in
mammals, leading to disrupted parturition and milk ejection, and that opioidergic
21
pathways in the hen can inhibit AVT release in response to osmoregulatory stimuli,
it is hypothesised that stress-induced oviposition delays could be due to opioidergic
inhibition of neurohypophysial AVT release.
1.7 Influence of Adrenaline on Uterine Contractions
In the oviduct of hens there are both alpha and beta adrenergic receptors, the
concentrations of which vary between different oviduct segments (Verma & Walker,
1974; Crossley et al., 1980). Adrenergic stimulation of alpha receptors induces
contraction in the smooth muscle of the oviduct while stimulation of beta receptors
causes relaxation. In the uterus the adrenergic receptors are mostly beta while those
in the uterovaginal sphincter are mostly alpha. As a result of this uneven
distribution, adrenergic stimulation causes relaxation of uterine muscle and
contraction of uterovaginal sphincter muscle, both in vitro and in vivo (Sykes, 1955;
Chen & Hawes, 1967; Verma et al., 1977; Crossley et al., 1980; Wechsung &
Houvenaghel, 1987).
Oviposition delays can be induced by injecting hens with adrenaline (Sykes,
1955; Crossley, 1980; Hughes & Gilbert, 1984). Indeed, injections of pituitrin, a
posterior pituitary extract containing AVT, are unable to induce oviposition in hens
that have been injected with adrenaline (Sykes, 1955). The induction of oviposition
delays by exogenous adrenaline is prevented by including propranolol, a beta
adrenergic receptor blocker, in the hens' diet (Crossley, 1983).
The release of adrenaline from the adrenal medulla into the circulation is
involved in mediating an animal's immediate responses to stress, and this has been
demonstrated for birds (Freeman, 1976; Harvey et al., 1984). It has been suggested
that adrenaline released in response to stress might cause oviposition delays by
directly inhibiting uterine contractions (Weiss & Sturke, 1952; Sykes, 1955; Hughes
& Black, 1976; Crossley, 1983). Crossley (1983) reported that saline injections
caused oviposition delays of about 4.5 h duration and that these were prevented by
dietary propranolol. It was suggested that the saline injections were stressful and
induced oviposition delays by causing the release of endogenous adrenaline which
suppressed uterine contractions. It is not known if propranolol can reduce or prevent
induction of oviposition delays by environmental stress.
Bostedt and Rudloff (1983) reported that carazolol, another adrenergic beta-
blocker, reduced the duration of parturition in sows and suggested that the stress of
labour itself causes adrenaline release and a consequent suppression of uterine
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contractions. Prolonged parturition in women may be due partly to increased levels
of circulating adrenaline associated with stress (Lederman et al., 1985). Inhibitory
adrenergic pathways have also been implicated in mechanisms underlying stress-
induced disruption of parturition in mammals (Bontekoe et al., 1977; Bosc &
Nicolle, 1979).
Stress-related beta adrenergic pathways inhibit induction of uterine
contractions (and hence oviposition) by AVT in the lizard Anolis carolinensis, and
by PGF2a in the gecko Haplodoctylus maculatus (Jones et al., 1983; Summers et
al., 1985; Cree & Guillete, 1991). However, at this time the uteri of A. carolinensis
and H. maculatus still respond to PGF2a and AVT, respectively, and so it is likely
that adrenaline is inhibiting the response to specific hormones rather than the ability
of the uterus to contract.
1.8 Outline of Thesis
The aim of this thesis is to describe the induction of oviposition delays by
environmental stress and to investigate the physiological mechanisms underlying
these delays. Several hypotheses accounting for these delays are proposed in
Section 1.5. The experiments reported here investigated two of these hypotheses in
particular: firstly, opioid peptides released in response to stress may inhibit AVT
release; secondly, adrenaline released in response to stress may directly suppress
uterine contractions.
Procedures common to several experiments are described in Chapter 2.
The aim of Chapter 3 is to describe the duration of oviposition delays caused
by social stress (relocation of hens from individual to group cages) and how this is
influenced by the timing of the stress. The suitability of social stress as a model for
investigating the physiological causation of these delays is confirmed.
Consequences of these oviposition delays for eggshell quality are also examined.
The hypothesis that stress delays oviposition by inhibiting neurohypophysial
AVT release predicts that plasma AVT concentrations will rise in association with
delayed oviposition but not during the delay. Furthermore, it predicts that plasma
PG concentrations are elevated both during the delay (as PG induced uterine
contractions are the stimulus for AVT release) and also in association with the
delayed oviposition. An alternative hypothesis, that delays are caused by stress-
related inhibition of ovarian PG release, also makes predictions concerning changes
in plasma PG and AVT concentrations associated with oviposition delays. In order
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to examine these possibilities, the aim of Chapter 4 is to examine changes in plasma
PG and AVT concentrations associated with stress-induced oviposition delays.
The hypothesis that stress delays oviposition by inhibiting AVT release
predicts that elevated uterine contraction frequency, the stimulus for AVT release,
occurs during these delays. The aim of Chapter 5 is to examine uterine contraction
frequencies associated with stress-induced oviposition delays.
If stress-induced oviposition delays are caused by a mechanism other than
inhibition of ovarian PG release, then these same processes might impair the ability
of exogenous PG injections to induce oviposition prematurely. The first aim of
Chapter 6 is to examine the effect of stress on the induction of premature oviposition
by exogenous PGF2a. If oviposition delays are due to a stress-related inhibition of
hormone release (either AVT or PGs) then injections of this hormone (either AVT or
PGs, respectively) should elevate circulating concentrations and end delays by
expelling the eggs. The second aim of Chapter 6 is to see if exogenous AVT or
PGF2a would end stress-induced oviposition delays.
If stress-induced oviposition delays are mediated by endogenous opioids then
their duration should be reduced by blocking the appropriate opioid receptors with
an antagonist. The aim of Chapter 7 is to investigate the effects of opioid receptor
antagonists on the duration of oviposition delays.
If endogenous opioids cause oviposition delays then exogenous opioids
should also do so. Chapter 8 investigates the effects of two exogenous opioids,
morphine and U50,488, on oviposition time.
It is hypothesised that opioids may delay oviposition by inhibiting AVT
release. The aim of Chapter 9 is to investigate the effects of U50,488 on premature
oviposition induction and associated AVT release caused by PGF2a injection.
In mammals a variety of stressors cause the release of endogenous opioids
(Rodgers & Randall, 1988) and it is assumed that this is also the case in hens. The
aim of Chapter 10 is to investigate the effect of social stress on opioid release using
frequency of headflicking in response to alerting stimuli, a putative index of hens'
opioid status, as a behavioural indicator.
It is hypothesised that adrenaline may act via beta adrenergic receptors to
suppress uterine contractions, and hence to delay oviposition, during stress. The aim
of Chapter 11 is to test this hypothesis through treatments with propranolol, a beta
adrenergic receptor blocker.
Chapter 12 provides a general discussion of stress-induced oviposition delays
and their underlying causation.
The method used to calculate when hens would normally have laid for days
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on which there was an experimental manipulation is validated in Appendix 1.
Validation of the radioimmunoassay used to measure AVT in avian plasma is
reported in Appendix 2. An investigation into the possibility that ovulation is also
delayed by social stress is reported in Appendix 3.
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CHAPTER 2: General Materials and Methods
In this chapter the procedures common to most of the experiments in this thesis
are described. Alternatives or modifications to these are described in the appropriate
chapters.
2.1 Animals and Husbandry
Hens (Gallus gallus domesticus) of two commercial egg-laying strains, ISA
Brown and Hisex, were used in this study. Except where Hisex is specified,
experiments used ISA Brown hens. These birds were reared in groups in commercial
brooders from day-old till 4 weeks of age, and then in groups in rearing cages for a
further 12 weeks. At 16 weeks of age the hens were moved to the middle tier of a
battery unit where they were housed individually in alternate cages (0.29 m wide x
0.46 m deep x 0.43-0.51 m high), so that none had immediate neighbours. The
lighting regime was 14L:10D, and lights on time varied from 7.00-9.00 between
experiments so that the peak period of oviposition occurred at a time convenient for the
required observations or manipulations. Food (standard layer mash; 160 g/kg protein,
11.0 MJ/kg metabolisable energy, 33 g/kg calcium) and water were provided ad
libitum. As most eggs were laid in the morning, husbandry procedures such as
feeding and cleaning were done in the afternoon to avoid any influence on morning
oviposition times.
Individual birds were identified by numbered wing bands or coloured leg
rings. Occasionally, when experimental procedures involved housing birds in groups,
individuals were numbered on their combs with a marker pen to facilitate identification
without further handling.
For experiments on oviposition, only hens aged from 24 to 57 weeks were
used. Before this many birds are not yet in regular lay. Towards the end of this
period the lag increases, egg sequence length decreases and the frequency of missing
eggs (e.g. those internally ovulated) increases (Lillpers & Wilhelmson, 1993a). As
this makes it more difficult to predict oviposition times and accurately calculate
expected oviposition times, younger birds were used where possible.
Mean body weights were 1.87 kg at 25 weeks of age (range: 1.7 to 2.1 kg)
and 2.16 kg at 47 weeks of age (range: 1.7 to 2.6 kg).
26
2.2 Recording Oviposition Times
To start with each cage was fitted with automatic oviposition recording
equipment, comprising a flap at the lower end of the sloping floor linked via a
magnetic switch to a digital stop-clock. When an egg rolled down the floor the flap
was deflected thus starting the stop-clock. Later, when the eggs were collected, the
stop-clock times were deducted from the present time to give the time when the egg
rolled out of the cage, and thus an indication of oviposition time. However, it became
apparent that some eggs were not rolling from the cage immediately after oviposition
and occasionally remained in the cage for several hours. Subsequently, cages were
inspected visually every 10-20 min during peak laying hours to allow more accurate
records of oviposition time to be made.
2.3 Definition and Calculation of Oviposition Times (Observed,
Predicted and Expected), Oviposition Delay and Change in Oviposition
Time
Observed Oviposition Time
The time when an egg was actually laid is described as the 'observed
oviposition time'. The observed oviposition time is also referred to as the oviposition
time.
Predicted Oviposition Time
From records of a bird's previous oviposition times it was often possible to
estimate the time of the next oviposition. This estimate is described as the 'predicted
oviposition time' and was used to determine when experimental procedures prior to
oviposition should be carried out.
Expected Oviposition Time
As many of the experiments were designed to examine the effects of different
treatments on oviposition time, it was necessary to calculate the 'expected oviposition
times', i.e. the times when ovipositions would actually have occurred in the absence
of any manipulation. This was done using the records of observed oviposition times
on the days before and after the treatment. In the middle of long egg sequences the
daily lag remains relatively constant, and for the calculations it was assumed that
oviposition time advanced by a similar increment each day. Expected oviposition time
was calculated as the mid-point between the observed oviposition times on the day
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before and the day after treatment. The observed oviposition time for the day before
treatment was always known (an essential prerequisite for treatment to proceed), but
sometimes observed oviposition time was not available for the day after treatment, e.g.
if this egg was laid with a soft shell and was therefore clearly premature. When this
occurred, expected oviposition time was calculated using the observed oviposition
time on the second day after treatment, again assuming that the lag was similar each
day. The assumption that oviposition time advances by a similar amount each day is
not valid for the first and last few eggs in a sequence (see reviews by Johnson (1986)
and Etches (1990)), and thus expected oviposition times could not be calculated for
these days. Consequently, where treatments occurred in either the first three or the
last three eggs in a sequence, these data were excluded from the analyses.
Appendix 1 describes an experiment to assess the accuracy of this method of
calculating expected oviposition time. When the expected oviposition times for 25
ovipositions were calculated using the observed oviposition times on the day before
and on the day after, they were on average 0 min later than the observed oviposition
times (95% confidence limits: -29 to 28 min). When expected oviposition times for
the 25 ovipositions were calculated using the observed oviposition times on the day
before and on the second day after, they were on average -2 min later than the
observed oviposition times (95% confidence limits: -32 to 27 min).
Oviposition Delay and Change in Oviposition Time (A Oviposition Time)
The terms oviposition delay and A oviposition time describe how late an
oviposition is with respect to the expected oviposition time.
The oviposition delay was calculated by deducting the expected oviposition
time from the observed oviposition time. Thus, when oviposition occurs later than
expected the oviposition delay is positive and when oviposition occurs earlier than
expected the oviposition delay is negative. Following the findings in Chapter 3,
oviposition delays longer than three hours were given a score of 180 min for the
analyses. Where it could not be assumed that oviposition delays would be caused by
some of the experimental treatments, the difference between observed and expected
oviposition times is described as the change in oviposition time (A oviposition time).
Thus, where oviposition occurs earlier than expected, A oviposition time is negative.
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2.4 Experimental Design
From a stock of hens whose oviposition times were recorded, an appropriate
number of birds whose next oviposition time could be predicted were selected and
then allocated randomly to the treatments. Before treatment, the presence of a hard-
shelled egg in the uterus of each selected hen was confirmed by palpation, a procedure
which does not influence oviposition time (Juhasz & van Tienhoven, 1964; Hughes et
al., 1986).
Where possible, all birds in an experiment were treated on the same day and
this should be assumed unless otherwise stated. However, because it was often not
possible to confidently predict oviposition times for a sufficient number of birds on
one day and some experimental protocols were too time-consuming to treat all birds on
one day, some experiments took place over several days. On each day, selected birds
were divided evenly and randomly between the treatments. Where appropriate, the
potential for day effects was included in the statistical analysis.
In most experiments, treatments such as injections took place at a specific time
before predicted oviposition time. However, as predicted oviposition time is only an
estimate of expected oviposition time, inevitably there was a range of times (instead of
a fixed time) between the treatment and the expected oviposition time.
2.5 Social Stress
In this thesis, relocation from individual cages to group cages was used as a
standard stressor for the induction of oviposition delays. Several birds, normally
four, were moved from their home cages (described in Section 2.1) to a group cage
(1.16 m wide x 0.46 m deep x 0.50-0.58 m high) in the top tier of a battery. This
procedure, involving both relocation and contact with unfamiliar birds, is referred to
as social stress and is similar to that described by Watt (1989). As a result of the
findings reported in Chapter 3, periods of stress did not normally extended for more
than 3.5 h after the predicted oviposition time.
2.6 Injection and Blood Sampling Procedures
To receive intra-venous (i.v.) injections, birds were restrained on their sides
and the brachial vein (wing vein) exposed by removing a few feathers. Solutions
were injected with the syringe needle (25G) pointing towards the body then, once the
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needle was withdrawn, temporary pressure was applied to the vein to prevent
haematoma. Intra-muscular (i.m.) injections were via the pectoral muscle (breast
muscle) with the bird restrained on its back. Injection volumes were proportional to
body weight.
To obtain a blood sample, the wing vein was exposed as above and 1-2 ml
blood was withdrawn with the syringe needle (25G) pointing away from the body.
Temporary pressure was applied to the vein to prevent haematoma. Blood samples
were transferred immediately to either micro-centrifuge tubes or sample tubes
containing an appropriate anticoagulant, and chilled on ice. For the measurement of
PGFM, 1.35 ml blood samples were placed in 1.5 ml micro-centrifuge tubes
containing 15 [il of 100 mM aspirin (prostaglandin synthesis inhibitor) and 150 p.1 of
3.8% citrate in 0.9% saline (anticoagulant). For AVT measurement, heparin coated
sample tubes were used. Following centrifugation at 1600 g for 10 min, the
supernatant (plasma) was removed and stored at -18°C until required.
2.7 Statistical Analysis
Many of the data obtained in this study were not distributed normally and were
therefore analysed using nonparametric statistical tests, such as the Mann-Whitney test
or sign test (Siegel & Castellan, 1988). When a more complex analysis was required,
e.g. to allow for potential day effects, the data were transformed to produce a more
normal distribution with an even distribution of variance. Parametric tests included the
t-test, analysis of variance (ANOVA) and the General Linear Model (GLM, a form of
analysis of variance which is robust for unbalanced data). When comparing means
with similar variances by t-test, the pooled version of this test was used as this is
slightly more powerful than the standard version. All statistical tests were two-tailed.
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CHAPTER 3: Experiments on the Duration of
Stress-Induced Oviposition Delays and Related
Eggshell Abnormalities
3.1 Introduction
Stressors, such as exposure to unfamiliar hens or relocation to novel
environments, can cause hens to delay oviposition (Scott, 1940; Hughes, 1979;
Hughes et al., 1986; Watt & Solomon, 1988; Watt, 1989). For hens which regularly
lay in nest sites, preventing or hindering access to these sites can also induce
oviposition delays (Duncan, 1970; Kite, 1985; Hughes et al., 1986; Cooper &
Appleby, 1994). When oviposition is delayed for short periods, the egg typically
acquires an additional layer of calcification which overlies the normal eggshell and
is described as "dusting" (Hughes et al., 1986). When oviposition is delayed for
longer periods, the next egg eventually arrives in the uterus and presses against the
delayed egg. As a consequence of this contact, the delayed egg's shell acquires a
"white band" and the second egg's shell is formed with a flattened ("slab") side
(Scott, 1940; van Middelkoop, 1971). Hughes et al. (1986) observed that the mean
duration of oviposition delay was 1.35 h for dusted eggs and at least 13 h for white-
banded eggs. These abnormalities reduce shell porosity of eggs intended for
incubation, thus compromising the embryos' health, (van Middelkoop, 1972), and
make eggs intended for domestic consumption unattractive to consumers (Hughes et
al., 1986). Consequently, these abnormal eggs are downgraded, resulting in loss of
revenue for egg producers. From an animal welfare perspective, eggshell
abnormalities associated with stress-induced oviposition delays might provide a
convenient means of identifying stressful conditions to which hens have been
exposed (Hughes etal., 1986; Mills etal., 1987b, 1991).
Although little is known about how the duration of oviposition delay is
affected by the timing of exposure to environmental stress, all stressors reported to
cause oviposition delays were present at the time when oviposition would normally
be expected. Kite (1985) reported that hens which normally laid in nest boxes would
regularly delay oviposition, for durations often exceeding 24 h, if access to the boxes
was prevented. These hens would lay delayed eggs within a few minutes of nest
boxes being made accessible again. In pilot experiments for the present study,
transport simulation (horizontal vibration at 1 Hz) and relocation from single cages
to group pens caused oviposition delays. Delayed eggs were usually laid within a
few hours of expected oviposition time or not until much later, often during the
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night. Furthermore, it was noted that oviposition often occurred within a few
minutes of stress ending. Transport simulation was not used in subsequent
experiments in this thesis as there were practical difficulties with recording
oviposition time during this.
The aim of the following study was to describe the duration of oviposition
delays caused by social stress and their consequences for eggshell quality with
respect to specific abnormalities. A second aim was to confirm that relocating hens
from individual cages to group cages would induce oviposition delays, as reported
by Watt (1989), and that this manipulation could be used as a standard stressor in
subsequent experiments in this thesis. In Experiment 1, hens were exposed to
periods of stress which started and finished at various times relative to predicted
oviposition time, thus allowing the distribution of oviposition times during stress to
be described and some information to be obtained about the effects of stress ending
after various durations of oviposition delay. Experiment 1 suggested that, for
ovipositions not occurring during exposure to stress, the duration of oviposition
delay (from expected oviposition time) at the time of stress ending influenced the
time from stress ending until observed oviposition time. This relationship was
investigated further in Experiment 2.
3.2 Experiment 1: Duration of Oviposition Delays Caused by Exposure to
Social Stress and Consequences for Eggshell Quality
3.2.1 Materials and Methods
From a stock of 78 hens, a total of 67 whose next oviposition times could be
predicted were selected over 7 days when they were between 43 and 52 weeks of
age. Selected hens were housed together in groups of 4 in an unfamilliar cage
(social stress) for 3-6 h, starting 0-4.5 h before predicted oviposition time (an
unselected stock bird was used to complete the final group of 4).
Eggs laid on the day of exposure to stress and on 2-11 days (mean = 7)
adjacent to this (control eggs) were classified as white-banded, slab-sided or
dusted/normal, as defined by Hughes et al. (1986). The dusted/normal classification
included eggs with no obvious dusting and those with a clearly visible layer of
additional calcification. The level of eggshell dusting on dusted/normal eggs was
measured by reflectometry at the centre of the broad pole, the point at which this
coating is greatest (Mills et al., 1991), as described by Mills et al. (1987a). Briefly,
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the reflectance (of light) of the dry shell was measured using a battery powered
eggshell reflectometer (Sharrard Developments Ltd., York). The eggshell was then
moistened, using a damp swab, to make the layer of additional calcification
transparent and so reveal the darker colour of the underlying eggshell. Wet shell
reflectance was measured and deducted from the dry shell reflectance to give the
dusting score. For heavily dusted eggs, the difference between wet and dry
reflectance measurements is high. It was clear that the level of dusting in the
absence of stress (control eggs) varied greatly between hens. To account for this, the
change in dusting associated with exposure to stress was calculated for each hen by
deducting the basal level of dusting (mean dusting score of control eggs) from the
dusting score of the egg laid on the day of stress.
3.2.2 Results
Duration ofOviposition Delays
For 17 of the 67 hens, expected oviposition time could not be accurately
calculated because records of oviposition times were incomplete (due to failures of
the automatic oviposition recording equipment, see Section 2.2), or because
exposure to stress was within three days of the egg sequence ending. Consequently,
these hens were excluded from the following analysis. Of the remaining 50 hens, 34
laid during stress while 16 did not and still carried their eggs when they were
returned to their original cages (i.e. when stress ended).
Thus, delaying of oviposition during stress ended either because oviposition
occurred during stress or because exposure to stress ended. Both these events
occurred at various times relative to expected oviposition time. In order to describe
the distribution of oviposition times during exposure to stress, instances where
exposure to stress ended before oviposition occurred (and where the actual time
when these birds would have laid if stress had continued is not known) must be
accounted for. This was done by calculating the "survivor function", an analysis
which describes the probabilities of oviposition occurring during stress relative to
time after expected oviposition time.
Calculation of survivor functions is described by Kalbfleisch and Prentice
(1980). Briefly, as the duration of exposure to stress increases relative to expected
oviposition time, the number of hens which have not yet laid and are still exposed to
stress decreases when a hen either lays or is removed from stress. For each of these
events the proportion of hens which could have laid but did not was calculated, i.e.
the probability of an individual laying at this event (probability = number of hens
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carrying an egg after the event / number of hens carrying an egg before the event).
At the time of each event the probability of an individual hen laying at or before this
event was calculated (probability = probability of laying at 1st event x probability of
laying at 2nd event... x probability of laying at latest event). Thus, the survivor
function describes the probability that an individual hen would still be carrying its
egg after various durations of exposure to stress relative to expected oviposition time
(Figure 3.1). From this function it can be seen that the probability of an individual
hen delaying oviposition for more than 1 h (for example) during continued exposure
to stress was 0.6. The maximum oviposition delay for a hen laying during stress was
3.0 h.
Duration of exposure to stress following
expected oviposition time (h)
Figure 3.1 Survivor function for Experiment 1, describing the relationship between
the probability that an individual hen will not yet have laid during exposure
to stress and the duration of exposure to stress after expected oviposition
time. The survivor function +1 SEM and the survivor function -1 SEM are
shown by the upper and lower dotted lines respectively. As duration of stress
increases, sample size decreases (because hens either lay or their exposure to
stress ends) and so SEM increases.
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For the 16 hens not laying during exposure to stress, the relationship between
the time when stress ended and the time when oviposition occurred is shown in
Figure 3.2. Hens usually laid shortly (< 2 h) after exposure to stress ended when this
occurred close to expected oviposition time, i.e. when oviposition delays were still
relatively short. In contrast, when stress did not end until several hours after
expected oviposition time, hens more often held their eggs until much later (> 2 h
after stress ending). The shortest delay beyond which a hen did not lay < 2 h after
stress ending was 2.4 h and the longest delay beyond which a hen laid < 2 h after
stress ending was 3.6 h. Thus, oviposition delays ended either a short time after
stress ending or not until much later and this may be related to a threshold of
between 2.4 h and 3.6 h oviposition delay. The hypothesis that hens become less
able to lay their eggs < 2 h after stress ending when oviposition delay exceeds 2.4 h
was tested in Experiment 2.
For 7 of the 8 hens laying shortly after stress ended, oviposition occurred 8 -
22 min (mean = 16 min) after stress ending (Figure 3.2). Although the 8th hen was
recorded as laying 105 min after stress ending, this may be an overestimate as clocks
triggered by eggs rolling from cages were used to automatically record oviposition
times and this egg might not have rolled from the cage until some time after it was
laid (see Section 2.2). For these 8 hens, the maximum oviposition delay was 3.8 h.
For the 8 hens not laying < 2 h after stress ending, oviposition took place
much later. One hen's egg did not roll from the cage and so observed oviposition
time was not recorded. For this hen, stress ended 2.9 h after expected oviposition
time and oviposition delay was > 5 h. Hen #48 laid after a delay of 23.6 h, at the
expected oviposition time of the next day's egg. There was no other oviposition by
hen #48 on the day after exposure to stress, although a single normal egg was laid on
each of the subsequent days. The times of these subsequent ovipositions suggest that
the egg on the day after stress was ovulated internally. For the other 6 hens, duration
of oviposition delay was 7.1-15.2 h (mean = 12.3 h).
Oviposition delays were classified as short-term if they were less than 5 h in
duration or long-term if they were longer than this. Therefore, oviposition delays
ending during exposure to stress were considered to be short-term. Although
behaviours other than oviposition were not recorded systematically, it was noted that
hens often adopted a characteristic hunched, tail down posture when oviposition
delays did not end shortly after stress ending (long-term delays).
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Figure 3.2 Relationship between the time from expected oviposition time until end
of stress (i.e. the duration of oviposition delay when stress ended) and the
time from stress ending until observed oviposition time. Only hens not
laying during stress in Experiment 1 are shown. The vertical dashed line
indicates 2.4 h, the time beyond which hens appear less likely to lay < 2 h
after stress ending (see text p. 34). Solid circles represent white-banded eggs
and open circles represent eggs with normal or dusted shells. The egg laid by
hen #48 is indicated.
Eggshell Abnormalities
Of the eggs laid following long-term oviposition delays, all but that of hen
#48 were white-banded (Figure 3.2), and in each case the subsequent egg was slab-
sided. Two of these slab-sided eggs were laid prematurely and were soft-shelled.
The delayed egg of hen #48 was heavily dusted (score = 8.11) compared with non
delayed eggs of this hen (mean score = 0.8). Short-term oviposition delays did not
cause slab-side or white-band eggshell abnormalities.
One hen's eggs were always speckled, preventing accurate measurement of
dusting, so were not included in the following analysis. Table 3.1 shows the levels
of eggshell dusting associated with short-term stress-induced oviposition delays.
Possible relationships between the duration of oviposition delay, the level of
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eggshell dusting on the delayed egg (i.e. the egg laid on the day of stress) and the
basal level of eggshell dusting were examined (not including eggs delayed long-
term). The level of dusting on the delayed egg was significantly and positively
correlated with the duration of oviposition delay (Spearman rank correlation
coefficient (rs)=0.342, n=41, P<0.05). There was also a correlation between the
duration of oviposition delay and the change in dusting level, relative to the basal
level, (rs=0.381, n=41, E<0.05). Basal level of eggshell dusting was significantly
and positively correlated with the level of eggshell dusting on the egg laid on the day
of stress (rs=0.649, n=41, P<0.01) but not with the change in dusting level of this
egg, relative to the basal level, (rs =0.020, n=41, P>0.05). When analysing possible
relationships between the basal level of eggshell dusting and the duration of
oviposition delay, hens that laid after stress ended were excluded as their duration of
delay was determined by the stress ending. Duration of oviposition delay and basal
level of dusting were not significantly correlated (rs =0.048, n=34, P>0.05).
Duration of oviposition







Mean dusting of eggs
laid on day of stress
(± SEM)
< 0.5 h 13 0.8 (0.1) a 1.3 (0.2) b
0.5-1.5 h 19 1.2 (0.2) a 2.0 (0.3) c
> 1.5 h 9 1.3 (0.4) a 3.1 (0.9) be
Table 3.1 Effects of short-term oviposition delays, of either < 0.5 h, 0.5-1.5 h
or > 1.5 h duration, on eggshell dusting in Experiment 1. Within rows
(paired t-test) and within columns (t-test), values with no common letter
differ significantly (P<0.05).
3.3 Experiment 2: Stress-Induced Oviposition Delays: Duration, Effects of
Exposure to Stress Ending and Consequences for Eggshell Quality
Experiment 1 suggested a relationship between the duration of oviposition
delay when stress ends and the time from stress ending until oviposition. When
oviposition delay was < 2.4 h, oviposition usually occurred about 16 min after stress
ended. In contrast, when oviposition delay was > 2.4 h, eggs were usually laid
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several hours after stress ending. The aim of Experiment 2 was to test the hypothesis
that oviposition will tend to occur < 2 h after stress ending if oviposition delay is
currently < 2.4 h and will tend to occur > 2 h after stress ending if oviposition delay
is already > 2.4 h. Hens were exposed to social stress for 0.33-6 h starting 1 h before
predicted oviposition time. Thus, it was expected that hens would be returned to
their home cages (when stress ended) with oviposition delays of various durations,
including some < 2.4 h and some > 2.4 h. Unlike Experiment 1, the time from the
start of stress until predicted oviposition time was constant in Experiment 2.
3.3.1 Materials and Methods
From 53 stock hens aged 26 weeks, 47 whose next oviposition times could be
predicted were selected over four days and exposed to social stress starting 1.0 h
before predicted oviposition time. Each hen was randomly allocated to receive one
of 47 possible durations of stress. These were 20, 30, 40 min... until 210 min (i.e. 10
min intervals), then 215, 220, 225 min... until 330 min (i.e. 5 min intervals), then
340, 350 and 360 min. Experiment 1 suggested that a threshold oviposition delay at
the time of stress ending, in the range of 2.4-3.6 h, might influence the time of
ovipositions occurring after stress ends. In the present experiment, it was hoped that
by including more periods of stress of medium duration, information about this
threshold would be maximised. Note that the predicted oviposition times of hens
exposed to short periods of stress (< 60 min) were after stress was due to end. As
several of the four hens in each group cage during stress were selected hens (the rest
being unselected stock birds), and these were all due to be stressed for different
periods, the composition of each group changed frequently.
Eggs laid on the day of exposure to stress, on the 3 days before this and on
the 3 days after this (i.e. 6 control eggs per hen) were classified as either white-
banded, slab-sided or dusted/normal. Shell dusting of dusted/normal eggs was
measured, as described in Section 3.2.1.
3.3.2 Results
Duration ofOviposition Delays
One hen was excluded from the analysis because records of its oviposition
times following treatment were incomplete. Of the remaining 46 hens, 27 laid
during exposure to stress while 19 did not and still carried their eggs when exposure
to stress ended. For these 19 hens, the relationship between the time from expected
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oviposition time until end of stress and the time from the end of stress until observed
oviposition time is shown in Figure 3.3. Numbers of ovipositions occurring either <
2 h or > 2 h after stress ended when oviposition was delayed either < 2.4 h or > 2.4 h
at the time of stress ending are shown in Table 3.2. This distribution differs
significantly from random (Fishers exact test; P<0.05), supporting the hypothesis,
from Experiment 1, that oviposition is more likely to occur < 2 h after stress ending
if it is currently delayed < 2.4 h and is more likely to occur > 2 h after if it is already
delayed > 2.4 h. The longest oviposition delay beyond which oviposition occurred <
2 h after stress ended was 4.3 h and the shortest oviposition delay beyond which
oviposition occurred > 2 h after stress ended was 1.5 h
>2-
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Figure 3.3 Relationship between the time from expected oviposition time until end
of stress (i.e. the duration of oviposition delay when stress ended) and the
time from stress ending until observed oviposition time. Only hens not
laying during stress in Experiment 2 are shown. The vertical dashed line
indicates 2.4 h, the time beyond which hens appeared less likely to lay < 2 h
after stress ending in Experiment 1. Solid circles represent white-banded





Time from stress ending
until observed oviposition
< 2 h > 2 h
< 2.4 h 11 1
> 2.4 h 3 4
Table 3.2 Number of hens laying either < 2 h or > 2 h after stress ended when
oviposition was delayed for either < 2.4 h or > 2.4 h at this time. Only hens
laying after stress in Experiment 2 are included.
12 3 4
Duration of exposure to stress following
expected oviposition time (h)
Figure 3.4 Survivor function for Experiment 2, describing the relationship between
the probability that an individual hen will not yet have laid during exposure
to stress and the duration of exposure to stress after expected oviposition
time. The survivor function +1 SEM and the survivor function -1 SEM are
shown by the upper and lower dotted lines respectively. As duration of stress
increases, sample size decreases (because hens either lay or their exposure to
stress ends) and so SEM increases.
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Observed oviposition times were only recorded for 2 of the 5 hens not laying
within 2 h of stress ending. The durations of these oviposition delays were 11.0 h
and 11.6 h. The other 3 eggs not laid within 2 h of stress ending were all delayed > 5
h.
The distribution of ovipositions occurring during stress is described by a
survivorship function (Figure 3.4), as in Experiment 1. From this function, it can be
seen that the probability of an individual hen delaying oviposition for more than 1 h
(for example) during social stress was 0.6. The maximum oviposition delay for a
hen laying during stress was 2.8 h.
Oviposition delays were classified as either short-term or long-term, as
described for Experiment 1. As in Experiment 1, it was noted that hens tended to
adopt a characteristic hunched, tail down posture when oviposition delays did not
end shortly after stress ending.
Eggshell Abnormalities
All 5 eggs delayed long-term were white-banded when they were eventually
laid (Figure 3.3) and in each case the next egg was slab-sided. Short-term
oviposition delays did not cause either of these eggshell abnormalities.
Table 3.3 shows the levels of eggshell dusting associated with short-term
stress-induced oviposition delays. Possible relationships between the duration of
oviposition delay, the level of eggshell dusting on the delayed egg (i.e. the egg laid
on the day of stress) and the basal level of eggshell dusting were examined (not
including eggs delayed long-term). The duration of oviposition delay was not
significantly correlated with either the level of eggshell dusting on the delayed egg
(rs=0.038, n=41, P>0.05) or the change in level of dusting on this egg, relative to
basal levels, (rs=0.006, n=41, P>0.05). Thus, although exposure to social stress
increased eggshell dusting (Table 3.3), this was not correlated with the duration of
oviposition delay. Basal level of eggshell dusting was significantly and positively
correlated with the level of eggshell dusting on the egg laid on the day of stress
(rs=0.633, n=41, P<0.01) but not with the change in dusting level on this egg,
relative to basal levels, (rs=0.156, n=41, P>0.05). When analysing possible
relationships between the basal level of eggshell dusting and the duration of
oviposition delay, hens that laid after stress ended were excluded as their duration of
delay was influenced by the stress ending. Duration of oviposition delay and basal
level of dusting were not significantly correlated (rs=-0.317, n=27, P>0.05).
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Duration of oviposition







Mean dusting of eggs
laid on day of stress
(± SEM)
< 0.5 h 13 0.8 (0.2) a 1.2 (0.3) ab
0.5-1.5 h 13 0.9 (0.2) a 1.9 (0.5) b
> 1.5 h 15 0.9 (0.2) a 1.9 (0.6) ab
Table 3.3 Effects of short-term oviposition delays, of either < 0.5 h, 0.5-1.5 h or
> 1.5 h duration, on eggshell dusting in Experiment 2. Within rows (paired
t-test) and within columns (t-test), values with no common letter differ
significantly (P<0.05).
3.4 Discussion
In Experiments 1 and 2, relocating hens from individual cages to group cages
containing unfamiliar hens caused many to delay oviposition. This is consistent with
the findings of Hughes et al. (1986), Watt and Solomon (1988) and Watt (1989),
who also found that relocation and contact with unfamiliar hens induced oviposition
delays.
In both Experiments 1 and 2, exposure to social stress ended at different
times relative to expected oviposition time, so hens that did not lay during stress
were returned to their home cages with oviposition delays of various durations. In
Experiment 1 these hens tended to lay < 2 h after stress ended if oviposition delay
was still short (e.g. 1 h) but tended to lay > 2 h after stress ended if oviposition delay
was long (e.g. 4 h). Consequently, it was hypothesised that there may be a threshold
duration of oviposition delay beyond which eggs can no longer be readily laid. In
Experiment 2, the proportion of hens laying < 2 h after stress ending was
significantly affected by the duration of oviposition delay (either < 2.4 h or > 2.4 h),
supporting hypothesis that oviposition becomes less likely after a threshold.
There was a range of oviposition delay durations within which eggs were
either laid < 2 h or > 2 h of stress ending in both Experiment 1 (2.4-3.6 h) and
Experiment 2 (1.5-4.3 h). Perhaps this reflects individual variation in the time of the
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threshold. The hypothesis that hens become unable to lay readily following a
threshold is supported by the observation that they did not lay during stress in either
experiment after delays of more than 3.0 h. Although the threshold is clearly not
described by a single time, for convenience it will be referred to as the 3 h threshold
from here on.
Oviposition can be delayed surgically by fixing a thread around the utero¬
vaginal sphincter to obstruct the passage of the egg. When this thread is removed by
a simple procedure 3 h after expected oviposition time, oviposition does not occur
until much later (Tanaka, 1976; Tanaka et al., 1984), supporting the hypothesis that
a threshold restricts oviposition to within 3 h after expected oviposition time.
Oviposition delays can be classified as either short-term (those occurring
before the threshold) or long-term (those occurring after the threshold). There
appears to be a period of several hours between the threshold and the ovipositions of
long-term delayed eggs when no eggs are laid, i.e. there were no medium duration
oviposition delays.
In both experiments, ovipositions that were delayed usually occurred within
25 min after stress ending when this occurred before the threshold, indicating that
the mechanisms underlying these delays can be reversed within this time. Kite
(1985) also found that hens laid delayed eggs within a few minutes after stress ended
(when closed nest boxes were opened). It is not surprising that oviposition did not
occur soon after stress ending when this was earlier than expected oviposition time
(Experiment 2), as this would have made them premature. Instead, these
ovipositions occurred near their expected times. This suggests that only stress at the
expected oviposition time will delay oviposition and is consistent with previous
reports (Hughes etal., 1986).
Ovipositions delayed beyond the 3 h threshold (long-term) eventually
occurred after delays of 7.1-15.2 h (excluding hen #48) and were sometimes
accompanied by premature oviposition of the next egg. A similar range of
oviposition delays is caused by treatment with indomethacin, a PG synthesis
inhibitor (Hertelendy & Biellier, 1978; Hiura et al., 1982; Saito etal., 1987; Balog &
Hester, 1991). It is not known what causes oviposition of these eggs. Presumably,
an increase in uterine contractions does not normally occur at this time, otherwise
premature expulsion of the soft shelled eggs normally present would result.
Irritation from a loop of thread sutured through the uterine wall causes premature
oviposition (Sykes, 1953b; Lake & Gilbert, 1964; Ogasawara et al., 1974). Perhaps
the presence of two eggs in the uterus (the delayed egg and the subsequent egg)
irritates the uterus, by over stretching it, and so leads to expulsion of the delayed
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egg. These contractions might also account for instances where the subsequent egg
was expelled prematurely.
In Experiment 1, hen #48 delayed oviposition for about 24 h and this egg was
eventually laid at the expected oviposition time of the next day's egg. There was no
evidence of this next egg, but the hen laid normally on subsequent days. Presumably
the egg which would normally have joined the delayed egg in the uterus was
ovulated internally and the uterine contractions for its oviposition expelled the
delayed egg. This is consistent with the above hypothesis that contact between the
delayed egg and the subsequent egg causes oviposition of the delayed egg.
An ovulation is not associated with the last oviposition of a sequence, with
the first ovulation of the next sequence occurring one or more days later. Thus, if
the oviposition of the last egg of a sequence was delayed then another egg would not
join it in the uterus for at least a day. Uterine contraction frequency rises in
association with the first ovulation of a sequence (Shimada & Asai, 1978), and this
might expel a delayed egg. Indeed, when the last oviposition of a sequence is
surgically delayed, by a temporary ligature closing the vagina, it eventually occurs in
association with the first ovulation of the next sequence (Tanaka et al., 1984).
Hence, it is predicted that where the last oviposition of a sequence has been delayed,
the delay will end in association with the first ovulation of the next sequence.
That a threshold prevents oviposition occurring after a delay of
approximately 3 h has not previously been reported and therefore its function and
underlying causation must be considered. In a normal egg cycle, increased uterine
contractions during the period of eggshell formation might expel the egg
prematurely and in a soft-shelled state. Such a loss of potential offspring would
reduce genetic fitness, and so mechanisms may have evolved to prevent uterine
contractions at inappropriate times. These might be responsible for the threshold
beyond which delayed eggs are no longer expelled.
Although several mechanisms for the threshold can be hypothesised,
evaluation of these is related to the understanding of the mechanisms underlying the
stress-induced oviposition delays themselves. For this reason the following
discussion is intended only to introduce these hypotheses and a more detailed
evaluation of their merits is left until the General Discussion (Chapter 12).
Ovarian PG release, which causes uterine contractions and so initiates
oviposition, may be controlled by endocrine changes of the ovulatory cycle (Etches
et al., 1990). Perhaps these endocrine changes define a window, with an upper limit
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defined by the threshold, outwith which this PG release does not occur and hence
oviposition is not initiated.
Although it is not known by how much the ovarian stores of PGs and their
precursors are depleted in association with oviposition, about 30% of
neurohypophysial AVT is released during a normal oviposition (Tanaka & Nakajo,
1962). Perhaps neurohypophysial AVT and/or ovarian PGs are released during
stress-induced oviposition delays and the threshold reflects the time beyond which
their stores are depleted and insufficient remains to cause oviposition.
In hens, oxytocin (and presumably AVT) inactivating enzyme activity of
both uterine tissues and plasma is lowest at the time of normal oviposition and then
rises within a few hours (Gilbert & Lake, 1964; Brzezinska et al., 1967; Brzezinska-
Slebodzinska et al., 1979). Possibly, the threshold is when the half-life of AVT is
reduced to the extent that any released is rapidly degraded and fails to induce
oviposition.
Both AVT and PGF2a injections induce premature oviposition more potently
when injected close to expected oviposition time, compared with other times in the
egg cycle, and this may reflect changing uterine sensitivity to these hormones (Rzasa
& Ewy, 1970; Hertelendy et al., 1975; Goto et al., 1985). Both the number of
uterine AVT receptors and their binding characteristics vary during the egg cycle,
under the influence of ovarian hormones, in such a way that the uterine contraction
inducing potency of circulating AVT is greatest around the normal oviposition time
(Takahashi et al., 1992, 1994). The uterine PG receptors may also show similar
changes (Asboth et al., 1985). Perhaps the threshold is the time beyond which
uterine sensitivity to AVT and/or PGs has reduced to the extent that these hormones
can no longer cause oviposition.
Chapter 7 describes experiments which test the abilities of AVT and PGF2a
injections to induce ovipositions delayed beyond the threshold. If AVT or PGF2a
are unable to expel these eggs then this would support the hypotheses that the
threshold was due to either reduced uterine sensitivity to AVT or PG or reduced
AVT half-life.
In both experiments, many hens laid during exposure to social stress and
there was much variation in the duration of their oviposition delays. Perhaps these
hens became tolerant to the disturbance and so were able to lay their eggs. Some
hens may be less susceptible to this form of stress, e.g. those which were dominant
within their social group, and so delayed their oviposition for shorter periods.
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All eggs delayed long-term, except that of hen #48, were white-banded and
the egg following each was slab-sided, and also soft-shelled if its oviposition was
premature. These abnormalities are caused by contact in the uterus between the
delayed egg and the recently ovulated egg (van Middelkoop, 1971). As discussed
already, the egg after the delayed egg of hen #48 may have been ovulated internally.
Therefore the lack of white-banding on this egg's shell is because no egg pressed
against it in the uterus. Some slab-sided eggs were laid prematurely, and
consequently had soft shells, and this has been reported previously (van Middelkoop,
1971). Eggshell dusting, but not white-banding, often resulted from short-term
oviposition delays. That long oviposition delays cause white-band and slab-side
abnormalities while short delays only cause dusting is in agreement with the findings
of Hughes etal. (1986).
It has been suggested that the maximum proportion of eggs that can be slab-
sided is 50%, as each is paired with a white-banded egg (Ivy et al., 1972). However,
during preliminary investigations for the current experiments, eggs were collected
which were both white-banded and slab-sided. Van Middelkoop (1971) also
reported that eggs may have both slab sides and white bands. This indicates that
oviposition of slab-sided eggs can also be delayed, and therefore more than 50 % of
eggs could, in theory, be slab-sided.
Hens normally laying in nest sites typically do not lay white-banded eggs in
these (van Middelkoop, 1971; R.Freir, personal communication; J.C.Cooper,
personal communication), suggesting that these ovipositions are not accompanied by
the pre-laying behaviours characteristic of normal oviposition. That delayed
ovipositions occur in the absence of pre-laying behaviour has also been observed by
Appleby (1986). Thus, in housing systems with nest sites, stress might cause some
eggs not to be laid in these sites by delaying oviposition so that it occurs in the
absence of pre-laying behaviour. Hence, oviposition delays could be one of the
causes of floor eggs.
The hunched posture of hens delaying oviposition beyond the threshold may
indicate abdominal pain (M.J.Gentle personal communication), possibly caused by
the presence of two eggs in the uterus.
As eggshell dusting is associated with oviposition delays (Hughes et al.,
1986; Watt, 1989), and this deposition of additional calcium carbonate is presumably
not instantaneous, a relationship between the duration of oviposition delay and the
level of eggshell dusting may be expected. Although exposure to social stress
increased the level of eggshell dusting in both Experiments 1 and 2, the level of
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eggshell dusting, and the increase over basal levels that this represented, was
correlated with the duration of oviposition delay only in Experiment 1. That hens in
Experiment 1 (43-52 weeks old) were older than those in Experiment 2 (26 weeks
old) may account for their different eggshell dusting responses to oviposition delay.
Although level of eggshell dusting in the absence of stress may be lower in older
hens (Mills et al., 1991), there are no reports comparing the effects of age on the
dusting caused by exposure to stress.
Hens that regularly lay dusted eggs are more fearful than hens which lay
normal eggs (Jones & Hughes, 1986; Mills et al., 1991). If fearful hens are more
likely to delay oviposition when stressed, the duration of oviposition delay may be
associated with the basal level of dusting. The present study does not support this
suggestion as the duration of oviposition delay was not correlated with the basal
level of eggshell dusting in either experiment.
In both Experiments 1 and 2, level of eggshell dusting on eggs laid on the
day of stress was associated with the basal level of eggshell dusting. This is not
surprising as hens normally laying heavily dusted eggs will presumably lay eggs
with at least that level of dusting on the day of stress. Basal level of eggshell dusting
was not correlated with the increase in eggshell dusting associated with stress,
relative to basal levels, in either experiment, suggesting that hens with high basal
levels of eggshell dusting do not lay down more additional calcium carbonate
(dusting) when stressed than hens with low basal dusting levels.
As a short-term oviposition delay can cause an egg to become dusted while a
long-term delay causes a white-banded egg and a slab-sided egg, the duration of
delay affects both the number of abnormal eggs and the severity of these
abnormalities. Consequently, the findings of this chapter may be of importance to
the poultry industry. Firstly, it appears that only periods of stress which span
expected oviposition times will cause oviposition delays, and this is consistant with
the findings of Hughes et al. (1986). Therefore, restricting disturbances to the
afternoon, when most hens will already have laid (Bahr & Johnson, 1991), should
avoid causing delays and related eggshell abnormalities. Secondly, the 3 h threshold
means that any unavoidable disturbances in the morning should be restricted to short
periods, perhaps 1-2 h, separated by 1 h of no disturbance. As hens usually lay
within 25 min of stress ending when oviposition delay is < 2 h, any ovipositions
delayed by the disturbance should then occur during the periods of no disturbance.
From an animal welfare perspective, the present findings support the view
(Hughes et al., 1986; Mills et al., 1987b, 1991) that certain eggshell abnormalities
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are caused by environmental stress, and so may provide a means of detecting such
disturbances. Although white-banded and slab-sided eggs clearly reflect oviposition
delays, the association between dusting and stress is less robust as this defect can
occur in the absence of stress and may be affected by the hen's age (Nys, 1991; Mills
etal., 1991).
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CHAPTER 4: Plasma PGFM and AVT
Concentrations Associated with Stress-Induced
Oviposition Delays
4.1 Introduction
Oviposition is initiated by the release into the circulation of PGs, including
PGF2a, from the ovarian follicles (see Shimada & Saito (1989) for a review). These
PGs increase the contraction frequency of uterine muscles and so trigger release of
neurohypophysial AVT into the circulation. AVT further promotes uterine
contractions, both directly and by stimulating synthesis of PGs within the uterine
tissues themselves. The peripheral plasma concentrations of 13,14-dihydro-15-keto
prostaglandin F2a (PGFM), a more stable but less active metabolite of PGF2a, and
PGF2a are directly correlated (Olson & Flertelendy, 1981). Peripheral plasma PGFM
concentration rises in association with oviposition and this is thought to reflect ovarian
PGF2a release (Hammond et al., 1980; Olson & Hertelendy, 1981; Olson et al.,
1986; Etches et al., 1990). Plasma AVT concentration rises about four-fold in
association with oviposition (Arad & Skadhauge, 1984; Tanaka et al., 1984; Rice et
al., 1985; Shimada et al., 1986; Koike et al., 1988). This rise starts about 5 min
before oviposition, reaches a maximum at the time of oviposition and then rapidly
decreases in the following 5 min.
A variety of environmental stressors can cause hens to delay oviposition
(Scott, 1940; Hughes, 1979; Hughes et al., 1986; Watt, 1989). Several mechanisms
by which stress might cause oviposition delays are hypothesised in Section 1.5. One
hypothesis is that stress causes an opioidergic inhibition of neurohypophysial AVT
release, a mechanism similar to that known to underlie stress-induced disruptions of
parturition and lactation in mammals (e.g. Haldar & Bade, 1981; Petherick et al.,
1993). A second hypothesis is that stress may inhibit ovarian PG release.
The hypothesis that stress-induced oviposition delays are due to inhibition of
AVT release leads to some predictions about the changes in plasma AVT concentration
associated with these delays. Firstly, AVT concentration should not rise to the levels
associated with normal oviposition during oviposition delays. If AVT concentration
was to rise during delays then stress would not be inhibiting its release and another
mechanism must be responsible for delaying oviposition. Secondly, AVT
concentration should rise in association with delayed oviposition. If this does not
occur then AVT would clearly not be essential for expulsion of the egg and therefore
inhibition of AVT release would be an unlikely cause of delays. This possibility must
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be considered as hens which have been neurohypophysectomised or treated with AVT
antiserum lay normally and this has cast doubt on the importance of AVT in the
oviposition process (Shirley & Nalbandov, 1956; Opel, 1965; Nakada et al., 1993,
1994).
As ovarian PG release initiates oviposition and triggers AVT release (via
uterine contractions), the hypothesis that stress-induced oviposition delays are due to
inhibition of AVT release also allows predictions concerning plasma PG
concentration. Firstly, PG concentration should rise at delayed oviposition.
Secondly, PG concentration should rise during oviposition delays. If this stimulus for
AVT release does not occur, the oviposition delays may not be due to inhibition of
AVT release.
If the second hypothesis, that stress-induced oviposition delays are due to
inhibition of ovarian PG release, is correct then PG concentration should rise at
delayed oviposition but not during the delay. Furthermore, AVT concentrations
should not rise during these delays as the stimulus for this, PG induced increase in
uterine contraction frequency, would not occur.
The aim of this study was to measure the changes in plasma PGFM and AVT
concentrations associated with stress-induced oviposition delays. In particular are
these concentrations elevated at delayed oviposition or during the delays?
To fully test for possible rises in plasma PGFM or AVT concentration during
oviposition delays, ensuring that any short duration rises are detected, would require
frequent removal of blood samples. There are two reasons why this was not
practicable. First, due to assay constraints, plasma PGFM and AVT concentrations
could only be measured in a limited number of samples. Second, formation of
haematoma often hinders serial sampling from wing veins. Although cannulating a
wing vein would allow more samples to be taken, it is not known in advance which
hens will be used in an experiment and therefore require this surgery. In the following
experiments a single blood sample was taken during each oviposition delay. Thus,
prolonged increases in hormone concentration should be detected, although short
duration increases might not be.
Experiment 1 describes changes in plasma PGFM concentration associated
with normal ovipositions and those delayed in response to social stress. In this
experiment measurements of PGFM concentration associated with normal ovipositions
were not directly comparable to those associated with delayed ovipositions and the
PGFM assay was not fully validated. Therefore, although the data obtained are
reported, further investigation involving a more balanced experimental design and a
full validation of the assay will be required before firm conclusions can be made.
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Experiment 2 describes changes in plasma AVT concentration associated with normal
ovipositions and those delayed in response to social stress.
4.2 Experiment 1: Plasma PGFM Concentrations Associated with
Stress-Induced Oviposition Delays
The aim of this experiment was to investigate plasma PGFM concentrations
associated with stress-induced oviposition delays. In particular, is PGFM
concentration elevated during these delays or at delayed oviposition?
4.2.1 Materials and Methods
From 35 stock hens aged 34 weeks, 9 whose next oviposition times could be
predicted were selected. In order to measure plasma PGFM concentrations associated
with normal oviposition, these hens were blood sampled 30 min before predicted
oviposition time, immediately after observed oviposition and 30 min after observed
oviposition (control treatment). Over three subsequent days, a further 13 hens whose
next oviposition times could be predicted were selected. In order to induce oviposition
delays, these hens were each exposed to a period of social stress starting 45 min
before predicted oviposition time (stress treatment). Blood samples were taken 30 min
before predicted oviposition time (during stress) and 30 min after predicted oviposition
time (during oviposition delay and during stress). Social stress was ended after the
second blood sample by returning each hen to its original cage. From Chapter 3, it
was expected that these hens would lay about 15 min after stress ended. A final blood
sample was taken immediately after these delayed ovipositions.
Blood samples were placed in micro-centrifuge tubes containing aspirin and
citrate (a prostaglandin synthesis inhibitor and an anti-coagulant, respectively; see
Section 2.6) and these were separately prepared for control and stress treatments.
Plasma PGFM concentrations were determined in duplicate by R.W.Kelly using the
assay procedure described by Harrison (1990). This assay has been validated for use
in human but not avian plasma. Therefore, to confirm a linear relationship between
actual and measured PGFM in avian plasma, stock plasma (taken immediately after
oviposition and therefore expected to have a high PGFM concentration) was serially
diluted with 0.9% saline.
Mean PGFM concentrations were compared between treatments by t-test
(pooled where standard deviations were similar) and between blood sampling times
within each treatment by paired t-test.
4.3.2 Results
Of the 13 hens exposed to social stress, 4 laid during stress and before 30 min
after predicted oviposition time and so were excluded from the assay and the analysis
(thus, n=9 for stress and control treatments).
The changes in mean plasma PGFM concentration associated with ovipositions
of undisturbed hens and those of hens exposed to social stress are shown in Table
4.1. Although PGFM concentration was higher immediately after oviposition than at
other sampled times for control hens, this was not significant. For the stress
treatment, PGFM concentration was significantly higher at oviposition than at other
Minutes after expected ng/ml PGFM.
Treatment Blood sample oviposition time.
Mean (±SEM)
Mean (±SEM)
control before oviposition -32.8 (5.9) 16.8 (13.4) abc
control immediately after
oviposition 1.4 (5.4) 32.4 (10.1) a
control after oviposition
27.2 (5.5) 14.4 (3.2) ab
stress before expected
oviposition time -28.4 (5.2) 2.8 (0.7) c
stress during oviposition
delay 33.3 (5.4) 7.7 (1.4) b
stress immediately after
oviposition 49.6 (4.3) 74.4 (13.9) d
Table 4.1 Mean blood sampling times and mean plasma PGFM concentrations
associated with ovipositions of undisturbed hens (control, n = 9) and
ovipositions of hens exposed to social stress (stress, n = 9). Mean PGFM
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Figure 4.1 Measured PGFM concentrations for plasma serially diluted with saline,
concentration was measured twice for undiluted plasma.
times. PGFM concentration was significantly higher at delayed oviposition (stress
treatment, mean oviposition delay = 48 min) than at normal oviposition (control
treatment, mean oviposition delay = 0 min). During oviposition delays PGFM
concentration was significantly higher than before expected oviposition time.
For the control treatment, the plasma PGFM concentration in one blood sample
taken 30 min before predicted oviposition time (123.8 ng/ml) was much higher than in
the other 8 samples taken at this time (mean = 3.4 ng/ml, SEM = 0.9). If this high
value is omitted, mean PGFM concentration before oviposition in control birds is
significantly lower than that at oviposition or at 30 min after predicted oviposition time
for both stress and control treatments. This mean PGFM concentration (3.4 ng/ml) is
similar to that for blood samples taken at the equivalent time (i.e. 30 min before
predicted oviposition time) from hens exposed to stress (2.8 ng/ml).
Halving dilutions of plasma with saline did not have a linear effect on PGFM
concentration (Figure 4.1).
4.3 Experiment 2: Plasma AVT Concentrations Associated with Stress-
Induced Oviposition Delays
The aim of this experiment was to investigate plasma AVT concentrations







elevated during these delays or at delayed oviposition? The design of this experiment
was improved, relative to Experiment 1, by randomly allocating hens between control
and stress treatments each day, so that data were balanced for potential day effects,
and by changing the time when stress ended (see below). The assay used to determine
AVT concentrations is validated in Appendix 2.
4.3.1 Materials and Methods
From 48 stock hens aged 25 weeks, 5-7 whose next oviposition times could
be predicted were selected on each of four days and randomly (but unevenly) divided
between control (n = 2-3 each day; total = 10) and stress (n = 3-5 each day, total = 15)
treatments. Except for the removal of three blood samples, one 30 min before
predicted oviposition time, one immediately after oviposition and one 30 min after
oviposition, hens of the control treatment were not disturbed to allow oviposition to
occur normally.
Hens allocated to the stress treatment were each exposed to a period of social
stress starting 45 min before and ending 45 min after predicted oviposition time (thus,
total duration = 90 min) in order to induce oviposition delays. From Chapter 3, it was
expected that many of these hens would lay about 15 min after stress ended, i.e. with
oviposition delays of around 60 min duration. Since some hens were expected to lay
during exposure to stress, more were allocated to the stress treatment than to the
control treatment each day. Blood samples were taken from these hens 30 min before
predicted oviposition time (during stress), 30 min after predicted oviposition time
(during oviposition delay and during stress) and immediately after ovipositions
occurring when stress ended. If stress had ended immediately following the second
blood sample and oviposition occurred soon after, it would not be known if this
oviposition would have occurred had the stress continued. Therefore, it would not be
possible to dissociate any high AVT concentration in a second blood sample from the
oviposition. It was in order to avoid this problem that stress was continued for 15 min
beyond the second blood sample (i.e. until 45 min after predicted oviposition time).
For 1 of the 10 hens allocated to the control treatment, the blood sample
immediately after oviposition was not taken. For a second hen, blood sample volumes
were small. For a third hen, expected oviposition time (retrospectively estimated) was
later than predicted oviposition time (prospectively estimated) so that the first blood
sample was taken only 2 min before expected oviposition time. As plasma AVT
concentration could only be measured for a limited number of blood samples, those
from these 3 hens were excluded. Of the 15 hens allocated to receive social stress, 4
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laid during the stress period (mean oviposition delay = 36 min), 2 did not carry hard-
shelled eggs on the day of treatment (possibly due to internal ovulation) and, for a
seventh hen, haematoma formed during removal of the first blood sample and
prevented removal of subsequent samples. For 2 of the 8 remaining hens, expected
oviposition time was more than 30 min before predicted oviposition time so that the
second blood samples were earlier than, and the stress periods ended close to (11 min
before and 8 min after), expected oviposition time. These 9 hens were excluded from
the assay and the analysis.
Thus, plasma AVT concentration was measured in blood samples from 7
control treatment and 6 stress treatment hens. These hens represented each treatment
on each day. Plasma AVT concentrations were measured using an AVP
radioimmunoassay kit as described in Appendix 2. Results presented are corrected for
extraction efficiency.
Mean AVT concentrations were compared between treatments by t-test (pooled
where standard deviations were similar) and between blood sampling times within
each treatment by paired t-test.
4.3.2 Results
Changes in mean plasma AVT concentration associated with ovipositions of
control hens and those of hens exposed to social stress are shown in Table 4.2. For
one hen (stress) the first blood sample was not included in the analysis as it was taken
8 min after expected oviposition time. For control hens, AVT concentration was five¬
fold higher at oviposition compared to 30 min earlier and returned to basal levels
within 30 min. Mean AVT concentration at delayed oviposition (stress treatment,
mean oviposition delay = 54 min) was similar to that at normal oviposition (control
treatment, mean oviposition delay = 1 min). Mean plasma AVT concentration during
oviposition delay was not elevated relative to other non-oviposition times. There is no
evidence to suggest that AVT concentration was elevated in any of the blood samples
taken during oviposition delays (maximum AVT concentration = 41.6 pg/ml). Social
stress did not alter mean AVT concentration at 30 min before expected oviposition
time.
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Minutes after expected pg/ml AVT.
Treatment Blood sample n oviposition time.
Mean (+SEM)
Mean (+SEM)
control before oviposition 7 -30.6 (3.9) 31.8 (4.4) a
control immediately after
oviposition 7 2.3 (5.6) 158.4 (15.6) b
control after oviposition
7 31.1 (5.1) 30.6 (3.8) a
stress before expected
oviposition time 5 -30.6 (5.3) 30.5 (6.1) a
stress during oviposition
delay 6 33.7 (7.6) 27.4 (5.3) a
stress immediately after
oviposition 6 54.7 (4.5) 157.5 (14.1) b
Table 4.2 Mean blood sampling times and mean plasma AVT concentrations
associated with ovipositions of undisturbed hens (control) and ovipositions of
hens exposed to social stress (stress). Mean AVT concentrations with a
common letter do not differ significantly (P>0.05). Mean AVT concentrations
with no common letter differ significantly (PcO.Ol).
4.4 Discussion
In Experiment 1, control and stress treatments were carried out on separate
days and for each micro-centrifuge tubes containing citrate and aspirin were separately
prepared. Therefore, potential effects of day and micro-centrifuge batch were not
controlled for in the comparison of stress and control treatments. Furthermore,
halving dilutions of plasma did not produce a linear change in PGFM concentration
and so the use of this assay for measuring PGFM in avian plasma was not validated.
Given these problems, the results must be interpreted cautiously and a further
experiment with a validation of the assay will be required before firm conclusions can
be made.
In control hens, PGFM concentration was elevated, although not significantly,
at the time of oviposition. That PGFM concentration rises in association with
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oviposition has been reported previously (Hammond et al., 1980; Olson &
Hertelendy, 1981; Olson et al., 1986; Etches et al., 1990). PGFM concentrations
recorded here, both before (16.8 ng/ml) and at oviposition (32.4 ng/ml), were much
higher than those reported previously, e.g. 0.27 ng/ml before oviposition and 1.75
ng/ml at oviposition (Olson & Hertelendy, 1981). In the present study PGFM
concentration was lower at 30 min before normal oviposition than at 30 min after
normal oviposition (control treatment), and this is consistent with previous reports
(Olson & Hertelendy, 1981).
For hens exposed to stress, PGFM concentration was higher at delayed
oviposition than during the delays or before expected oviposition time, presumably
reflecting ovarian PG release in association with these ovipositions. This is consistent
with the view that PG release causes oviposition (Shimada & Saito, 1989). During
oviposition delays, PGFM concentration was higher than before expected oviposition
time, and this may be due to ovarian PG release. The hypothesis that stress delays
oviposition by inhibiting AVT release predicts that ovarian PG release, indirectly the
stimulus for AVT release, should occur during these delays. The finding that PGFM
concentration was elevated during oviposition delays, relative to before expected
oviposition time, is consistent with this hypothesis. However, compared with the
control treatment, PGFM concentration at 30 min after expected oviposition time was
lower in hens exposed to stress. Due to the experimental design, the contribution of
factors other than treatment, e.g. micro-centrifuge batch, towards this difference
cannot be assessed. If stress does reduce plasma PGFM concentration then
oviposition delays may be due to inhibition of ovarian PG release. Although PGFM
concentration was significantly higher at delayed oviposition than at normal
oviposition, it is not clear why this should be so, although factors other than treatment
may again contribute towards this difference.
In control hens, AVT concentration rose five-fold in association with normal
oviposition and this is consistent with previous reports (Arad & Skadhauge, 1984;
Tanaka etal., 1984; Rice etal., 1985; Shimada et al., 1986; Koike et al., 1988). AVT
concentrations recorded here, both before (31.8 pg/ml) and at oviposition (158.4
pg/ml), were higher than those reported previously, e.g. about 20 pg/ml before
oviposition and about 80 pg/ml at oviposition (from the figures of Tanaka et al.
(1984)). For hens exposed to stress, AVT concentration rose in association with
delayed oviposition, reaching concentrations similar to those associated with normal
oviposition. Therefore, AVT release may be an important component of the
oviposition process. AVT concentration was not elevated in any of the blood samples
taken during oviposition delays, supporting the hypothesis that stress causes
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oviposition delays by inhibiting AVT release. In mammals, stress-related disruptions
to parturition and lactation are due to opioidergic inhibition of oxytocin release (e.g.
Leng & Russell, 1989). Stress may similarly inhibit AVT release in hens and so delay
oviposition. The alternative hypothesis, that delays are due to inhibition of ovarian
PG release, also predicts that AVT release will occur at delayed oviposition but not
during the delay (see Introduction). Indeed, any oviposition delaying mechanism
which prevents the stimulus for AVT release (PG induced uterine contractions), e.g.
direct adrenergic suppression of uterine contractions, should cause the observed
changes in AVT concentration. Therefore, the present findings are also consistent
with the hypothesis that stress causes oviposition delays by preventing the stimulus
for AVT release, i.e. PG induced uterine contractions.
In this study a specific type of stress-induced oviposition delay was
considered, i.e. around 55 min duration with oviposition occurring about 15 min after
stress ending, and this warrants justification. This was the shortest duration of delay
during which a blood sample could be taken about 30 min after expected oviposition
time. If stress was continued for longer than 30 min (Experiment 1) or 45 min
(Experiment 2) past predicted oviposition time, then a greater proportion of hens
would be expected to lay during stress. Blood samples were taken at delayed
ovipositions which occurred shortly after stress ending rather than those occurring
during stress for practical reasons. It was not possible to continually observe hens
during stress in order to remove blood samples immediately after oviposition. Ending
stress, allowing oviposition to occur about 15 min later, made oviposition time more
predictable, and it was this predictability that allowed delayed ovipositions to be
sampled accurately.
To summarise, plasma PGFM concentration was elevated in association with
both normal ovipositions and those delayed for about 50 min in response to social
stress. For hens exposed to stress, plasma PGFM was significantly higher during
oviposition delays than before expected oviposition time, possibly reflecting release of
ovarian PGs and so supporting the hypothesis that stress-induced oviposition delays
are due to inhibition of AVT release. However, further investigation and validation of
the assay will be required to verify these findings. Plasma AVT concentration was
elevated in association with both normal ovipositions and those delayed for about 50
min in response to social stress and there was no evidence of elevated plasma AVT
concentration during oviposition delays. This suggests that oviposition delays are due
to inhibition of AVT release and/or the stimulus for this, i.e. PG induced uterine
contractions.
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CHAPTER 5: Recording Uterine Contractions in
vivo with Extraluminal Strain Gauge Transducers
5.1 Introduction
Uterine contraction frequency varies in a characteristic manner during the daily
egg laying cycle (Shimada & Asai, 1978; Shimada & Etches, 1986; also see Section
1.4.1). In the 5-6 h after oviposition, while there is no egg in the uterus, contraction
frequency is low (< 5 per min). Once an egg enters the uterus, contraction frequency
increases to about 10 per min and this is maintained until just before oviposition. At
that time contraction frequency rises two-fold, to about 20 per min, and this causes
expulsion of the egg in about 3 min. Ovarian PGs and neurohypophysial AVT are
released in association with oviposition and their elevated plasma concentrations are
thought to cause the increase in contraction frequency (Shimada & Saito, 1989).
Indeed, a two-fold rise in contraction frequency, similar to that associated with normal
oviposition, accompanies ovipositions induced prematurely by injection of PGF2a
(Shimada & Asai, 1979).
Several lines of evidence suggest that ovarian PG release causes an increase in
uterine contraction frequency which then triggers AVT release (see review by Shimada
and Saito (1989) and Chapter 1 p. 14). This AVT acts to further promote uterine
contractions, both directly and by stimulating PG production within the uterine
tissues. As contractions (induced by PGs) act as the stimulus for AVT release and are
also caused by the AVT once it is released, it is not known how much, or for how
long, contraction frequency must be elevated to stimulate AVT release. Although
investigating uterine contraction frequencies of neurohypophysectomised hens (in
which AVT release is not thought to occur; see Chapter 1 p. 14 & 15) might be a useful
way to describe this trigger for AVT release, these experiments have not yet been
reported. As AVT presumably causes further AVT release by inducing uterine
contractions, a positive feedback loop is formed and is thought to have a cascading
effect on the development of uterine contractions (see review by Shimada and Saito
(1989) and Chapter 1 p. 10).
A variety of stressors, such as relocation to novel environments and exposure
to unfamiliar hens, can cause hens to delay oviposition (Scott, 1940; Hughes, 1979;
Hughes et al., 1986; Watt, 1989). One hypothesis to explain these delays is that AVT
is important for expelling the egg and a stress-related opioidergic inhibition of AVT
release prevents oviposition (see Chapter 1). Thus, it is suggested that stress disrupts
the AVT-related escalation of uterine contraction frequency that follows, and is
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initiated by, a rise in uterine contraction frequency induced by ovarian PGs. This
hypothesis predicts that an increase in uterine contraction frequency, the stimulus for
AVT release, should occur at the expected oviposition time when oviposition is
delayed in response to stress. If this stimulus does not occur, then opioidergic
inhibition of AVT release may not be the primary cause of stress-related oviposition
delays. Instead, this would suggest an alternative hypothesis in which stress acts to
prevent the stimulus for AVT release. Therefore if an increase in uterine contraction
frequency during oviposition delay, which may be the stimulus for AVT release, was
identified then this would support the hypothesis that inhibition of AVT release causes
the delays.
The aim of this study was to investigate the uterine contraction frequencies
associated with stress-induced oviposition delays. In particular, is there any evidence
to suggest that frequency is elevated at expected oviposition time, i.e. is the stimulus
for AVT release present?
Muscle contractions can be monitored by recording electromyographic (EMG)
activity with implanted electrodes and this technique has been used to investigate the
frequency of uterine muscle contractions in hens (e.g. Shimada, 1978; Roche &
Brard, 1978). Contractions can also be monitored by directly recording movements of
the muscle. Strain gauge transducers (SGTs) have been used to directly record
contractions of uterine muscle in rabbits (Hawk et al., 1982), ewes (Hawk & Conley,
1985) and cows (Burton et al. 1987). Although SGTs have been used to record
contractions of various sections of the avian gut (Duke & Kostuch, 1975, Savory et
al., 1981), their use for recording avian uterine contractions has not been reported.
As the expertise and equipment for recording muscle contractions by SGT was
available, this technique was used to monitor the frequency of uterine contractions.
As this use of SGTs has not previously been reported, a second aim of this study was
to assess the suitability of SGTs for recording avian uterine contractions.
Unfortunately, the SGTs used had fragile wires which often broke preventing the
recording of uterine contractions in many hens. For this reason a full investigation of
the changes in uterine contraction frequency associated with oviposition delays was
not possible and SGT recordings from only two hens are presented.
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5.2 Changes in Uterine Contraction Frequency Associated with Normal
Oviposition, Oviposition Delayed by Stress and Oviposition Induced
Prematurely by PGF2a Injection
To validate the use of SGTs for recording uterine contractions, recordings
associated with normal oviposition and oviposition induced prematurely by PGF2a
injection were compared with published reports. Uterine contractions associated with
oviposition delayed in response to environmental stress were then recorded.
5.2.1 Materials and Methods
Hens known to lay eggs in long and predictable sequences were used in this
study. Following overnight food deprivation, anaesthesia was induced with 3% and
maintained with 2.5% halothane in 2 1/min O2. Via an abdominal incision, a SGT was
sutured through each corner onto the extraluminal uterine wall. The recording lead
was passed subcutaneously to emerge at a plug between the hen's shoulders. During
initial operations it proved difficult to identify the uterine portion of the oviduct in the
absence of an egg and so subsequent operations were performed in the morning when
hens were carrying hard-shelled eggs. These eggs were either released during the
operations or laid a few hours after. The position of the SGT on the oviduct was
confirmed by post-mortem examination.
The SGTs were provided by G.E.Duke (University of Minnesota, USA).
They were 14 x 10 x 2.5 mm, and were embedded in a silastic envelope with wires in
1.5 mm diameter silastic tubing. Their construction was described by Bass and Wiley
(1972) and their use for measuring gut motility in birds by Duke and Kostuch (1975)
and Savory et al. (1981). Flexing SGTs alters their electrical resistance and so they
record changes in muscle shape and not changes in muscle tension.
Uterine contractions were recorded via a lead connecting the plug in the hen's
back to a paper recorder (Elcomatic) with conditioning amplifiers (Fylde), a procedure
that did not inhibit the hens' movements. During recording, hens were continuously
observed to ensure that the lead did not become detached or trapped. For each
recording trace the number of uterine contractions in each 2 min period was counted
manually. Examples of these traces can be seen in Figure 5.1. In some recordings
peaks appeared to have two components. It was assumed that these components
reflected the contractions of longitudinal and circular muscles and so each double peak
was counted as a single contraction.
Uterine contractions associated with normal oviposition were recorded from
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hens in their home cages. Delayed oviposition was induced by relocation to a circular
plastic cage (40 cm in diameter, 43-51 cm high) in an unfamiliar room. This stressor
was used as exposure to unfamiliar hens, social stress, might disrupt the direct lead
recording procedure. Uterine contractions associated with oviposition prematurely
induced by 0.5 fig/kg PGF2a (as described in Section 6.2) were also recorded.
5.2.2 Results
Due to problems with SGT wires snapping, information about uterine
contractions associated with oviposition was obtained from only two hens (#538 and
#555). For some recordings there was much background "noise", presumably due to
respiration and movements of other organs close to the SGT, and this made
identification of uterine contractions more difficult. Typical recordings of uterine
contractions 20 min before and immediately before normal oviposition are shown in
Figure 5.1.
Figure 5.2 shows the uterine contraction frequencies associated with one
normal oviposition of hen #538. Figure 5.3 shows the uterine contraction frequencies
associated with three normal ovipositions and one oviposition induced prematurely by
PGF2a injection for hen #555. A two-fold rise in uterine contraction frequency, from
20-25 in 2 min to 40-50 in 2 min, starting approximately 3 min before the egg was
expelled was associated with each of these ovipositions. Once the egg was expelled
the amplitude of the SGT recordings became very small and it was usually not
possible to identify further contractions.
Uterine contraction frequencies associated with relocation to an unfamiliar
environment and the resulting oviposition delay (47 min) are shown for hen #555 in
Figure 5.4. There was no apparent effect of relocation on contraction frequency
before oviposition. Figure 5.4 does not indicate any elevation of contraction
frequency, relative to basal levels, at expected oviposition time or during the
oviposition delay. Uterine contraction frequency rose about two-fold in association




Figure 5.1 Typical SGT recordings of uterine contractions 20 min before normal
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Figure 5.2 Uterine contraction frequencies of hen #538 associated with one normal
oviposition. Solid arrow indicates observed oviposition time. On the



































Figure 5.3 Uterine contraction frequencies of hen #555 associated with three
normal ovipositions (A, B and C) and one oviposition induced prematurely by
0.5 P-g/kg PGF2a (D). As in Figure 5.2, horizontal axes show time after
expected oviposition time. Solid arrows indicate observed oviposition time.
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Figure 5.4 Uterine contraction frequencies of hen #555 associated with one
oviposition delayed by relocation to an unfamiliar environment. Hollow
circles indicate contraction frequencies before relocation and solid circles
indicate contraction frequencies after relocation. As in Figure 5.2, negative
values on the horizontal axis indicate frequencies recorded before expected
oviposition time.
5.4 Discussion
A two-fold rise in uterine contraction frequency from about 10 to 20 per min,
starting about 3 min before the egg was expelled, was recorded in association with
normal ovipositions. This change in frequency, measured by SGT, is the same as that
measured previously by EMG (Shimada & Asai, 1978; Wechsung & Houvenaghel,
1988). A similar change in contraction frequency accompanied oviposition induced
prematurely by PGF2a injection and this is also consistent with published reports
(Shimada & Asai, 1979). These similarities between the present study, using SGT,
and published studies, using EMG, suggest that both are recording the same events
and so validate the use of SGTs for recording uterine contractions.
The change in uterine contraction frequency associated with an oviposition
occurring after a short delay (47 min) was similar to that associated with normal
ovipositions, and there was no evidence of increased frequency at expected
oviposition time during the delay. One hypothesis to explain stress-induced
oviposition delays is that they are due to inhibition of AVT release. If this hypothesis
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is correct then an increase in uterine contraction frequency induced by ovarian PGs,
the stimulus for AVT release (Shimada & Saito, 1989), should occur at expected
oviposition time. There are two possible reasons why no such increase was found in
the present study. First, contraction frequency was elevated during the oviposition
delay (in a way that would normally initiate oviposition) but this increase was not
detected because it was either too small in magnitude or too short in duration. Thus,
the hypothesis that oviposition is delayed by inhibition of AVT release may be correct
but the experimental technique used here was not sensitive enough to detect the rise in
contraction frequency that stimulates AVT release. Second, an increase in contraction
frequency did not occur and so the hypothesis is incorrect. Instead, oviposition is
delayed because the stimulus for AVT release does not occur. Perhaps stress delays
oviposition by preventing ovarian PGs from inducing uterine contractions, possibly
by a direct adrenergic suppression of these muscles, or by inhibiting PG release. As
neither the magnitude nor duration of the increase in uterine contraction frequency
required to trigger AVT release have been described (see Introduction), it is not
possible to differentiate between these two interpretations. Furthermore, only one
delayed oviposition was recorded here and further investigation will be required before
firm conclusions can be drawn.
One way in which the stimulus required for AVT release could be described is
to measure uterine contraction frequencies associated with injections of exogenous
PGs. By injecting doses ranging from those too low to cause oviposition to those
which do cause oviposition, it might be possible to describe the maximum increase in
uterine contraction frequency which does not initiate oviposition. This would suggest
the minimum stimulus required to induce oviposition and presumably AVT release.
A second aim of this study was to investigate the suitability of SGTs for
recording avian uterine contractions. Although changes in contraction frequency
recorded in association with four normal ovipositions and one induced prematurely by
PGF2a injection were similar to published reports, there were several factors which
may limit the usefulness of SGTs for this application. Firstly, the amplitude of
background "noise" on SGT recordings was often relatively high compared with the
amplitude of uterine contractions, making some contractions difficult to identify. The
presence of an incompressible egg presumably prevents the uterine muscles shortening
and so uterine contractions will tend to cause changes in muscle tension (isometric
contractions) rather than changes in muscle length (isotonic contractions). SGTs
record changes in muscle shape and changes in muscle shape may be relatively small
for isotonic contractions. Consequently, (unlike contractions in parts of the avian
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gut), uterine contractions may cause only small changes in SGT shape and so
deflections caused by respiration and movements of adjacent organs appear relatively
large. Secondly, contractions of the empty uterus could not usually be recorded, yet
EMG studies suggest that contraction frequency remains elevated for a short time after
oviposition (Shimada & Asai, 1978; Wechsung & Houvenaghel, 1988). Presumably
the empty uterus provides insufficient tension to flex SGT. Thus, although the
problems encountered with wires snapping could presumably be overcome, there are
other unresolvable problems which restrict the usefulness of SGTs for recording
uterine contractions. Direct lead recording was also a limitation as this prevented the
use of social stress.
In conclusion, SGTs are not ideally suited for measuring uterine contractions
in hens, primarily because the egg restricts changes in muscle length. From
recordings of uterine contraction frequency associated with one delayed oviposition,
there was no evidence to suggest that contraction frequency is elevated during stress-
induced oviposition delays. This may be because elevated contraction frequency, the
stimulus for AVT release, did not occur, in which case the delays may not be due to
inhibition of AVT release. Alternatively, a rise may have occurred but was too short
or small to be detected.
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CHAPTER 6: Oviposition Inducing Potency of
Exogenous AVT and PGF2a in Relation to Stress
and Oviposition Delays
6.1 Introduction
Oviposition is initiated by the release of PGs - primarily PGF2a - from
ovarian follicles (see Shimada & Saito (1989) for a review). These PGs increase the
contraction frequency of uterine muscles and so trigger release of AVT from the
neurohypophysis and into the circulation. This AVT further promotes uterine
contractions, both directly and by stimulating production of PGs within uterine
muscles, and so contributes towards expelling the egg from the uterus. Various
environmental stressors induce oviposition delays (e.g. Hughes et al., 1986) and one
hypothesis is that these are due to opioidergic inhibition of AVT release (see Section
1.5) - a mechanism like that underlying stress-induced disruptions of parturition and
lactation in mammals (e.g. Haldar & Bade, 1981; Petherick et al., 1993). An
alternative hypothesis is that stress might some how delay oviposition by inhibiting
ovarian PG release (see Section 1.5).
The experiments described in Chapter 3 suggest that a threshold of about 3 h
oviposition delay defines an upper limit beyond which oviposition of the delayed egg
can no longer occur until the subsequent egg joins it in the uterus several hours later.
Before this threshold (i.e. when oviposition delay has not yet reached about 3 h)
ovipositions occurred shortly after (about 15 min) stress ending and often occurred
during stress. These delays were described as short-term. However, once
oviposition delays exceeded the 3 h threshold, ovipositions were unlikely to occur
either during stress or if stress ended. Instead the eggs were laid much later, 7-15 h
after expected oviposition time, and these delays were described as long-term. Thus,
the threshold is defined as the time after expected oviposition time beyond which
oviposition does not occur until much later (after a long-term delay). Several
mechanisms to explain the threshold were hypothesised (see Section 3.4). Briefly the
threshold may reflect changes in either release of, uterine responses to or half-lives of
AVT and/or PGs.
Exogenous PGs can induce oviposition prematurely, an i.v. dose of 1 jag
PGF2a/hen expelling eggs in a mean time of 7.8 min when injected 1-4 h before
expected oviposition time (Goto et al., 1985). Assuming each hen in that study
weighed around 2 kg, 1 fig/hen would be about 0.5 (tg/kg. Murakami et al. (1990)
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found that plasma AVT concentrations rise in association with ovipositions induced
prematurely by intra-uterine injection of 1 pg PGF2a/hen. They suggest that
neurohypophysial AVT is released in response to an increase in uterine contraction
frequency caused by the PGF2a and this AVT acts to further promote uterine
contractions and so to assist with expulsion of the egg. Exogenous AVT also induces
premature oviposition, an i.v. dose of 0.1 pg/kg expelling eggs in a mean time of 5.4
min when injected 2-3 h before expected oviposition time (Rzasa & Ewy, 1970).
Ovarian PGs are not released when oviposition is induced prematurely by AVT (Olson
& Hertelendy, 1981).
To investigate the mechanisms underlying stress-induced oviposition delays
and the threshold (beyond which delayed ovipositions do not occur until much later;
see above), plasma AVT and PGF2a concentrations were elevated by injection in the
following experiments. If stress induces oviposition delays by a mechanism other
than inhibition of ovarian PG release (e.g. by inhibiting AVT release or suppressing
uterine contractions), and if such a mechanism is also active when hens are exposed to
stress before expected oviposition time, then stress might reduce the ability of
exogenous PGF2a to induce premature oviposition. Experiment 1 tested this
possibility. If oviposition delays are due to inhibition of neurohypophysial AVT
release then injection of exogenous AVT should end these delays. Alternatively, if
oviposition delays are due to inhibition of ovarian PG release then injection of
exogenous PG should end these delays. Experiment 2 investigated the effects of AVT
injections and of PGF2a injections on stress-induced oviposition delays. If the
threshold is due to either changes in uterine response to AVT and/or PGF2a or
changes in the half-lives of these hormones then the ability of AVT and/or PGF2a
injections to end delays is likely to be reduced after the threshold. Experiment 3
investigated the abilities of exogenous AVT and PGF2a to end long-term stress-
induced oviposition delays.
69
6.2 Does Stress Affect Premature Induction of Oviposition by
Exogenous PGF2a?
The aim of this experiment was to investigate the effect of social stress on
induction of premature oviposition by PGF2a injection.
6.2.1 Materials and Methods
From 35 stock hens aged 57 weeks, 21 whose next oviposition times could be
predicted were selected and randomly allocated to receive a PGF2a injection following
either no disturbance (control, n = 11) or a period of social stress which started
approximately 3 h before predicted oviposition time (stress, n = 10). A stock solution
of 1 mg PGF2a (PGF2a tris salt, Sigma) in 1 ml of 95% ethanol was prepared and
stored at -20°C. Each day, 25 pi of stock PGF2a was diluted with 0.9% saline to 1
ug/ml. Injections were 0.5 ml/kg i.v. and approximately 1.5 h before predicted
oviposition time (i.e. during short-term oviposition delays). This dose of PGF2a
(0.5 pg/kg) is similar to the lowest with which Goto et al., (1985) were able to induce
oviposition 1-4 h prematurely. The times from injection until observed oviposition
(oviposition induction times) were recorded. Control hens were replaced in their
cages immediately after injection. As it was not known if PGF2a injection would
make hens more vulnerable to injury from other birds by inducing oviposition, hens
exposed to social stress were not returned to group cages after injection. Instead, they
were placed in an open cardboard box (base = 25 cm x 45 cm) in an unfamiliar room
and this was intended to maintain stress in the form of an unfamiliar environment.
6.2.2 Results
For 7 hens (4 x stress treatment, 3 x control treatment), injection was within 2
days of the egg sequence ending and, as this prevented accurate calculation of
expected oviposition time, these hens were excluded from the analysis. Another hen
(control treatment) received its injection sub-cutaneous rather than i.v. and was also
excluded from the analysis.
Injections were 57-186 min (mean = 108 min) before expected oviposition
time. Ovipositions occurring within 15 min of injection were considered to have been
induced. Effects of control and stress treatments on induction of premature
oviposition by PGF2a are shown in Table 6.1. Oviposition induction times were
compared using rank statistics, with the highest rank allocated to the two non-induced
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ovipositions. There was no difference in oviposition induction times between stress
and control treatment (Mann-Whitney, w=30.5, P>0.05).
Control Stress
Number of injected hens
Number of ovipositions induced









Table 6.1 Effects of control and stress treatments on the number of ovipositions
induced prematurely by 0.5 )lg/kg PGF2a and on mean (+SEM) oviposition
induction times.
6.3 Do Injections of AVT or PGF2a End Short-Term Stress-Induced
Oviposition Delays?
The aim of this experiment was to find out if short-term stress-induced
oviposition delays could be ended by injection of PGF2a or AVT.
6.3.1 Materials and Methods
From 58 stock hens aged 32 weeks, 27 whose next oviposition times could be
predicted were selected. To induce oviposition delays, selected hens were each
exposed to social stress, starting 30 min before predicted oviposition time, on one of
three days (n = 9 each day). Each day, hens were randomly allocated to receive an
injection of either 0.9% saline, 0.1 |lg/kg AVT or 0.5 ]i.g/kg PGF2a (n = 3 each)
during their oviposition delays. Each day, 27 unselected stock hens were randomly
divided into 9 groups of 3 in such a way that hens in each group were strangers to
each other. Each of the 9 selected hens was exposed to social stress by housing it
with one of these groups.
AVT ([ARG8]-vasotocin acetate salt, Sigma) was dissolved in 0.9% saline
(0.2 p.g/ml) and stored at -18°C until required. Preparation of PGF2a is described in
Section 6.2.1. All injections were 0.5 ml/kg i.v. and 40 min after predicted
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oviposition time. Thus, injections were after oviposition had been delayed for 40 min
and were 70 min after stress started. This dose of AVT (0.1 pg/kg) induces
oviposition 2-3 h prematurely (Rzasa & Ewy, 1970). From hens' responses to
PGF2a injection in Experiment 1, it was decided that hens should be returned to their
group cages immediately after injection in the present experiment. Oviposition
induction times were recorded. All hens in a group were returned to their home cages
as soon as the injected hen laid or, if this did not occur, 3 h after its predicted
oviposition time.
6.3.2 Results
Seven hens (2 x AVT treatment, 5 x PGF2a treatment) laid during stress and
< 40 min after predicted oviposition time. These hens were not injected as they no
longer carried eggs at 40 min after predicted oviposition time (the intended injection
time).
For the remaining hens, oviposition delays due to social stress were 14-61 min
(mean = 42 min) at the time of injection. Four hens receiving saline did not lay during
stress and so their oviposition induction times were calculated as the time from
injection until 3 h past expected oviposition time. All AVT and PGF2a injections
induced oviposition within 10 min (Table 6.2). As some saline treated hens did not
lay during stress, oviposition induction times were compared between pairs of
treatments using rank statistics. Both AVT and PGF2a injections induced oviposition
more rapidly than did saline injections (respectively by Mann-Whitney: w=28,
p<0.001; w=10, P<0.01). Thus, the oviposition delaying effect of social stress was
ended by injection of either 0.1 pg/kg AVT or 0.5 pg/kg PGF2a.
Injection n induction time (min)
Saline 9 102.3 (17.6)
AVT 7 2.0 (0.5)
PGF2a 4 5.1 (1.7)
Table 6.2 Mean (+SEM) oviposition induction times following injections of either
saline, 0.1 pg/kg AVT or 0.5 pg/kg PGF2a for hens delaying oviposition
short-term during social stress.
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6.4 Do Injections of AVT or PGF2a End Long-Term Stress-Induced
Oviposition Delays?
The aim of this experiment was to find out if injections of AVT or PGF2a
would end long-term stress-induced oviposition delays. Only about one quarter of
hens exposed to social stress can be expected to delay oviposition beyond the
threshold (see Figures 3.1 and 3.4 and Section 3.4) and this creates two problems
when designing experiments to investigate its underlying mechanisms. First, to
induce a required number of long-term oviposition delays for an experiment, about
four times as many hens must be exposed to social stress. Second, it cannot be
assumed that hens delaying oviposition beyond the threshold represent a random
sample of the whole population as some hens may be more likely than others to delay
oviposition for this long. It is not possible to predict which hens will delay their
ovipositions beyond the threshold. Therefore, a large and complex experiment would
be required to compare the effects of AVT and PGF2a injections on long-term
oviposition delays with similar injections at other times (e.g. before expected
oviposition time and during short-term oviposition delay). As such an experiment was
impractical, the effects of these injections on long-term oviposition delays were not
directly compared with their effects at other times and this experiment was undertaken
as an exploratory study.
6.4.1 Materials and Methods
AVT injections
Eighteen hens aged 48 weeks were each exposed to social stress for 4 h,
starting 0.5 h before predicted oviposition time. From Chapter 3, this treatment was
expected to induce long-term oviposition delays (i.e. delays which do not end before
the threshold and are therefore 7-15 h in duration) in about 1/4 of the hens. Four hens
did not lay during exposure to stress or in the hour after they were returned to their
original cages, and it was assumed that their ovipositions were delayed long-term.
These 4 hens each received 0.1 |ig/kg AVT (see Section 6.3.1) approximately 6 h after
predicted oviposition time and oviposition induction time was recorded. As long-term
oviposition delays cause white-banded and slab-sided eggshells (see Chapter 3),
eggshell abnormalities were also recorded.
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PGF2a injections
Eighteen hens aged 21 weeks were exposed to social stress as described
above. Four hens delayed oviposition long-term and each received 0.5 (tg/kg PGF2a
(see Section 6.2.1) approximately 5 h after predicted oviposition time. Oviposition
induction times and eggshell abnormalities were recorded.
6.4.2 Results
AVT injections
For each hen, oviposition delay at time of injection and oviposition induction
time are shown in Table 6.3. Both eggs not laid within 15 min of injection were
white-banded when they were eventually laid, at an unknown time, and the egg
following each was slab-sided. Although both eggs laid within 15 min of injection
appeared normal, the egg following each was soft-shelled and was laid prematurely at
an unknown time.
Table 6.3 Oviposition induction time following AVT injection (0.1 (ig/kg) for each
of 4 hens delaying oviposition long-term in response to social stress.
PGF2a injections
For each hen, oviposition delay at time of injection oviposition and induction
time are shown in Table 6.4. The three eggs not laid within 15 min of injection were
white-banded when they were eventually laid, at an unknown time, and the egg
following each was slab-sided. Neither the egg laid within 15 min of injection nor the
egg following it appeared abnormal.
Oviposition delay at
























Table 6.4 Oviposition induction time following PGF2a injection (0.5 fig/kg) for
each of 4 hens delaying oviposition long-term in response to social stress.
6.5 Discussion
In Section 6.2, there was no difference between stress and control treatments
in the time taken for exogenous PGF2a to induce premature oviposition. If stress
causes oviposition delays by disrupting the oviposition process subsequent to ovarian
PG release, e.g. by inhibiting AVT release or by directly suppressing uterine
contractions, then it might be expected to increase the time taken for PGF2a to induce
oviposition. However this did not occur, so the results are consistent with the
hypothesis that oviposition delays are caused by inhibition of ovarian PG release.
However, as discussed below, a dose of 0.5 ftg/kg PGF2a may be sufficient to
overcome other mechanisms which disrupt oviposition. Another two explanations
may account for the similar effects of stress and control treatments. First, the injection
procedure was itself stressful and so hens from both treatments may have been
stressed when injected. Second, hens from the stress treatment were isolated in a box
after injection and this situation may have been less stressful than the group cage, so
reducing any effect of social stress on premature induction of oviposition.
In Section 6.3, short-term oviposition delays were ended by exogenous AVT
or PGF2a. Interpretation of this, with respect to the mechanisms underlying stress-
induced oviposition delays, is complicated by the fact that elevated plasma PG levels
cause AVT release (by inducing uterine contractions) and therefore AVT release is not
independent of elevated plasma PG (exogenous or endogenous).
The finding that injections of exogenous AVT end short-term stress-induced
oviposition delays is considered first. This is consistent with the hypothesis that these
delays are due to inhibition of AVT release. In mammals, stress-induced disruptions
of parturition and lactation are at least partly due to inhibition of oxytocin release by
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endogenous opioids (e.g. Haldar & Bade, 1981; Petherick et al., 1993), and hence
opioids might act to inhibit AVT release in hens. However, as AVT injections induce
premature oviposition without causing release of ovarian PGs (Olson & Hertelendy,
1981), the finding here that AVT injections end stress-induced oviposition delays is
also consistent with the alternative hypothesis that these delays are due to inhibition of
the stimulus for AVT release, i.e. ovarian PG release.
The finding that injections of exogenous PGF2a end short-term stress-induced
oviposition delays is also consistent with the hypothesis that delays are due to
inhibition of ovarian PG release. Little is known about the mechanisms controlling
ovarian PG release (Shimada & Saito, 1989), and it is not clear how they might be
disrupted by stress. AVT is released in association with oviposition induced
prematurely by exogenous PGF2a and is thought to contribute towards expelling the
egg (Murakami et al., 1990). If the effects of AVT are important for the induction of
oviposition by PGF2a injection, and if AVT release is inhibited by the stress causing
oviposition delays, then it might be expected that PGF2a injections would end these
delays relatively slowly or not at all. However, exogenous PGF2a ended all four
oviposition delays and, although not directly comparable, the mean induction time of
5.1 min is similar to that (7.8 min) following 1 (tg/hen PGF2a i.v. 1-4 h before
expected oviposition time (Goto et al., 1985). Hence, AVT release following PGF2a
injection is either not inhibited by social stress or not essential for induction of
oviposition.
If a mechanism other than inhibition of AVT or PG release causes stress-
induced oviposition delays, then injection of either 0.1 flg/kg AVT or 0.5 (tg/kg
PGF2a is clearly able to overcome it. If the plasma volume of hens is assumed to be
6% of their body weight (Medway & Kare, 1959), injecting 0.1 flg/kg AVT should
raise plasma concentration by 1670 pg/ml. The increase in plasma AVT associated
with normal oviposition is much less than this at around 60 pg/ml (Tanaka et al.,
1984). Injection of 0.5 |ig/kg PGF2a should elevate plasma concentration by 8330
pg/ml. Measurements of the rise in plasma PGF2a at normal oviposition vary,
including rises of between 500 and 1000 pg/ml and less than 100 pg/ml (from the
figures of Olson et al. (1986) and Saito et al. (1987) respectively). Thus, plasma AVT
and PGF2a concentrations following these injections will have been considerably
higher than those associated with spontaneous oviposition and this must be considered
when interpreting the results. Perhaps stress-induced oviposition delays are due to
inhibition of AVT release, but the dose of exogenous PGF2a was sufficient to end
these delays despite reduced AVT. Alternatively, adrenaline released in response to
stress may delay oviposition by directly suppressing uterine contractions (Weiss &
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Sturkie, 1952; Hughes & Black, 1976; Crossley, 1983). The doses of AVT and
PGF2a injected might overcome adrenergic suppression of uterine contractions to end
oviposition delays. Thus, although short-term stress-induced oviposition delays were
ended by AVT or PGF2a injection, it cannot be concluded that the delays were due to
inhibition of these hormones as the doses administered may have been sufficient to
override other mechanisms.
In Section 6.4, injections of AVT or PGF2a were inconsistent at inducing
oviposition of eggs delayed by social stress beyond the 3 h threshold. Equivalent
injections rapidly induce premature oviposition (Rzasa & Ewy, 1970; Goto et al.,
1985; also see Section 6.2) and end short-term oviposition delays (Section 6.3). This
supports the hypotheses that oviposition does not occur after the threshold because
either uterine sensitivity to AVT or PGs is reduced or the half-life of these hormones
in circulation is reduced (see Chapter 3). A reduction in sensitivity to AVT or PGs
could be due to changes in numbers of specific receptors and changes in the binding
characteristics of these, while changes in circulating levels of appropriate enzymes
could affect the half-lives of these hormones (see p. 44 & 45). For a further
discussion of mechanisms responsible for the threshold, see Chapter 12.
Exogenous AVT and PGs induce uterine contractions and oviposition most
potently when injected shortly before expected oviposition time, and become
progressively less potent if they are injected at earlier times in the egg cycle (Rzasa &
Ewy, 1970; Goto et al., 1985; Shimada et al., 1987). However, as there is not
normally an egg in the uterus 6 h after oviposition, the effects of AVT and PG
injections on uteri containing eggs at this time have not previously been reported. In
the present study (Section 6.4) stress was used to delay oviposition so that there was
an egg in the uterus 6 h after normal (expected) oviposition time. At this time,
injection of either AVT or PGF2a induced oviposition in only a small proportion of
hens and then only relatively slowly (compared with Section 6.3). This suggests that
the uterine contraction inducing potency of these injections may be low in the period
after normal oviposition time and before the next egg enters the uterus.
Long-term oviposition delays not ended by AVT or PGF2a injection resulted
in white-banded and slab-sided eggs and this is consistent with the findings of Chapter
3 and those of van Middelkoop (1971) and Hughes et al. (1986). It is not clear why
eggs subsequent to those expelled by AVT during long-term delays were laid
prematurely with soft shells. An intra-uterine irritant in the form of a loop of thread
sutured to uterine muscle causes premature oviposition (Sykes, 1953b; Lake &
Gilbert, 1964; Ogasawara et al., 1974). Perhaps expulsion of long-term delayed eggs
by AVT causes damage or irritation to the uterus and this causes premature expulsion
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of the next egg. However, premature oviposition of the next egg did not occur when a
long-term delay was ended by PGF2a injection.
To summarise, there was no effect of stress on induction of premature
oviposition by exogenous PGF2a. Injections of AVT or PGF2a rapidly ended short-
term stress-induced oviposition delays but only ended a small proportion of long-term
oviposition delays and then only relatively slowly.
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CHAPTER 7: Do Opioid Antagonists Reduce the
Duration of Stress-Induced Oviposition Delays?
7.1 Introduction
It is hypothesised that opioids released in response to stress cause oviposition
delays in hens by inhibiting neurohypophysial AVT release (see Section 1.6). In
mammals, stress-related disruptions of parturition and lactation are due to a similar
opioidergic inhibition of oxytocin release (see Petherick et al. (1993) for a review).
The ability of opioid receptor antagonists to reduce these disruptions implicates
endogenous opioids in the underlying mechanisms. For example, moving rats from
their nesting cages to the unfamiliar environment of a glass chamber mid-parturition
prolongs labour, a response which is reduced by treatment with naloxone, a non¬
specific opioid receptor antagonist, (Leng et al., 1987; Leng et al., 1988). Naloxone
also reduces the disruption of parturition caused by moving sows to an unfamiliar
environment after the birth of their first piglet (Lawrence et al., 1992). Naltrexone,
another non-specific antagonist, reduces the inhibition of milk yield induced by briefly
relocating lactating mice to an unfamiliar and hot environment (Haldar & Bade,
1981).
The experiments reported in this chapter investigated the role of endogenous
opioids in the mechanisms underlying stress-induced oviposition delays through
treatments with three opioid antagonists: nalmefene, MR2266 and nor-binaltorphimine
(norBNI). If opioids are involved in the causation of oviposition delays then blocking
the appropriate receptors with an antagonist should reduce the duration of these
delays.
Nalmefene is a non-specific opioid antagonist which increases headflick
frequency and suppresses feeding, drinking and stereotyped pecking in fowls (Savory
& Hughes, 1988; Savory et al., 1989; Savory et al., 1992). MR2266, which has
highest affinity for kappa opioid receptors but is also potent at mu receptors, also
partially suppressess stereotyped pecking in broiler breeder fowls (Kostal & Savory,
1994). NorBNI is a more specific antagonist of kappa receptors than is MR2266,
although it crosses the blood brain barrier relatively poorly (McKnight & Rees, 1991).
NorBNI has been used as a specific kappa receptor antagonist in studies of memory
formation in chicks (Colombo et al., 1992) and investigations into the effects of kappa
agonists on isolated chick neurone membranes (Fletcher & Chiappinelli, 1993;
Maderspach & Nemeth, 1993). Further details concerning the selectivity of these
antagonists are given in Table 1.3.
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As naltrexone and naloxone are the most commonly used non-specific opioid
receptor antagonists in mammalian studies it is appropriate to compare their
pharmacological properties with those of nalmefene. The affinity of nalmefene for mu
receptors is similar to that of naltrexone but about four times greater than that of
naloxone (Michel et al., 1985). Its affinity for kappa and delta receptors is 2-3 times
greater than that of naltrexone and 4-12 times greater than that of naloxone (Michel et
al., 1985). In behavioural tests, nalmefene antagonises morphine induced analgesia
much more potently than either naltrexone or naloxone (Hahn et al., 1975). In
addition to its greater potency, nalmefene antagonises opioid receptors for longer
durations than either naltrexone or naloxone (Vizi et al., 1976; VanVugt, 1989).
Delta opioid receptors have not been implicated in the control of oxytocin
release in mammals (Bicknell et al., 1985) and so the effects of specific delta opioid
receptor antagonism was not investigated in the present study. Although naloxone and
naltrexone are often used as mu-receptor antagonists they are not very specific and no
truly selective non-peptide blocker is available (McKnight & Rees, 1991).
Consequently, the effect of selective mu-receptor antagonism on the duration of stress-
induced oviposition delays was not investigated.
7.2 Does Treatment with Nalmefene Reduce the Duration of Stress-
Induced Oviposition Delays? Experiment 1
The aim of this experiment was to investigate the effect of nalmefene on the
duration of stress-induced oviposition delays.
7.2.1 Materials and Methods
From 36 naive stock hens aged 27 weeks, 18 whose next oviposition times
could be predicted were selected over two days and randomly allocated to receive an
injection of either 0.9% saline or nalmefene (n = 9 each), each followed by a period of
social stress. Nalmefene (6-desoxy-6-methylene naltrexone; Key Pharmaceuticals,
Miami) was dissolved in 0.9% saline (1 mg/ml) and stored at -18°C until required.
Nalmefene and saline were both injected i.v. at 0.5 ml/kg, 30 min before predicted
oviposition time. This dose of nalmefene was expected to provide a high level of
opioid antagonism without sedation (Savory & Hughes, 1988).
Immediately after injection, each hen was exposed to stress by placing it in a
group cage containing five unfamiliar hens. This stress was ended by returning the
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hen to its home cage once it had laid, or after a period of 3.5 h if oviposition did not
occur. As there were insufficient unselected stock hens to make up independent stress
groups for each of the 18 injected hens, some group cages contained more than one
injected hen. As predicted oviposition times varied, periods of stress began at
different times for each hen and so individual injected hens were never exposed to
each other for the full duration of their stress periods. When injected hens were added
to or removed from group cages, the number of stock birds was altered to maintain the
group size of six.
As individual treated hens were not exposed to each other for the full duration
of their stress period, group effects were not included in the analysis. It was to reduce
the influence of individual hens on the level of stress experienced by others in the
same group that a group size of six was used here, rather than four as in previous
experiments.
7.2.2 Results
One hen (saline treatment) did not lay during exposure to stress and its
oviposition delay was considered to be 180 min for the following analysis. Table 7.1
shows the mean durations of stress-induced oviposition delay after injection of either
saline or nalmefene. Delays were significantly longer after saline injection than after
nalmefene injection (Mann-Whitney; w=55, P<0.01).
Table 7.1 Mean (+SEM) durations of oviposition delay for hens exposed to social










7.3 Does Treatment with Nalmefene Reduce the Duration of Stress-
Induced Oviposition Delays? Experiment 2
In Experiment 1, treatment with nalmefene reduced the duration of stress-
induced oviposition delays. However, as group composition often changed during
stress periods and some injected hens were placed in the same group cage, hens did
not all receive identical and unrelated periods of stress. The aim of Experiment 2 was
to confirm the results of Experiment 1 and to avoid the above criticisms through the
use of an improved experimental design.
7.3.1 Materials and Methods
Twenty-seven Hisex hens aged 29 weeks were housed individually in bottom
tier battery cages. These hens had been used in a study of feather pecking
development (Savory & Mann, submitted) during which they were housed in floor
pens in groups of 5-8 until 26 weeks of age, when they were transferred to the battery
cages. An additional 69 stock hens (ISA Brown, 39 weeks old), housed individually
in middle tier battery cages, were used to make up groups for stressing the injected
hens.
From the 27 hens, 23 whose next oviposition times could be predicted were
selected and randomly allocated to receive an injection of either 0.9% saline (n = 11)
or 0.5 mg/kg nalmefene (n = 12), each followed by a period of social stress. These
injections are described in Section 7.2. Immediately after injection, each hen was
exposed to social stress by placing it in a group cage with three stock hens for a period
of 4.0 h, after which it was returned to its original cage. Hence, in contrast to
Experiment 1, the composition of each stress group was constant, all hens were
exposed to stress for the same duration and all stress groups were independent.
7.3.2 Results
Two hens laid before they were due to be injected and another laid as it was
restrained to receive its injection. These three hens (2 x nalmefene treatment, 1 x
saline treatment) were excluded from the analysis (so, n = 10 for both treatments).
Table 7.2 shows the mean durations of stress-induced oviposition delay following
injection of either saline or nalmefene. Delays were significantly longer after saline









Table 7.2 Mean (+SEM) durations of oviposition delay for hens exposed to social
stress after injection of either saline or 0.5 mg/kg nalmefene (n = 10 each) in
Experiment 2.
7.4 Does Treatment with MR2266 Reduce the Duration of Stress-
Induced Oviposition Delays?
In Sections 7.2 and 7.3 the duration of stress-induced oviposition delays was
reduced by treatment with the non-selective opioid receptor antagonist nalmefene, thus
implicating endogenous opioids in the causation of these delays. The aim of the
following experiment was to investigate the role of kappa opioid receptors through use
of the preferential kappa receptor antagonist MR2266.
7.4.1 Materials and Methods
From 35 stock hens aged 29 weeks, 20 whose next oviposition times could be
predicted were selected over three days and randomly allocated to receive an injection
of either 0.9% saline or 2 mg/kg MR2266 (n = 10 each), each followed by a period of
social stress. MR2266 (Boehringer, Ingelheim, Germany) was dissolved in 0.1M
hydrochloric acid, then made up to a concentration of 2 mg/ml with 0.9% saline. Both
the MR2266 solution and the saline for control injections were adjusted to pH 5.9 by
titration with sodium hydroxide. Injections were i.v., 1 ml/kg and 30 min before
predicted oviposition time. This dose of MR2266 corresponds to the highest dose
used in a study of the role of opioid receptor subtypes in stereotyped behaviour of
broiler breeder fowls (Kostal & Savory, 1994).
Immediately after injection, each hen was exposed to social-stress by placing it
in a group cage containing seven unfamiliar hens. This stress was ended by returning
the hen to its home cage once it had laid, or after a period of 3.5 h if oviposition did
not occur. As there were insufficient remaining stock hens to make up independent
stress groups for each of the 20 injected hens, some injected hens were stressed in the
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same cage. Predicted oviposition times varied and so each hen's period of stress
began at a different time. When an injected hen was added to or removed from a
group cage, the number of stock hens was altered to maintain the group size of eight.
As group composition varied during the stress periods, injected hens were not
exposed to each other for the full duration of their stress periods and so group effects
were not included in the analysis. A group size of eight was used here, rather than
four or six as in previous experiments, in order to reduce the influence of individual
hens on the level of stress experienced by others in the same group.
7.4.2 Results
Four hens (3 saline and 1 MR2266) did not lay during exposure to stress and
their oviposition delays were considered to be 180 min for the following analysis.
Table 7.3 shows the mean durations of stress-induced oviposition delay after injection
of either saline or MR2266. As the data were normally distributed and had an even
distribution of variance, parametric statistics (GLM) were used for the analysis.
Neither treatment (F=1.35; 1, 14 df; P>0.05), day (F=1.75; 2, 14 df; P>0.05) nor an
interaction between day and treatment (F=1.04; 2, 14 df; P>0.05) had a significant
effect on the duration of oviposition delays.
Table 7.3 Mean (+SEM) durations of oviposition delay for hens exposed to social









7.5 Does Treatment with nor-Binaltorphimine Reduce the Duration of
Stress-Induced Oviposition Delays?
In Section 7.4, treatment with the kappa receptor antagonist MR2266 slightly,
but not significantly, reduced the duration of stress-induced oviposition delays.
Perhaps complete antagonism of kappa receptors was not achieved with 2 mg/kg
MR2266 and a higher dose would have reduced delay duration more effectively.
However, MR2266 antagonises mu receptors in addition to kappa receptors (Magnan
et al., 1982), and so the effect of MR2266 cannot be attributed unambiguously to
kappa receptor antagonism. The aim of the following experiment was to investigate
the effect of norBNI, a kappa opioid receptor antagonist with higher selectivity than
MR2266, on the duration of stress-induced oviposition delays.
7.5.1 Materials and Methods
From 48 naive stock hens aged 25 weeks, 18 whose next oviposition times
could be predicted were selected and randomly allocated to receive an injection of
either 0.9% saline or 0.5 mg/kg norBNI, both followed by a period of social stress.
As there were insufficient unselected stock hens to make up 18 independent stress
groups, two selected hens and two stock hens were placed in each group cage (thus,
there were four birds in each stress group). The 18 selected hens were divided into
pairs with similar predicted oviposition times. One hen from each pair was randomly
chosen to receive norBNI, with the other receiving saline.
NorBNI (17,17'-bis(cyclopropylmethyl)6,6',7,7'tetradehydro 4,5,4',5'-
diepoxy-6,6'(imino)[7,7'-bimorphinan]-3,3',14,14'tetroldihydrochloride; Research
Biochemicals Incorporated, Natick, MA) was dissolved in 0.9% saline (1 mg/ml).
This solution was prepared on the day of injection as norBNI is unstable in solution.
NorBNI and saline were both injected i.v. at 0.5 ml/kg, 30 min before predicted
oviposition time. The dose of norBNI (0.5 mg/kg) was chosen as, when injected i.v.,
it fully prevents the disruption of rat parturition induced by U50,488 (Douglas et al.,
1993). Periods of social stress began immediately after injection and lasted 3.5 h.
7.5.2 Results
Table 7.4 shows the mean durations of stress-induced oviposition delay after
injection of either saline or norBNI. Although delay duration was greater for hens
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receiving norBNI than for hens receiving saline, this difference was not significant








Table 7.4 Mean (+SEM) durations of oviposition delay for hens exposed to social
stress after injection of either saline or 0.5 mg/kg norBNI (n = 9 each).
7.6 Discussion
In the present experiments social stress caused hens to delay oviposition and
this is consistent with the findings reported in earlier chapters. The duration of these
delays was significantly reduced by nalmefene and this suggests that endogenous
opioids are involved in their underlying physiological causation. In mammals,
environmental stressors disrupt the milk ejection reflex and prolong parturition,
processes dependant on neurohypophysial oxytocin. These disruptions can be
reduced by treatment with a non-specific opioid antagonist and it has been shown that
they are due to an opioid mediated inhibition of oxytocin release (e.g. Haldar & Bade,
1981; Leng et ai, 1988). In hens, neurohypophysial AVT is released at oviposition
and is involved in inducing the uterine contractions which expel the egg (Shimada &
Saito, 1989). It is hypothesised that stress induced oviposition delays may be due to
an opioidergic inhibition of AVT release (see Section 1.6). The finding that nalmefene
reduces the duration of these delays supports this hypothesis. At the magnocellular
neurone level, opioids can inhibit hormone release in mammals by acting either within
the neurohypophysis (peripherally, kappa receptors) or within the hypothalamus
(centrally, mu and kappa receptors) (see Bicknell (1985) for a review). As nalmefene
is a non-specific antagonist and can cross the blood brain barrier, experiments with
nalmefene do not suggest where or by which receptor types endogenous opioids may
act to inhibit AVT release.
MR2266 slightly, but not significantly, reduced the duration of stress-induced
oviposition delays. Although often considered to be a specific kappa antagonist,
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MR2266 also has a high affinity for mu-receptors (Magnan et al,. 1982).
Consequently, the interpretation of the present finding with respect to receptor types is
somewhat ambiguous. One interpretation is that mu receptors mediate oviposition
delays and the slight reduction in delay duration was due to some mu-receptor
antagonism. This explanation is consistent with the observation that norBNI, a
specific kappa receptor antagonist, did not reduce delay duration. Another
interpretation is that oviposition delays are mediated by kappa receptor pathways and
the slight reduction in delay duration was due to antagonism of these receptors.
Possibly both kappa and mu receptors are involved in delaying oviposition. That
MR2266 did not significantly reduce delay duration may be because the dose (2
mg/kg) was too low to adequately antagonise the relevant receptors (mu or kappa).
The same dose of MR2266 (2 mg/kg) suppresses stereotypic pecking by broiler
breeder fowls for only a short time, with no effects evident 30-45 min after injection
(Kostal & Savory, 1994). Hence, MR2266 might have a relatively short half-life in
hens and this might have contributed to its lack of effect on oviposition delay duration.
If this is the case then MR2266 injections nearer the expected oviposition time than
those in the present experiment might cause a greater reduction in delay duration.
NorBNI did not reduce the duration of stress-induced oviposition delays. As
the posterior pituitary lies outside the blood brain barrier, and so is exposed to
circulating norBNI, this finding suggests that peripheral kappa receptors do not have
an important role in the causation of the delays. This is consistent with the suggestion
that opioid receptors are not associated with the terminals of the avian AVT neurone
(see Section 1.6.1). Although norBNI crosses the blood brain barrier only poorly, an
i.v. dose similar to that used here completely prevents the disruption to parturition of
rats caused by the selective kappa receptor agonist U50,488 (Douglas et al., 1993).
As U50,488 can inhibit oxytocin release both centrally and peripherally (Pumford et
al., 1993; Russell et al., 1993), this systemic dose of norBNI is presumably able to
antagonise central kappa receptors in the rat. Thus, the present study may also
suggest that central kappa receptors do not have a major role in the causation of
oviposition delays during stress.
If the opioidergic mechanism which mediates oviposition delays does not
involve kappa-receptors, then presumably it involves mu and/or delta receptors. Mu
but not delta opioid receptors have been implicated in the opioidergic control of
oxytocin release in mammals (Bicknell, 1985) and so, by analogy, it may be mu rather
than delta receptor pathways that delay oviposition. A specific delta receptor
antagonist, such as naltrindole (McKnight & Rees, 1991), could be used to confirm
that these receptors are not involved.
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The mean duration of stress-induced oviposition delay following saline
injection was shorter in Section 7.3 (29.0 min) than in Sections 7.2, 7.4 and 7.5
(82.3, 92.0 and 86.4 min, respectively). In contrast to Sections 7.2, 7.4 and 7.5, the
hens in Section 7.3 had been housed in groups in floor pens until three weeks before
they were used in the current experiment, and this may have reduced the stress
associated with relocation from individual to group cages. Additionally, as ISA
Brown hens were used in Sections 7.2, 7.4 and 7.5 and Hisex hens in Section 7.3,
the differences in delay duration could be related to the strain of hen used. Although
the different group sizes used in some of these experiments may also contribute
towards the different durations of oviposition delays, this is likely to be a minor factor
as the group sizes in Sections 7.3. and 7.5. were the same, yet the delays were longer
in the latter.
In conclusion, the present experiments indicate that endogenous opioids are
involved in the mechanisms underlying stress-induced oviposition delays in hens.
Although peripheral kappa receptors are not responsible for these delays, central mu
and kappa receptors may be.
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CHAPTER 8: Effects of Exogenous Opioid
Agonists on Oviposition Time
8.1 Introduction
It is hypothesised that stress-induced oviposition delays are the result of an
opioid mediated inhibition of AVT release from the posterior pituitary (see General
Introduction). The finding that treatment with an opioid receptor antagonist,
nalmefene, reduces the duration of these delays supports this hypothesis (Chapter 7).
If stress does act via opioidergic pathways to induce oviposition delays then it should
be possible to induce similar delays by administering exogenous opioid receptor
agonists. This chapter investigated the effects of two such agonists, morphine and
U50,488, on oviposition time.
Morphine, a specific mu receptor agonist (see Section 1.6.1), inhibits
neurohypophysial oxytocin release in mammals, thus prolonging parturition and
disrupting lactation (Haldar & Sawyer, 1978; Russell & Spears, 1983; Russell et al.,
1989). In mammals, morphine acts centrally to inhibit neurohypophysial hormone
release (e.g. Pumford et al., 1991). Morphine has often been used as an opioid
agonist in studies of nociception in domestic fowls and has strain dependent analgesic
and hyperalgesic effects which are naloxone reversible (Hughes, 1990). Although
morphine inhibits osmotically stimulated AVT release in day-old chicks and in laying
hens (Xu et al., 1991; Dublecz et al., 1992), its effects on oviposition have not been
described previously.
In rats, the selective kappa opioid receptor agonist U50,488 (see Section 1.6.1
and Von Voigtlander et al., 1983) inhibits neurohypophysial oxytocin release,
prolonging parturition, and inhibits AVP release (Oiso et al., 1988; Douglas et al.,
1993). In mammals, U50,488 acts both centrally and peripherally to inhibit
neurohypophysial hormone release (Zaho et al., 1988a; Pumford et al., 1993; Russell
et al., 1993). U50,488 has been used as a specific agonist of kappa receptors of chick
neurones in vitro, where it is antagonised by norBNI (Fletcher & Chiappinelli, 1993).
Effects of U50,488 on oviposition in hens have not been described previously.
As delta opioid receptors have not been implicated in the opioidergic control of
oxytocin release in mammals (Bicknell, 1985, 1993), the effects of a delta opioid
receptor agonist were not investigated in this study.
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8.2 Effects of a Range of Doses of Morphine on Oviposition Time
The aim of this experiment was to investigate the effects of morphine, at a
range of doses, on hens' oviposition times. From this Experiment, a dose of 6 mg/kg
morphine was chosen for further testing in Section 8.3.
8.2.1 Materials and Methods
From 35 stock hens aged 40 weeks, 26 whose next oviposition times could be
predicted were selected over three days and allocated randomly to receive an injection
of either 0.9% saline (n = 6) or 2.5, 5 or 10 mg/kg morphine (n = 5, 8 and 7). This
range includes doses found to inhibit the milk ejection reflex in mice and rats (Haldar
& Sawyer, 1978; Russell & Spears, 1983) and to prolong labour in rats (Russell et
al., 1989), and doses in excess of those found to inhibit osmotically stimulated AVT
release in both chicks and laying hens (Xu et al., 1991; Dublecz et al., 1992).
Morphine (morphine sulphate, Sigma) was dissolved in 0.9% saline (10 mg/ml) and
stored at room temperature until required. This solution was injected at 0.25, 0.5 and
1 ml/kg for doses of 2.5, 5 and 10 mg/kg morphine, respectively. Saline injections
were 0.5 ml/kg. All injections were i.v., 40 min before predicted oviposition time.
8.2.2 Results
Four hens (1 x 2.5 mg/kg, 2x5 mg/kg and 1 x 10 mg/kg morphine
treatments) were excluded from the analysis as their egg sequences ended within two
days of the injection, thus preventing accurate calculation of expected oviposition
times.
The mean A oviposition time (see Section 2.3 for definition and calculation of
this) for each treatment is shown in Table 8.1. There were no significant differences
between any pairs of treatments (all R>0.05 by t-test). However, the SEM tends to
increase as the dose rises, indicating that the A oviposition time is more variable
following higher doses of morphine. To investigate this trend, the effect of morphine
on individual ovipositions was examined.
Figure 8.1 shows the time from injection until expected oviposition time and
the time from injection until observed oviposition time for each hen. As described
previously (Section 2.3), hens were all injected at the same interval before predicted
oviposition times and then expected oviposition times, more accurate estimates of
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Injection Mean A oviposition time (min)
Saline 7.5 (7.9)
2.5 mg/kg Morphine -2.0 (6.6)
5 mg/kg Morphine -4.5 (13.9)
10 mg/kg Morphine -11.7 (15.6)
Table 8.1 Mean (+SEM) A oviposition time after injection of either saline (n = 6)






















Time from injection until
expected oviposition time (min)
° Saline
A 5 mg/kg morphine
2.5 mg/kg morphine
10 mg/kg morphine
Figure 8.1 The time from injection, of either saline or 2.5, 5 or 10 mg/kg
morphine, until expected oviposition time and the time from injection until
observed oviposition time for each hen. The diagonal dashed line indicates the
expected oviposition time relative to the two axes. Points below this line
indicate ovipositions that occurred earlier than expected and points above this
line indicate ovipositions that occurred later than expected.
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when oviposition would normally have occurred, were calculated a day later. As
expected oviposition times usually differed slightly from predicted oviposition times,
there was a range of times from injection until expected oviposition time in this
experiment. From Figure 8.1, it can be seen that 3 of the 6 hens receiving 5 mg/kg
morphine and 3 of the 6 hens receiving 10 mg/kg morphine laid earlier than expected
and within 15 min of these injections. As the sample sizes in this experiment were
small and the injections were relatively close to expected oviposition time, it is not
clear if 5 and 10 mg/kg morphine injections can act to induce some ovipositions
prematurely or if the distribution of oviposition times simply reflects random variation.
Similarly, it is not clear if 5 or 10 mg/kg morphine injections delay oviposition when
they do not induce it prematurely. Injections of saline or 2.5 mg/kg morphine did not
appear to affect oviposition time.
8.3 Effects of 6 mg/kg Morphine on Oviposition Time
In Section 8.2, injections of 5 or 10 mg/kg morphine appeared to induce some
ovipositions prematurely. However, as the sample sizes were small and the injections
were administered relatively close to expected oviposition time, it is not clear whether
the apparent oviposition inducing effect of morphine was real or due to random
variation. The aim of the following experiment was to investigate the effects of 6
mg/kg morphine on oviposition time. Larger sample sizes than those in Section 8.2
were used and, in order that any ovipositions inductions would be more obvious,
injections were administered earlier relative to predicted oviposition time.
8.3.1 Materials and Methods
From 34 stock hens aged 44 weeks, 23 whose next oviposition times could be
predicted were selected over six days and allocated randomly to receive an injection of
either 0.9% saline (n = 9) or 6 mg/kg morphine (n = 14). It was suspected from
Section 8.2 that morphine may have two effects on oviposition time, i.e. it either
induces oviposition prematurely or does not. To increase the chance of detecting such
a bimodality, more hens were allocated to the morphine treatment than to the saline
treatment. Morphine was dissolved in 0.9% saline (12 mg/ml) and stored at room
temperature until required. Morphine and saline were both injected i.v. at 0.5 ml/kg,
75 min before predicted oviposition time. The dose of 6 mg/kg morphine was within
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expected oviposition time (min)
° Saline 6 mg/kg morphine
Figure 8.2 The time from injection, of either saline or 6 mg/kg morphine, until
expected oviposition time and the time from injection until observed
oviposition time for each hen. The diagonal dashed line indicates expected
oviposition time relative to the two axes. Points below this line indicate
ovipositions that occurred earlier than expected oviposition time and points
above this line indicate ovipositions that occurred later than expected
oviposition time.
8.3.2 Results
One hen (saline treatment) was excluded from the analysis as its egg sequence
ended within two days of injection, thus preventing accurate calculation of expected
oviposition time.
Figure 8.2 shows the time from injection until expected oviposition time and
the time from injection until observed oviposition time for each hen. As described in
Section 8.2.2, there was a range of times from injection until expected oviposition
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time. Of the 14 hens receiving morphine, 6 laid 8-13 min (mean = 10 min) after
injection, and these ovipositions were 28-101 min (mean = 65 min) before their
expected times. As these ovipositions were premature and occurred at a relatively
short and regular interval after injection, it appears that morphine may have induced
them. The remaining 8 hens receiving morphine laid either around the expected time
(n = 5) or somewhat later (n = 3). No ovipositions occurred within 15 min of a saline
injection.
Ifmorphine did induce oviposition prematurely in some hens but not in others,
then the distribution of observed oviposition times, relative to expected oviposition
times and injection times, is not expected to be unimodal. Therefore, the aim of the
following analysis was to test the data for unimodality. If morphine induced some
ovipositions prematurely then the observed times of these should be related to injection
times. Conversely, observed times of other ovipositions (non-induced) might be
related to their expected times. To allow for the variation in injection time, a score was
calculated for each oviposition by dividing the time from injection until observed
oviposition time by the time from injection until expected oviposition time. Thus,
premature ovipositions have a score less than one, ovipositions occurring at the
expected time have a score equal to one and delayed ovipositions have a score greater
than one. These scores for both morphine and saline injected hens are shown in
Figure 8.3.
To test the null hypothesis that the distribution of the scores of the morphine
treated hens was unimodal, the data were analysed using the procedure of Silverman
(1981; see also Sinnett-Smith & Waddington, 1992). Briefly, the distribution of the
14 scores was smoothed by overlaying each score with a normal distribution of fixed
variance. Changing the variance alters the amount of smoothing and increasing the
amount of smoothing results in a distribution with fewer modes. The distribution of
the 14 scores was smoothed just enough to generate a unimodal distribution (i.e. any
less smoothing would produce a bimodal distribution). From this generated
distribution, 500 simulated random samples of 14 values were drawn, and each of
these was smoothed using the same variance that gave the distribution from the
original scores.
As only 8 of the 500 simulations (1.6%) had a unimodal distribution when
smoothed, the probability that the original scores were distributed unimodally is
0.016. As 348 of the 500 simulations (69.6%) were distributed bimodally, the
probability that the original scores were distributed bimodally is 0.696. Hence, the
probability that the distribution has more than two modes is 0.288 (1-(0.696+0.016) =
0.288). Thus, it was concluded that the distribution of oviposition times following
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Figure 8.3 Distribution of scores for hens receiving an injection of either 6 mg/kg
morphine or saline. For each hen the score was calculated by dividing the time
from injection until observed oviposition time by the time from injection until
expected oviposition time (see text, p.93). The six hens whose ovipositions
were induced by morphine all have scores less than 0.3.
morphine injection was not unimodal (P<0.05) but may be bimodal (P>0.05). The
finding that the distribution was not unimodal supports the hypothesis that morphine
has more than one effect on oviposition time (i.e. it does or does not induce
oviposition prematurely).
For the saline treated hens, there were too few scores (n = 8) to permit an
analysis of their distribution using the Silvermann (1981) procedure. However, for
these hens there is no suggestion of bimodallity in the distributions of either
oviposition delay durations (Figure 8.2) or scores (Figure 8.3).
Although systematic behavioural observations were not made, it was noted that
hens whose ovipositions were induced prematurely by morphine injection tended to
show characteristic pre-laying behaviours, such as pacing and sitting, at expected
oviposition time.
For the following analysis the six ovipositions which occurred prematurely and
within 15 min of the morphine injection are considered to have been induced by this
treatment (see above analysis). There was no significant difference in the times from
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morphine injection until expected oviposition time between the ovipositions which
were induced and those which were not (t-test; t=l .34, 6df, P>0.05).
The mean A oviposition times for hens receiving saline and for those receiving
morphine but whose ovipositions were not induced by this treatment are shown in
Table 8.2. The mean A oviposition time following injection of morphine was
significantly longer than that following injection of saline (t-test; t=2.73, 13df,
P<0.05). If it is assumed that the hens whose ovipositions were induced by morphine
were a random sample of the population (see Discussion), this result suggests that
morphine delays oviposition in some birds when it does not induce it.
Table 8.2 Mean (+SEM) A oviposition time after saline injection (n = 8) or 6
mg/kg morphine injection where this did not induce oviposition (n = 8).
8.4 Effects of a Range of Doses of U50,488 on Oviposition Time
The aim of this experiment was to investigate the effects of U50,488, at a
range of doses, on hens' oviposition times. From this experiment a dose of 4 mg/kg
U50,488 was chosen for further testing in Section 8.5.
8.4.1 Materials and Methods
From 35 stock hens aged 40 weeks, 24 whose next oviposition times could be
predicted were selected over two days and randomly allocated to receive an injection of
either 0.9% saline (n = 5) or U50,488 at 1, 2, 4 or 5 mg/kg (n = 5, 8, 4 and 2). This
range of U50,488 doses includes some that, when administered systematically to rats,
inhibit electrical activity of putative oxytocin neurones, inhibit AVP release and
prolong labour (Clarke & Wright, 1989; Douglas et al., 1993; Pumford et al., 1993).
U50,488 (tranj'-(-l-)-3,4-dichloro-N-methyl-N-[2-(l-pyrrolidinyl)-cyclohexyl]-
benzeneacetamide methane sulphonate salt; Research Biochemicals Incorporated,
Natick, MA) was dissolved in 0.9% saline (4 mg/ml) and stored at 4°C until required.






This solution was injected at 0.25, 0.5, 1.0 and 1.25 ml/kg for doses of 1, 2, 4 and 5
mg/kg U50,488, respectively. Saline injections were 0.5 ml/kg. All injections were
i.v., 40 min before predicted oviposition time. Mean A oviposition times were
compared between treatments by t-test.
8.4.2 Results
Two hens (1x2 mg/kg and 1 x 4 mg/kg U50,488 treatments) were excluded
from the analysis as their egg sequences ended within two days of injection, thus
preventing accurate calculation of expected oviposition times.
Mean A oviposition time for each of the treatments and the statistical
comparasons between these are shown in Figure 8.4. For each U50,488 dose, mean
A oviposition time was positive, indicating that treatment with U50,488 tends to cause
oviposition delays. Injection of 4 mg/kg U50,488 caused the greatest delay relative to
saline treatment (Figure 8.4).
Saline 1 mg/kg 2 mg/kg . 4 mg/kg 5 mg/kg
Figure 8.4 Mean (+SEM) A oviposition times following injection of either saline (n
= 5) or U50,488 at 1, 2, 4 or 5 mg/kg (n = 5, 7, 3 and 2). Means with no common
letter differ significantly (P<0.01) and means with a common letter do not differ
significantly (P>0.05).
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8.5 Effects of 4 mg/kg U50,488 on Oviposition Time
In Section 8.4, treatment with U50,488 delayed oviposition time, 4 mg/kg
causing the longest delays. The aim of the following experiment was to confirm,
through the use of a larger sample size, that 4 mg/kg U50,488 injections delay
oviposition.
8.5.1 Materials and Methods
From 35 stock hens aged 47 weeks, 23 whose next oviposition times could be
predicted were selected over two days and randomly allocated to receive an injection of
either 0.9% saline (n = 12) or 4 mg/kg U50,488 (n = 11). U50,488 was dissolved in
0.9% saline (5 mg/ml) and stored at 4°C until required. U50,488 and saline were
both injected i.v. at 0.8 ml/kg, 30 min before predicted oviposition time.
8.5.2 Results
One hen (saline treatment) laid as it was restrained for injection, another
(U50,488 treatment) laid before it was due to be injected and a third (U50,488
treatment) did not receive its full injection volume. These three hens were excluded
from the analysis.
Mean A oviposition times after injections of either saline or 4 mg/kg U50,488
are shown in Table 8.3. The mean A oviposition time after 4 mg/kg U50,488 injection
was significantly longer than that after saline injection (t-test; t=2.76, 4 df, P<0.05).
This confirms that injection of 4 mg/kg U50,488 delays oviposition.
Injection Mean A oviposition time (min)
Saline 5.0 (6.4)
4 mg/kg U50,488 26.4 (4.4)
Table 8.3 Mean (+SEM) A oviposition time after injection of either saline (n = 11)
or 4 mg/kg U50,488 (n = 9).
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8.6 Does Treatment with Nalmefene Reduce the Duration of
Oviposition Delays Induced by U50,488?
In Sections 8.4 and 8.5, injections of 4 mg/kg U50,488 caused oviposition
delays. U50,488 is known to prolong labour in rats partly by directly inhibiting
uterine contractions in a non opioidergic manner and partly by inhibiting
neurohypophysial oxytocin release in an opioidergic manner (Douglas et al., 1993). It
is not known if U50,488 delays oviposition by direct uterine effects or through its
actions as an opioid receptor agonist. If U50,488 delays oviposition by acting as an
opioid agonist then these delays should be prevented by treatment with an opioid
antagonist. The aim of the following experiment was to see if co-treatment with the
non-specific opioid antagonist nalmefene would reduce the duration of oviposition
delays induced by U50,488 injection.
8.6.1 Materials and Methods
From 48 stock hens aged 27 weeks, 30 whose next oviposition times could be
predicted were selected over 5 days and randomly allocated to receive one of four
injections. These were 0.9% saline, 4 mg/kg U50,488, 4 mg/kg U50,488 + 0.5
mg/kg nalmefene, and 0.5 mg/kg nalmefene (n = 8, 7, 7 and 8, respectively). This
dose of nalmefene reduces the duration of stress-induced oviposition delays (Chapter
7). U50,488 was dissolved in 0.9% saline (8 mg/ml and 16 mg/ml) and stored at 4°C
until required. Nalmefene was dissolved in 0.9% saline (1 mg/ml and 2 mg/ml) and
stored at -18°C until required. Shortly before injection of U50,488 + nalmefene,
equal volumes of 16 mg/ml U50,488 and 2 mg/ml nalmefene were mixed to give
concentrations of 8 mg/ml and 1 mg/ml, respectively. All injections were 0.5 ml/kg
i.v., 30 min before predicted oviposition time. Mean durations of oviposition delay
were compared between treatments by t-test (pooled where standard deviations were
similar).
8.6.2 Results
Mean durations of oviposition delay following each of the four injection
treatments and the statistical comparisons between these are shown in Figure 8.5.
Oviposition delays following injection of U50,488 were significantly longer than those
following any of the other three injection treatments. Thus, 4 mg/kg U50,488 induced
oviposition delays but this response was reduced by co-treatment with nalmefene.
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There were no significant differences between saline, U50,488 + nalmefene and
nalmefene treatments. Thus, compared with the saline controls, 4 mg/kg U50,488 in
the presence of 0.5 mg/kg nalmefene did not induce oviposition delays. Furthermore,











Figure 8.5 Mean (+SEM) durations of oviposition delay following injection of
either saline (n = 8), 4 mg/kg U50,488 (n = 7), 4 mg/kg U50,488 + 0.5
mg/kg nalmefene (n = 7) or 0.5 mg/kg nalmefene (n = 8). Means with no
common letter differ significantly (P<0.05).
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8.7 Do AVT Injections End the Oviposition Delaying Effect of
U50,488?
Injections of 4 mg/kg U50,488 cause oviposition delays in a naimefene
reversible manner (Sections 8.4, 8.5 and 8.6). In mammals, U50,488 disrupts
parturition and it is hypothesised that this is due to inhibition of oxytocin release
(Douglas et al., 1993). This hypothesis is supported by the finding that these
disruptions are associated with reduced plasma oxytocin concentrations and are ended
by oxytocin injection (Douglas et al., 1993). Possibly U50,488 delays oviposition by
inhibiting neurohypophysial AVT release. If this hypothesis is correct, then injecting
exogenous AVT should end these delays and allow oviposition to proceed. The aim of
the following experiment was to see if the oviposition delaying effect of U50,488 can
be ended by injecting AVT.
8.7.1 Materials and Methods
From 25 Hisex hens aged 31 weeks and reared as described in Section 7.3, 20
whose next oviposition times could be predicted were selected and randomly allocated
to receive an injection of either 0.9% saline or 0.1 ug/kg AVT (n = 10 each), each
following an injection of 4 mg/kg U50,488. This dose of AVT ends stress-induced
oviposition delays (Chapter 6). U50,488 was dissolved in 0.9% saline (8 mg/ml) and
stored at 4°C until required. U50,488 solution was injected i.v. (0.5 ml/kg) 30 min
before predicted oviposition time. Twenty min after predicted oviposition time each
hen received a second injection: either saline or AVT (as described in Section 6.3) and
the time from this until observed oviposition, the oviposition induction time, was
recorded. From the experiments described in Sections 8.4, 8.5 and 8.6 it was
expected that most hens receiving 4 mg/kg U50,488 would still be carrying their egg
20 min after predicted oviposition time.
8.7.2 Results
The egg sequences of three hens (2 x saline treatment, 1 x AVT treatment)
ended within one day of treatment, thus preventing accurate calculation of their
expected oviposition times These hens and another (saline treatment) which did not
carry an egg on the day of treatment were excluded from the analysis.
Three of the seven remaining hens allocated to receive saline and six of the nine
remaining hens which had been allocated to receive AVT laid before they were due to
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receive these injections (i.e. before 20 min after predicted oviposition time). Thus
only four hens received a saline injection and three hens an AVT injection. Mean times
from saline and AVT injections until observed ovipositions are shown in Table 8.4.
The time from injection until observed oviposition was significantly shorter for AVT
injection than for saline injection (t-test; t=3.86, 3df, P<0.05). The mean oviposition
delay for all seven birds allocated to receive saline was 17.4 min (+ 8.6 SEM).
Table 8.4 Mean (+SEM) oviposition induction times following injection of either
saline (n = 4) or AVT (n = 3) 20 min after the predicted oviposition times of
hens treated with 4 mg/kg U50,488.
8.8 Discussion
As some birds receiving 6 mg/kg morphine i.v. laid prematurely and shortly
after this injection, it appears that morphine can act to induce some ovipositions
prematurely. The distribution of observed oviposition times following morphine
injection was not unimodal, but may be bimodal, supporting the conclusion that this
treatment has more than one effect, i.e. it does or does not induce oviposition. Hens
whose ovipositions were considered to have been induced prematurely by injection of
morphine performed pre-laying behaviours at expected oviposition time, confirming
that these ovipositions were indeed premature. Saline injections did not appear to
induce premature oviposition in any of the experiments described in this chapter.
The finding that morphine induces some ovipositions prematurely was
unexpected. In rats, similar i.v. doses of morphine inhibit release of
neurohypophysial oxytocin and so prolong parturition (Russell et al., 1989; Pumford
et al., 1991; Pumford et al., 1992). Morphine also disrupts the milk-ejection reflex in
both mice and rats, a process known to be dependent on oxytocin release (Haldar &
Sawyer, 1978; Russell & Spears, 1983). Furthermore, at doses lower than those









laying hens (Xu et al., 1991; Dublecz et al., 1992). Consequently, it had been
predicted that morphine would induce oviposition delays by inhibiting
neurohypophysial AVT release.
Although some ovipositions which were not induced by morphine were
delayed relative to those of saline treated hens, this finding must be interpreted
cautiously. As it is not known why morphine induced some ovipositions, it is not
known if these represented a random sample of the treated hens. Therefore, the
duration of oviposition delays of non-induced ovipositions may not be representative
of all hens. For example, morphine may have induced oviposition in hens which
would have laid slightly earlier than expected on the day of treatment (had there been
no treatment), but not in hens which would have laid slightly later than expected. If
this happened then the mean A oviposition time of the morphine treated hens whose
ovipositions were not induced would be greater than that for the control hens, even
though morphine did not actually delay oviposition. If it is assumed that the hens in
which oviposition was induced by morphine were a random sample of the population,
the results would indicate that morphine acts to delay some ovipositions when it does
not induce them. As described above, morphine inhibits oxytocin release in mammals
and inhibits osmotically stimulated AVT release in chicks and hens. Therefore,
morphine might delay oviposition by inhibiting neurohypophysial AVT release.
It is not known by what mechanism morphine acts to induce some ovipositions
prematurely, or even if it is acting as an opioid agonist. As the hens whose
ovipositions were induced and those whose ovipositions were not induced were
injected at similar times (relative to expected oviposition time), the mechanism by
which morphine acts to induce oviposition does not appear to be related to the time of
injection. It is also not known if particular hens are more succeptable than others to
this effect ofmorphine, or if it occurs with equal probability in all birds.
Morphine is reported to have more than one effect on the release of substance P
from rat trigeminal nucleus slices. Morphine inhibits release at low and medium
concentrations but facilitates release at intermediate (i.e. between low and medium) and
higher concentrations (Suarez-Roca et al., 1992). As various specific receptor
antagonists inhibit different parts of morphine's multiphasic effect on substance P
release, it is thought that morphine may act via different receptor types to cause these
different effects, and that the effects are dose related because morphine has different
affinities for each receptor type (Suarez-Roca & Maixner, 1992). Perhaps, by acting
on more than one opioid receptor type, morphine has both facilitatory and inhibitory
effects on AVT release and so can induce oviposition (by facilitating release) or delay
oviposition (by inhibiting release). This hypothesis would be supported if it was
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shown that the separate oviposition inducing and delaying effects of morphine were
differentially prevented by specific antagonists of different opioid receptor types.
Although U50,488 generally inhibits electrical activity of oxytocin neurones in vivo, it
sometimes increases activity at low concentrations, opposite effects which may be
associated with its actions on different sub-types of the kappa opioid receptor
(Pumford et al., 1993). As different subtypes of a receptor may be linked to different
G-proteins, and so may have different effects when stimulated, an opioid agonist can
affect neuronal activity in opposite ways (Shen & Crain, 1989). Perhaps the
oviposition inducing and delaying effects of morphine are mediated by different
subtypes of one opioid receptor type. It has been reported that morphine occasionally
has a stimulatory effect on the activity of putative oxytocin neurones in the rat
supraoptic nucleus (Leng et al., 1990; Pumford et al., 1991).
An alternative possibility is that morphine acts directly on uterine muscle to
promote contractions which expel some eggs prematurely. Widy-Tyszkiewicz et al.
(1978) found that morphine caused small dose dependent increases in contractions of
isolated rat uteri, while Acevedo and Contreras (1987) observed that morphine
enhanced, in a non-opioid manner, the contraction inducing effects of adrenaline on
uteri that had been isolated from mice which had been chronically exposed to
morphine. By contrast, morphine has also been reported to have no effect on either
spontaneous or oxytocin induced contractions of isolated rat uteri (Russell et al.,
1989), and to slightly inhibit the stimulated contractions of in vitro uteri from non¬
pregnant rats and mice (Acevedo & Contreras, 1984; Sivalingam & Pleuvry, 1985). If
opioid receptor antagonism does not prevent the premature induction of oviposition by
morphine, then this effect may be due to non-opioid actions of morphine on the uterus.
This possibility could be tested by investigating the effects of morphine on hens'
uterine contractions, in vivo and in vitro.
The main conclusion from the experiments involving U50,488 is that this
kappa receptor agonist can induce oviposition delays in undisturbed hens. This effect
was prevented by nalmefene, thus confirming that U50,488 acted as an opioid agonist.
The finding that such an exogenous agonist induces oviposition delays supports the
hypothesis that stress-induced oviposition delays could be mediated by endogenous
opioids.
In anaesthetised rats, U50,488 reduces the firing rate of putative oxytocin
neurones in the supraoptic nuclei and inhibits electrically stimulated oxytocin release
(Pumford et al., 1993; Russell et al., 1993). Thus, U50,488 can inhibit oxytocin
release by acting in the hypothalamus (centrally) and in the neurohypophysis
(peripherally). As kappa receptors have not been associated with the terminals of AVT
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neurones (see Section 1.6.2) it is unlikely that U50,488 inhibits AVT release at the
level of the posterior pituitary. Therefore, U50,488 may act centrally to inhibit
neurohypophysial AVT release and hence delay oviposition. Although the route
through which uterine contractions stimulate AVT release has not been described, it
may involve a spinal reflex similar to that which triggers oxytocin release in mammals
during parturition and lactation (Edquist & Stabenfeldt, 1993). Therefore, a further
possibility is that U50,488 acts within the spinal cord to suppress the passage of
excitatory stimuli from the uterus to the hypothalamus, and so to inhibit AVT release.
Morphine can act on spinal sites to inhibit the milk ejection reflex in lactating rats, a
process dependent on oxytocin release (Wright, 1985). As U50,488 can cross the
blood brain barrier, the experiments reported here do not indicate where U50,488 may
be acting to inhibit AVT release.
It should be noted that the dose of U50,488 required to delay oviposition (4
mg/kg) was higher than those doses required to inhibit release of oxytocin and AVP
and to disrupt parturition in mammals (Oiso et al., 1988; Douglas el al., 1993;
Pumford et al., 1993; Russell et al., 1993). As the dose used was relatively high, the
possibility that U50,488 may have had non-specific activity which contributed towards
the effects reported here cannot be excluded.
The finding that AVT injection ends the oviposition delaying effect of U50,488
(Section 8.7) is consistent with the hypothesis that these delays are caused by
inhibition ofAVT release. The hypothesis that U50,488 inhibits AVT release is tested
in Chapter 9.
A further finding in this chapter is that nalmefene injection alone does not alter
the oviposition time of undisturbed hens compared with saline injection (Section 8.6).
This suggests that inhibitory opioidergic pathways do not control oviposition time in
undisturbed hens.
In Section 8.7, U50,488 did not appear to induce oviposition delays as
potently as in the preceding experiments (Sections 8.4, 8.5 and 8.6). Perhaps the
Hisex strain of hen in Section 8.7 and the ISA Brown strain in Sections 8.4, 8.5 and
8.6 respond differently to U50,488, and this was responsible for the differences in
delay duration. Differences in duration of oviposition delay induced by social stress
were also found between these strains (Chapter 7).
To summarise, U50,488 had a delaying effect on oviposition, and this was
prevented by nalmefene and ended by exogenous AVT. Morphine induced some
ovipositions prematurely but may have delayed others. These findings support the
hypothesis that stress-induced oviposition delays are caused by endogenous opioids
acting to inhibit AVT release.
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CHAPTER 9: Effects of U50,488 and Nalmefene
on PGF2a-Induced Premature Oviposition and
Associated Changes in Plasma AVT
Concentration
9.1 Introduction
In mammals, endogenous opioids released in response to stress inhibit the
release of neurohypophysial oxytocin and so disrupt parturition and lactation (Haldar
& Bade, 1981; Petherick et al., 1993). Exogenous opioid agonists, such as the kappa
receptor selective U50,488, also inhibit oxytocin release, by acting in both the
hypothalamus and the neurohypophysis (Zaho et al., 1988a; Pumford et al., 1993;
Russell et al., 1993), and so disrupt parturition and lactation (Clarke & Wright, 1989;
Douglas et al., 1993). In hens, the durations of stress-induced oviposition delays are
reduced by nalmefene treatment, thus implicating endogenous opioids in the
underlying mechanism (Chapter 7). Oviposition delays can also be induced by i.v.
administration of U50,488 (Chapter 8), and it is hypothesised that opioidergic
inhibition of neurohypophysial AVT release is involved in the mechanism underlying
these delays and those induced by environmental stress. The aim of the following
study was to test the hypothesis that U50,488 would inhibit, in an opioidergic
manner, the release of AVT associated with PGF2a induced uterine contractions.
Treatments with nalmefene, a non-selective opioid receptor antagonist, were included
so that any effects of U50,488 could be attributed to its actions on opioid receptors.
PG release from the ovary is the initial event of spontaneous oviposition and
triggers, by inducing uterine contractions, the release of AVT from the posterior
pituitary (Shimada & Saito, 1989). Intra-uterine injection of exogenous PGF2a
induces oviposition prematurely within a few minutes and this is associated with a rise
in plasma AVT concentration (Saito etal., 1987; Shimada etal., 1987a; Murakami et
al., 1990). Premature ovipositions can also be induced by i.v. PGF2a (1 (ig/hen),
these occurring approximately 8 min after injections given 1-4 h before expected
oviposition time (Goto et al., 1985). In the following experiments, PGF2a injections
were used to induce uterine contractions and so stimulate AVT release, and the effects
of treatments with U50,488 and nalmefene on both the induction of oviposition and
the rise in plasma AVT concentration were investigated.
There were two possible times at which blood samples could be taken to
investigate the effect of the experimental treatments on PGF2a induced AVT release:
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either a fixed time after PGF2a injection or at the time of induced oviposition. As it
was expected that U50,488 would inhibit AVT release, and as AVT release following
PGF2a injection contributes towards the expulsion of the egg (Murakami et al.,
1990), it was not known if treatment with U50,488 would prevent PGF2a injections
from inducing premature oviposition. Therefore, blood samples were taken at a fixed
time after the PGF2a injections in Experiment 1. Because of problems with the assay
procedure, no measures of AVT concentrations in the blood samples taken during
Experiment 1 were obtained, and consequently only the effects of the treatments on
oviposition induction by PGF2a injection are reported. As all PGF2a injections
induced ovipositions following each treatment in Experiment 1, blood samples were
taken immediately after the induced ovipositions in Experiment 2 rather than at a fixed
time after injection.
9.2 Experiment 1: Rate of Premature Oviposition Induction by
Exogenous PGF2a
The aim of this experiment was to investigate the effects of treatments with
U50,488 and nalmefene on both the rate of premature oviposition induction caused by
PGF2a injection and the plasma AVT concentrations 5 min after these PGF2a
injections. However, because of problems with the assay, no measurements of AVT
concentration were obtained and only the effects of treatments on the premature
induction of oviposition by PGF2a are reported.
9.2.1 Materials and Methods
On each of eight days, four hens whose next oviposition times could be
predicted were selected from a stock of 34, between 52 and 55 weeks of age. Each
day the four hens were randomly and evenly divided between four injection
treatments: saline, 4 mg/kg U50,4880, 4 mg/kg U50,488 + 0.5 mg/kg nalmefene, and
0.5 mg/kg nalmefene (thus, n = 8 for each treatment). This dose of U50,488 causes
oviposition delays (Chapter 8) and this dose of nalmefene reduces the duration of
oviposition delays induced by both 4 mg/kg U50,488 (Chapter 8) and social stress
(Chapter 7). A first blood sample to assess basal plasma AVT concentrations was
taken from each hen 1.5 h before predicted oviposition time, and then the treatment
injection (see section 8.6.1 for details) was administered. PGF2a (0.5 p.g/kg), a dose
known to induce premature oviposition within a few minutes, was then injected (see
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section 6.2.1 for details) 15-26 min (mean = 20 min) later. For each bird the times
from PGF2a injection until oviposition, the oviposition induction times, were
recorded and a second blood sample was taken 5.0 min after this injection.
Because of problems with the assay, AVT concentrations in the blood samples
taken during this experiment were not determined and only the effects of the treatments
on oviposition induction times are reported.
9.2.2 Results
The expected oviposition times of six hens (2 x saline, 2 x U50,488, 2 x
nalmefene) could not be calculated as their egg sequences ended within three days of
treatment. Another hen, due to receive U50,488 + nalmefene, did not carry an egg on
the day of injection. These hens and another (saline) which laid before receiving its
PGF2a injection were excluded from the following analysis (thus: saline, n = 5;
U50,488, n = 6; U50,488 + nalmefene, n = 7; nalmefene, n = 6).
PGF2a injections were 0.8-2.2 h (mean = 1.3 h) before expected oviposition
times and induced oviposition in every hen. Mean oviposition induction times for
each treatment are shown in Figure 9.1. The effects of treatments with saline,
U50,488 + nalmefene and nalmefene were compared by t-test. Although the
oviposition induction times tended to be longer after both U50,488 + nalmefene and
nalmefene treatments than after saline treatment (Figure 9.1), only the difference
between U50,488 + nalmefene and saline treatments was significant at P<0.05 (t =
2.64). As two U50,488 treated birds laid after the blood sampling procedure, which
was 5.0 min after PGF2a injection, this may have influenced the timing of these
ovipositions, rank statistics were used to compare the oviposition induction times after
U50,488 treatment with those following other treatments. Although the oviposition
induction times tended to be longer after U50,488 treatment compared with saline,
there were no significant differences between the U50,488 treatment and any of the







Saline U50,488 U50,488 Nalmefene
+ Nalmefene
Figure 9.1 Mean (+SEM) oviposition induction times after injection of 0.5 |lg/kg
PGF2a in hens treated with either saline (n = 5), 4 mg/kg U50,488 (n = 6), 4
mg/kg U50,488 + 0.5 mg/kg nalmefene (n = 7) or 0.5 mg/kg nalmefene (n =
6) in Experiment 1. Note that two ovipositions (U50,488 treatment) occurred
after the blood sampling procedure 5.0 min after PGF2a injection.
9.3 Experiment 2: Rate of Premature Oviposition Induction by
Exogenous PGF2a and Associated changes in Plasma AVT
concentration
The aim of this experiment was to investigate the effects of treatments with
U50,488 and nalmefene on both the rate of premature oviposition induction caused by
PGF2a injection and the plasma AVT concentrations after these PGF2a injections.
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9.3.1 Materials and Methods
Over four days a total of 24 hens (4 on each of two days and 8 on each of two
days) whose next oviposition times could be predicted were selected from a stock of
32, between 27 and 32 weeks of age. On each day the hens were randomly and
evenly divided between four injection treatments: saline, 4 mg/kg U50,4880, 4 mg/kg
U50,488 + 0.5 mg/kg nalmefene, and 0.5 mg/kg nalmefene (thus n = 6 for each
treatment). The treatments were the same as those used in Experiment 1 and are
described in Section 8.6.1. These injections were given 1.5 h before predicted
oviposition time and then, to assess their effects on basal plasma AVT concentrations,
a first blood sample was taken 7-28 min (mean =13 min) later. Following this blood
sample each hen received i.v. 0.5 ftg/kg PGF2a (for injection details see Section
6.2.1). Oviposition induction times were recorded and a second blood sample was
taken from each hen immediately after induced oviposition.
AVT concentration in plasma from each blood sample was determined in
duplicate using a radioimmunoassay (Peninsula Laboratories Inc.) which is described
and validated in Appendix 2. Mean plasma AVT concentrations were compared
between treatments by t-test (pooled where standard deviations were similar) and
between blood sampling times within each treatment by paired t-test.
9.3.2 Results
PGF2a injections were 0.5-1.9 h (mean = 1.1 h) before expected oviposition
times and induced oviposition within 25 min in all but one bird (U50,488 treatment).
The mean oviposition induction times after treatments with saline, U50,488 +
nalmefene or nalmefene were compared by t-test. Although the mean induction times
were slightly longer after treatments with U50,488 + nalmefene and nalmefene than
after saline (Figure 9.2), there were no significant differences between any of these
treatments (all P>0.05). Because premature oviposition was not induced by PGF2a
in one bird receiving U50,488, the effects of this treatment on oviposition induction
time were compared with the other treatments using rank statistics, allocating the
highest rank to the oviposition which was not induced (thus, n = 6 for all treatments).
Oviposition induction times after treatment with U50,488 were significantly longer
compared with saline (Mann-Whitney, w=55, P<0.01), but not compared with




Saline U50,488 U50,488 Nalmefene
+ Nalmefene
Figure 9.2 Mean (+SEM) oviposition induction times after injection of 0.5 pg/kg
PGF2a in hens treated with either saline, 4 mg/kg U50,488, 4 mg/kg
U50,488 + 0.5 mg/kg nalmefene or 0.5 mg/kg nalmefene in Experiment 2 (n =
5 for U50,488 treatment, as one oviposition was not induced, and n = 6 for
the other three treatments).
The effects of the four injection treatments on plasma AVT concentrations
before PGF2a injection and at the time of induced oviposition are shown in Figure
9.3. There were no significant differences in mean plasma AVT concentrations before
PGF2a injection between any pair of treatments (all P>0.05). For all treatments, the
mean plasma AVT concentrations were significantly greater at the time of induced
oviposition compared with those before PGF2a injection (all P<0.05). Mean plasma
AVT concentrations at the time of induced oviposition were similar after treatment with
saline, U50,488 + nalmefene or nalmefene and these were higher than that after























Figure 9.3 Mean (+SEM) plasma AVT concentrations before injection of
PGF2a (dark bars) and at the time of oviposition induced by i.v. exogenous
PGF2a (light bars) in hens treated with either saline, 4 mg/kg U50,488, 4
mg/kg U50,488 + 0.5 mg/kg nalmefene or 0.5 mg/kg nalmefene (n = 5 for
U50,488 treatment at the time of induced oviposition, as one oviposition was
not induced, and n = 6 for all other means)
oviposition was significantly lower in birds receiving U50,488 than in birds receiving
saline (P<0.05). There were no significant differences in plasma AVT concentration
at the time of induced oviposition between any other pair of treatments. Compared
with the saline and U50,488 treatments, there was greater variation in the plasma AVT
concentrations at the time of induced oviposition for U50,488 + nalmefene and
nalmefene treatments, as indicated by the larger SEMs (Figure 9.3).
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9.4 Discussion
In both Experiments 1 and 2, i.v. PGF2a administered to saline treated hens
(controls) induced premature oviposition within a few minutes and, in Experiment 2, it
was shown that plasma AVT concentrations were elevated in association with these
ovipositions. Saito et al. (1987), Shimada et al. (1987a) and Murakami et al. (1990)
have also reported that plasma AVT concentrations are elevated at the time of
ovipositions induced prematurely by exogenous PGF2a. The plasma AVT
concentrations at the time of induced ovipositions in the present study were similar to
those at the time of spontaneous oviposition (Chapter 5) and this is consistent with the
findings of Saito et al. (1987).
In Experiment 2, oviposition induction times were significantly longer
following U50,488 treatment compared with saline treatment. A similar, although non
significant, effect was observed in Experiment 1. It was also found (Experiment 2)
that mean plasma AVT concentration at the time of induced oviposition was
significantly lower after U50,488 injection than after saline injection. In mammals,
U50,488 inhibits AVP release in response to dehydration, hyperosmolality and
hypovolemia (Oiso et al., 1988), and inhibits release of both oxytocin and AVP
vasopressin from isolated neurohypophyses in response to electrical stimulation (Zaho
et al., 1988a, Russell et al., 1993). A possible interpretation of the present results is
that release of neurohypophysial AVT, stimulated by PGF2a induced uterine
contractions, was inhibited by U50,488, and consequently plasma AVT
concentrations at induced oviposition were reduced in U50,488 treated hens. As AVT
released after PGF2a injection promotes uterine contractions and thus contributes
towards the expulsion of the egg (Murakami et al., 1990), the longer oviposition
induction times after U50,488 treatment may be a consequence of suppressed AVT
release.
In both Experiments 1 and 2, oviposition induction times tended to be longer
and more variable after U50,488 + nalmefene and nalmefene treatments compared
with saline treatment. In Experiment 2, the plasma AVT concentrations at induced
oviposition also tended to be more variable after U50,488 + nalmefene and nalmefene
compared with saline. The hypothesis that U50,488 inhibits AVT release in an
opioidergic manner predicts that opioid receptor antagonism should prevent this
inhibition, and hence that plasma AVT concentrations should not be depressed
following U50,488 + nalmefene treatment relative to saline treatment. Mean plasma
AVT concentrations at the time of induced ovipositions after treatments with saline,
U50,488 + nalmefene and nalmefene were all similar, and were higher than that for
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U50,488. However, as a result of the large variability observed after U50,488 +
nalmefene and nalmefene treatments, no significant differences in plasma AVT
concentrations at induced oviposition were found between these treatments and either
saline or U50,488 treatment. Thus, it was not possible to confirm if the reduced AVT
release following U50,488 treatment was mediated by opioid receptors.
In addition to its property as a kappa opioid receptor agonist, U50,488 can act
in a non opioid manner to directly suppress contractions of smooth muscle (Hayes et
al., 1988). Indeed, parturition of rats is delayed by U50,488 acting both to inhibit
oxytocin release in an opioidergic manner and to directly suppress uterine contractions
in a non opioidergic manner (Douglas et al., 1993). Nalmefene completely prevented
the oviposition delaying effect of 4 mg/kg U50,488 in Section 8.6, indicating that
U50,488 delays oviposition in an opioidergic manner and not by directly suppressing
uterine contractions through non-opioid mechanisms. Hence it is unlikely that
U50,488 increased oviposition induction times and reduced AVT release in the present
experiment by directly suppressing uterine contractions. Indeed, the fact that all eggs
but one were expelled prematurely indicates that uterine contractions, the stimulus for
AVT release, were present.
There were no differences between any of the treatments in plasma AVT
concentrations before PGF2a injection. The lack of an effect of nalmefene may
indicate that basal AVT release is not regulated by endogenous opioids, and the lack of
an effect of U50,488 may indicate that basal AVT release is not inhibited by opioids
acting via kappa receptors. Alternatively, treatments with U50,488 and nalmefene
may affect basal AVT release but these effects were not evident due to the short time
between treatment and blood sampling (mean = 13 min). Oiso et al. (1988) found that
basal plasma AVP concentrations were reduced in rats 60 min after receiving 5 mg/kg
U50,488 subcutaneously.
In mammals, opioids can act in the hypothalamus (mu and kappa receptors)
and in the neurohypophysis (kappa receptors only) to inhibit the release of
neurohypophysial hormones (see Bicknell (1985) for a review). Opioids may also act
on spinal sites to inhibit reflex oxytocin release (Wright et al., 1985). In hens, only
one type of opioid receptor (not yet identified) has been found in the neurohypophysis
and it appears that this receptor is located on the terminals of mesotocin but not AVT
neurones (Martin et al., 1992; Kawashima et al., 1995; also see General Introduction).
As opioid receptors have not been associated with the terminals of AVT neurones, it is
unlikely that U50,488 inhibits AVT release by acting on the neurohypophysis. In
Chapters 7 and 8, both stress and U50,488 delayed oviposition in a nalmefene
reversible manner, and it was hypothesised that these delays were due to opioidergic
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inhibition of neurohypophysial AVT release. The finding that U50,488 inhibits the
release of AVT associated with PGF2a-induced premature ovipositions supports the
hypothesis that opioids can inhibit AVT release and that such a mechanism may
underlie oviposition delays.
Of the 32 hens selected for treatment in Experiment 1, 7 had to be excluded
from the analyses of results because their egg sequences ended within three days of
treatment or because no egg was carried on the day of treatment. By contrast, none of
the 24 hens selected for treatment in Experiment 2 were excluded from the analysis.
The hens in Experiment 1 (52-55 weeks old) were older than those in Experiment 2
(27-32 weeks old) and this may account for the above difference between the
Experiments. As older birds tend to lay shorter sequences (i.e. fewer eggs per
sequence) than younger birds which are at the peak of egg production (Lillpers &
Wilhelmson, 1993a), the incidence of egg sequences ending within three days of
treatment will tend to be greater for older birds. As the frequency of internal
ovulations increases with age (Lillpers & Wilhelmson, 1993a), and as internally
ovulated eggs probably account for instances where selected birds did not carry hard-
shelled eggs on the day of treatment, excluding hens from analysis for this reason is
likely to occur more often in experiments with older birds.
To summarise, U50,488 delayed the premature induction of oviposition
following PGF2a injection and this was associated with reduced AVT release. This
finding supports the hypothesis that opioids can act to inhibit AVT release and that
such a mechanism may underlie oviposition delays.
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CHAPTER 10: Use of Headflick Frequency as a
Behavioural Indicator of Hens' Opioid Status as
Affected by Social Stress
10.1 Introduction
It is hypothesised that endogenous opioids released in response to stress are
involved in the mechanism underlying oviposition delays, and that they act by
inhibiting release of AVT from the posterior pituitary (see General Introduction). To
evaluate this hypothesis it is important to consider the effect of the social stress used
in this study on the opioid status of the hens. In mammals, concentrations of
endogenous opioids in both brain and plasma are elevated in response to various
stressors (e.g. Madden et al., 1977; Rodway et al., 1993). As opioidergic inhibition
of neurohypophysial hormone release can be either central or peripheral (Bicknell,
1985), stress-induced oviposition delays could be due to elevated opioid activity in
either brain or plasma.
Although the concentrations of various opioids in mammalian plasma and
brain tissues can be measured by assay techniques, these are unsuitable for
measuring the effect of social stress on release of endogenous opioids in hens.
Firstly, opioid assays have not been validated for use in hens. Secondly, it is not
known which endogenous opioids might influence oviposition. Thirdly, important
stress-related changes in the opioid content of various brain regions may be small, so
there are practical difficulties in their measurement (Akil et al., 1988).
In addition to direct measurement of opioid levels, opioid status of mammals
can be investigated using behavioural indices which typically reflect pain perception.
For example, in rats the latency from a locally applied painful stimulus to tail-
flicking correlates with brain opioid activity (Madden et al., 1917; Kulling et al.,
1989). Behavioural tests of analgesia have been used to demonstrate release of
endogenous opioids in response to various environmental stimuli, such as stress,
novelty and feeding (Rodgers & Randall, 1989). Environmentally and
pharmacologically induced analgesia in chicks have been studied by measuring
behavioural responses to painful stimuli, such as pressure applied to foot (Schneider,
1961), high temperature applied to foot or plucked area of skin (Fan et al., 1981;
Sufka & Hughes, 1990; Sufka et al., 1994), and electric shock applied to wing or leg
(Bardo & Hughes, 1978; Rager & Gallup, 1986). These tests have not been used for
measuring analgesia in adult hens. Hence, the following study investigated the
possible use of hens' headflick response to alerting stimuli, a putative measure of
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arousal or responsiveness, as a behavioural indicator of opioid status. From an
ethical perspective, measures of headflicking are preferable because they do not
involve nociceptive stimulation, as used in tests of analgesia.
Headflicks, also described as headshakes, are distinctive and rapid lateral
movements of the hen's head (Kruijit, 1964). The frequency of headflicking is
elevated in response to alerting stimuli, such as the presence of an observer or
exposure to noise, and is thought to indicate the level of arousal of the hen (Hughes,
1983; Savory et al., 1993a). Arousal has been described as "a hypothetical
physiological variable which correlates with overall behavioural responsiveness and
activity, not necessarily always in terms of overt physical behaviour, but also as
covert nervous system activity" (Delius, 1970 p. 175). Savory and Hughes (1988)
found that treatment with the non-specific opioid antagonist nalmefene influences
the frequency of headflicking by laying hens in a dose dependant manner. A low
dose (0.2 mg/kg) and high doses (0.8 and 1.6 mg/kg) of nalmefene did not alter
headflick frequency while an intermediate dose (0.4 mg/kg) elevated it. One
interpretation was that endogenous opioids have de-arousing properties and that, by
blocking opioid receptors and so removing a basal opioid influence, nalmefene
increases the level of arousal and consequently the frequency of headflicking. Low
levels of headflicking following 0.8 and 1.6 mg/kg nalmefene were thought to
represent reduced arousal due to sedative effects of this drug at these higher doses.
Nalmefene has similar dose dependant effects on spontaneous headflick frequency in
broiler breeder fowls (Savory et al., 1993a). Thus, the frequency of headflicking
may be related positively to the level of arousal and negatively to opioid status in
such a way that increases in endogenous opioid activity are expected to cause de-
arousal and so reduce headflick frequency.
The parent stock of broiler chickens, (broiler breeders) are maintained on a
restricted feeding regime to control their body weight, and as a result are chronically
hungry (Savory et al., 1993b). Savory et al. (1993a) reared broiler breeders on 3
levels of food intake: restricted rations (R), 2 x restricted rations (2R) and ad lib.
food access (AL; food intake was about 3 x restricted rations). At 21 weeks of age
headflick frequency during noise was significantly greater for the AL than the R
birds, with 2R birds being intermediate. Although studies of opioid-like
immunoreactivity in brains from these birds were inconclusive (Savory et al.,
1993a), there were significant increases in delta and mu opioid receptor densities in
R birds (compared with 2R and AL) in certain areas of the striatum (Savory &
Stewart, in preparation). As opioid status is influenced by the density of opioid
receptors in addition to the amount of opioid release, these findings are consistent
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with the hypothesis that headflick frequency reflects opioid status.
It was predicted that exposing hens to social stress would cause the release of
endogenous opioids and these would, through their de-arousing properties, reduce
the frequency of headflicking. In Experiment 1, it is shown that social stress causes
a reduction of hens' headflick frequency relative to control treatment. Experiment 2
examined, through the use of the non-selective opioid receptor antagonist nalmefene
(see Section 1.6.1 for outline of pharmacology), the role of endogenous opioids in
the stress-related reduction in headflick frequency observed in Experiment 1.
However, in Experiment 2, social stress did not depress headflick frequency as it had
in Experiment 1, and so the possibility that the saline injection procedure, present in
Experiment 2 but not Experiment 1, influenced headflick frequency was tested in
Experiment 3.
10,2 Experiment 1: Effect of Social Stress on Headflick Frequency
The aim of this experiment was to test the hypothesis that social stress would
reduce the frequency of headflicking by hens.
10.2.1 Materials and Methods
The headflick responses to alerting stimuli of 20 hens aged 53 weeks were
tested following both stress and control treatments. Hens were allocated randomly
to receive either the stress treatment on the first of three consecutive days and the
control treatment on the second and third or vice versa (n = 10 each). The third day
of testing was included to allow an analysis which included possible treatment carry¬
over effects. Hens were either exposed to social stress for a period of 21-59 min
(mean = 38 min) before testing or left undisturbed until testing (control). Testing
involved isolating each hen in a cage (30 cm wide, 45 cm deep, 37-46 cm high), with
solid sides and a sloping mesh floor in the middle tier of a battery cage system
contained in an unfamiliar room, where it was exposed to a standard 4 min of
varying noise (music) stimulation. The number of headflicks during this period was
recorded on a tally counter by an observer sitting opposite and in full view of the
hen. The noise was expected to increase the frequency of spontaneous headflicking
by acting as an alerting stimulus (Savory et al., 1993a), so improving the ability to
detect differences in arousal between the two treatments. The test conditions also
included a novel environment and the presence of an observer, both of which elevate
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the frequency of headflicking (Hughes, 1983). Hens were tested alternately from
control and social stress treatments, with the order and time of testing birds being the
same on both days. As the headflick response may show a diurnal rhythm (Preston,
1984), it was important that observations on each bird were made at a similar time
each day. All birds were tested in the afternoon and, as it is not known if pre-laying
behaviour or oviposition affect headflick frequency, birds which had not already laid
were palpated to confirm that they did not carry a hard-shelled egg.
10.2.2 Results
Figure 10.1 shows the effects of stress and control treatments on days 1 and 2
(the first exposure to each) on headflicking. It can be seen that there was much


























Figure 10.1 The effect of stress and control treatments on the number of headflicks
during 4 min of exposure to novel noise in an unfamiliar room for hens
receiving either stress on day 1 and a control treatment on day 2 (A) or vice
versa (B).
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was conducted. Considering only days 1 and 2; 15 of the 20 birds showed more
headflicking after control treatment than after stress, 4 birds headflicked more after
stress treatment than after control treatment and 1 bird showed no difference. Thus,
social stress significantly lowers the frequency of headflicking in response to the
novel stimuli of the test conditions (sign test, P<0.05).
To test for possible day, bird and treatment carry-over effects, the data were
log transformed to normalise their distribution and produce a more homogeneous
scatter of variance, thus permitting the use of parametric statistics. There were
significant effects of treatment (F=25.01; 1,37 df; P<0.001 by ANOVA) and bird
(F=43.41; 18,37 df; P<0.001 by ANOVA) but not day of testing (F=0.77; 2,37 df;
P>0.05 by ANOVA) on the number of headflicks. A test for carry-over effects
found no significant influence of previous treatment on headflick response
(X 2=0.36, 1 df, P>0.05).
Back-transformed mean number of headflicks in 4 min was 27.2 for the
control treatment and 18.1 for the stress treatment (corrected for bird and potential
day effects by GLM).
10.3 Experiment 2: Does Nalmefene Prevent the Reduction of Headflick
Frequency Associated with Social Stress?
In Experiment 1, the frequency of headflicking in response to alerting stimuli
was significantly lower following exposure to social stress compared with no stress.
One interpretation of this finding is that social stress causes the release of
endogenous opioids which, through their de-arousing properties, reduce the
frequency of headflicking. If the stress-related reduction of headflick frequency is
mediated by endogenous opioid release then this reduction should be prevented by
treatment with an opioid receptor antagonist. Experiment 2 investigated the effect of
nalmefene, a non-selective opioid receptor antagonist, on the stress-related reduction
in headflick frequency.
10.3.1 Materials and Methods
The headflick responses to alerting stimuli of 16 hens aged 30 weeks were
tested following each of four treatments: saline injection, saline injection then social
stress, 0.5 mg/kg nalmefene injection, 0.5 mg/kg nalmefene injection then social
stress. Each bird was exposed to a different treatment on each of four consecutive
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days according to the following design. Latin squares balanced for carry-over
effects and for n treatments have n different treatment orders, such that each
treatment follows each other treatment only once and each treatment occurs once
each day (John, 1971). For four treatments there are two possible Latin squares
balanced for carry-over effect and thus eight different treatment orders. Two birds
were allocated to each of these possible treatment orders (i.e. two of each Latin
square). Thus, each treatment followed each other treatment four times, each
treatment occurred four times each day and each bird received each treatment once.
The order of testing the 16 birds was randomised for day 1, then this order was
maintained for the following days so that individuals could be tested at the same
time each day. As in Experiment 1, all treatments were in the afternoon and birds
were palpated beforehand if it was not known if they carried a hard-shelled egg.
Nalmefene (6-desoxy-6-methylene naltrexone, Key Pharmaceuticals, Miami)
was dissolved in saline (1.0 mg/ml) and stored at -18°C until required. Following
0.5 ml/kg i.m. injection of 0.9% saline or nalmefene, hens were either exposed to
social stress or returned to their home cages until headflick frequency testing. An
additional 24 hens, also 30 weeks of age, were used to make up the stress groups (8
groups x 3 hens), the composition of which varied each day so that all four hens in
each group were always strangers. The number of headflicks during 4 min exposure
to alerting stimuli was tested 36-63 min (mean = 53 min) after injection by the
procedure described in Experiment 1 but with the following modification. As the
cage used for testing in Experiment 1 was no longer available, during test periods
hens were placed in a single cage (40 cm wide, 45 cm deep, 45 cm high) with mesh
sides and a level solid floor.
The data were log transformed to provide a more normal distribution and
homogeneity of variance. To allow for zero values, 1 was added to each score
before transformation.
10.3.2 Results
As the carry-over on day 1 was the same for all birds (i.e. no previous
treatment), carry-over and day effects were not independent and so could not be
included in the same GLM analysis. As there was no significant influence of
previous treatment on the number of headflicks (F=1.34; 3,39 df; P>0.05), carry over
was excluded from the analysis. There were significant effects of bird (F=29.95;
15,42 df; P<0.001) and treatment (F=7.07; 3,42 df; P<0.001), but not of day (F=2.3;
3,42 df; P>0.05) on the number of headflicks. To clarify the treatment effects, the
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treatment means (corrected for bird and potential day effects by GLM) were
compared by t-test. The treatment means with 95% confidence limits and the results
of the treatment comparisons are shown in Figure 10.2. Nalmefene elevated the
number of headflicks relative to the control (saline) treatment, both with and without
social stress. Social stress did not affect the number of headflicks, following either

















Saline Saline Nalmefene Nalmefene
+ Stress + Stress
Figure 10.2 Back-transformed mean number of headflicks in 4 min with 95%
confidence limits (corrected for bird and potential day effects by GLM) for
each of 4 treatments: saline injection, saline injection plus social stress, 0.5
mg/kg nalmefene injection, 0.5 mg/kg nalmefene injection plus social stress
(n = 16 each). Means with different letters differ significantly (P<0.05).
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10.4 Experiment 3: Do Intramuscular Saline Injections Affect Headflick
Frequency?
Although hens headflicked less frequently in response to alerting stimuli after
social stress than after no stress in Experiment 1, this effect of stress was not found
in' Experiment 2. One possible explanation for this difference is that the i.m.
injection procedure, present in Experiment 2 but not in Experiment 1, was stressful
or painful causing endogenous opioid release and so reducing headflick frequency in
all treatments (i.e. in birds exposed to stress and in those which were not). The fact
that mean headflick frequency for the control treatment in Experiment 2 (stress +
saline injection; 13.6 headflicks in 4 min) was lower than that in Experiment 1
(stress alone; 27.2 headflicks in 4 min) is consistent with this suggestion. To test the
possibility that the i.m. injection procedure may reduce headflick frequency,
Experiment 3 compared the effects of saline injection and no injection on the
frequency of headflicking.
10.4.1 Materials and Methods
The headflick response of 12 hens aged 31 weeks was tested following both
saline injection and control treatments. The birds were randomly allocated to receive
either the injection treatment on the first of two consecutive days and the control
treatment on the second or vice versa (n = 6 each). Birds were injected i.m. with 0.5
ml/kg saline 36-55 min (mean = 45 min) before testing or left undisturbed until
testing (controls). All treatments were in the afternoon and birds were palpated
beforehand if it was not known if they carried a hard shelled egg. The number of
headflicks during 4 min exposure to varying noise was tested as in Experiment 2.
The data were log transformed to provide a more normal distribution and




There was a significant effect of bird (F=4.22; 11,10 df; P<0.05 by GLM) but
not of treatment (F=3.29; 1,10 df; P>0.05 by GLM) or day (F=0.63; 1,10 df; P>0.05
by GLM) on the number of headflicks. For both treatments the mean number of
headflicks (corrected for bird and potential day effects by GLM) with 95%



















Figure 10.3 Back-transformed mean number of headflicks in 4 min with 95%
confidence limits (corrected for bird and potential day effects by GLM)
following saline injection or no treatment (n = 12 each).
10.5 Discussion
As headflick frequency may reflect the level of arousal and is elevated
following treatment with an opioid antagonist it is thought that endogenous opioids
may have de-arousing properties (Hughes, 1983; Savory & Hughes, 1988; Savory et
al., 1993a). In Experiment 1, the reduction of hens' headflick frequencies caused by
social stress may reflect the release of endogenous opioids. This explanation is
consistent with reports that various stressors, including social stress, cause opioid
release in mammals (e.g. Madden et al., 1977; Rodway et al., 1993). If the stress-
related reduction of hens' headflick frequency is indeed opioid mediated, then this
finding supports the hypothesis that opioids released in response to social stress may
be involved in the mechanism underlying oviposition delays.
To confirm that the stress-related reduction of headflick frequency observed
in Experiment 1 reflects release of endogenous opioids, Experiment 2 was designed
to test whether antagonism of opioid receptors could prevent this response.
However, in Experiment 2, which investigated the effect of nalmefene on stress-
related reduction of headflick frequency, social stress did not reduce the frequency of
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headflicking. Additionally, mean headflick frequency for the control treatment in
Experiment 2 (stress + saline injection; 13.6 headflicks in 4 min) was lower than that
in Experiment 1 (stress alone; 27.2 headflicks in 4 min). It is not clear why stress
depressed headflick frequency in Experiment 1 but not in Experiment 2, why
headflick frequency varied between the control treatments of these two experiments
and if these two differences are related. There were some differences between these
experiments which may be important. First, it is possible that the injection
procedure, present in Experiment 2 but not in Experiment 1, was itself stressful or
painful and so caused the release of endogenous opioids which depressed headflick
frequency in all hens (both those exposed to stress and the controls) in such a way
that the effects of stress were masked. However, as there was no effect of i.m saline
injections on headflick frequency in Experiment 3, it is unlikely that this procedure
accounts for the lack of effect of stress in Experiment 2. Second, the test conditions
in which headflick frequencies were measured differed slightly between Experiments
1 and 2 and this may have influenced the headflick response. Although it is not clear
how headflicking might be affected by different test conditions, the results of
behavioural tests of analgesia in mammals can be greatly influenced by subtle
changes in test procedure (Amit & Galina, 1986). For example, Bodnar et al. (1984)
found that by varying the temperature applied to the tail in the rat tail-flick assay,
opposite results to the same treatments could be generated (i.e. analgesia vs. algesia).
Third, the duration of social stress prior to headflick frequency testing was longer in
Experiment 2 (mean = 53 min) than in Experiment 1 (mean = 38 min) and perhaps
the lack of effect of stress in Experiment 2 reflects a time related release of
endogenous opioids during social stress. In mammals the presence of opioid based
stress-induced analgesia is sometimes related to the duration of the stress (see
Rodgers & Randall, 1988). Fourth, the hens in Experiment 1 (53 weeks old) were
older than those in Experiment 2 (30 weeks old) and, although it is not clear how,
age may influence the effects of stress on headflick frequency.
In Experiment 2, 0.5 mg/kg nalmefene significantly increased, relative to
treatment with saline, headflick frequency following either social stress or no stress.
Savory and Hughes (1988) and Savory et al. (1993a) found that similar doses of
nalmefene also elevated headflick frequency of immature hens of an egg-laying
strain and of broiler breeders, and suggested that this reflects increased arousal due
to antagonism of endogenous opioids which have de-arousing properties. The
present study demonstrates that opioid receptor antagonism also increases headflick
frequency in mature laying hens.
A further finding from these experiments is that there is much interbird
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variation in the frequency of headflicking in response to alerting stimuli and this is
consistent with the findings of Hughes (1983). It is therefore desirable, when
investigating the effects of different treatments on headflick frequency, that
experiments are designed in such a way that each hen acts as its own control.
Sherwin et al. (1993) reported that food deprivation followed by
transportation for 6 h increased the latency to the first headflick following
presentation of an alerting stimulus to broiler chickens. As longer latencies to first
headflick are likely to reflect reduced headflick frequencies, their results suggest that
food deprivation followed by transportation may reduce headflick frequency. Thus,
both social stress and transportation following food deprivation reduce headflick
frequency, and it is hypothesised that this reflects the release of endogenous opioids
with de-arousing properties.
To validate the use of headflick frequency as a measure of opioid status
further experiments are required. It still needs to be confirmed, through treatment
with an opioid antagonist, that the stress-related reduction in headflick frequency
observed in Experiment 1 is indeed opioid mediated. If low headflick frequencies
reflect endogenous opioid release then it would be predicted that headflick frequency
would be reduced by injection of exogenous opioid agonists. However, in such
experiments it may be difficult to separate opioid agonist effects from potential
sedative effects. The effects of other environmental stimuli which are thought to
alter hens' opioid status on headflick frequency could be investigated. For example,
as feeding is thought to cause the release of endogenous opioids (Savory etal., 1989)
and reduces in a naloxone reversible manner the performance of pain related
behaviours associated with injection of sodium urate into the ankle joint (Wylie,
1995), it is predicted that feeding will act to reduce headflick frequency. As tests of
analgesia are often used as measures of opioid status in mammals (Rodgers &
Randall, 1988), it would be interesting to compare the effects of various
environmental stimuli on both headflick frequency and analgesia in hens. Although
there are no established methods for testing analgesia in adult hens, tests such as the
hot plate test are frequently used in chicks (e.g. Hughes, 1990). As chicks show
headflicking in response to alerting stimuli (personal observations), they could be
used in a study comparing headflicking and analgesia.
As arousal is a higher brain process and endogenous opioids do not cross the
blood brain barrier, it is likely that opioids influencing headflick frequency originate
and act centrally. However, as with tests of analgesia, changes in headflick
frequency provide no information on which opioids are released in response to
environmental stimuli.
126
In conclusion, although social stress reduced headflick frequency in
Experiment 1, no such effect was found in Experiment 2 and so the role of opioids in
stress-related reduction of headflick frequency could not be tested. However, in
Experiment 2 the opioid antagonist nalmefene did increase headflick frequency,
indicating normal inhibitory opioid tone on this activity. The results of Experiment
1 could still be consistent with the hypothesis that opioid release is involved in the
mechanism underlying oviposition delays induced by social stress.
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CHAPTER 11: Does Propranolol Reduce the
Duration of Stress-Induced Oviposition Delays?
11.1 Introduction
The release of adrenaline, from the adrenal glands and into the circulation, is
involved in mediating hens immediate responses to stressors (Freeman, 1976; Harvey
et al., 1984). Exogenous adrenaline acts via beta adrenergic receptors to cause
relaxation of the hen uterus in vitro (Sykes, 1955; Crossley et al., 1980) and delays
oviposition in vivo (Sykes, 1955; Crossley, 1983) (see Section 1.7 for a review). It
has been hypothesised that stress delays oviposition by causing an adrenergic
suppression of uterine contractions (Sykes, 1955; Weiss & Sturkie, 1952; Hughes &
Black, 1976; Crossley, 1983). If this is correct then treatment with propranolol, a
beta adrenergic receptor blocker, should reduce the duration of these delays. The aim
of the following study was to test this prediction. Effects of propranolol on
environmentally induced oviposition delays have not been reported previously.
In the first experiment (Section 11.2) propranolol prevented stress-induced
oviposition delays. However, it also appeared to induce premature oviposition of
control hens and a second experiment (Section 11.3) was designed to further
investigate this.
11.2 Does Treatment with 10 mg/kg Propranolol Reduce the Duration
of Stress-Induced Oviposition Delays?
The aim of this experiment was to investigate the effects of propranolol on the
oviposition times of both undisturbed hens and those exposed to social stress. In
particular, would propranolol reduce the duration of stress-induced oviposition
delays?
11.2 Materials and Methods
From 35 naive hens aged 24 weeks, a total of 31 whose next oviposition times
could be predicted were selected over two days. Selected hens were randomly
allocated to receive either 0.9% saline injection (n = 7), 0.9% saline injection followed
by social stress (n = 8), 10 mg/kg propranolol injection followed by social stress (n =
8) or 10 mg/kg propranolol injection (n = 8). A lower dose of propranolol (5 mg/kg)
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suppresses object pecking in broiler breeder fowls, but only for up to 1 h, without
apparent sedation (Savory & Kostal, 1994). In order to provide a longer lasting effect
10 mg/kg was used in the present experiment, a dose which influences the respiratory
quotient of cockerels for several hours without affecting daily activity level (MacLeod
& Watson, 1992).
Propranolol (+propranolol hydrochloride; Research Biochemicals
Incorporated, Natick, MA) was dissolved in 1M acetic acid then diluted with 0.9%
saline to a concentration of 20 mg/ml. Both the propranolol solution and the saline for
control injections were adjusted to pH 6.0 by titration with sodium hydroxide and
acetic acid. Injections were 0.5 ml/kg i.m., 40 min before predicted oviposition time.
Immediately after injection, each hen due to receive stress was placed in a
group cage together with three unfamiliar hens. These unfamiliar hens were from an
additional stock of 57-week-old hens, housed individually in bottom tier battery cages.
For all hens in a group, exposure to social stress was ended by returning them to their
original cages once the injected hen laid, or after a period of 4 h if this did not occur.
Hens that were not due to be stressed were returned to their original cages immediately
after injection.
11.2.2 Results
Two hens (1 x propranolol + stress treatment, 1 x propranolol treatment) were
excluded from the following analysis as they laid before they were due to be injected
(i.e. more than 40 min before predicted oviposition time).
Four hens, all receiving saline + stress, did not lay during stress and were
considered to have oviposition delays of 180 min for the following analysis. Mean
oviposition delay duration for each of the four treatments and the statistical
comparisons between these are shown in Figure 11.1. Social stress induced
oviposition delays and propranolol significantly reduced the duration of these.
Indeed, there was no significant difference in delay duration between hens receiving
saline but not stress and those receiving propranolol and exposed to stress. For hens
not exposed to social stress, propranolol caused ovipositions to occur earlier than
expected. It should be noted that injections were 40 min before predicted oviposition
time and so some hens receiving propranolol but not stress laid shortly (range = 8-48
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+ Stress + Stress
Figure 11.1 Mean (+SEM) duration of oviposition delay for hens receiving either
saline injection, saline injection + social stress, 10 mg/kg propranolol injection
+ social stress or 10 mg/kg propranolol injection (n = 7-8 for each). Means
with different letters differ significantly (P<0.05 by Mann-Whitney).
11.3 Does Propranolol Affect Oviposition Time of Undisturbed Hens?
In Section 11.2, hens receiving propranolol injection but not social stress laid
earlier than expected and this effect was significant when compared with the control
treatment (saline injection). Presumably propranolol injection could act in either of
two ways to cause this effect. First, it may act to initiate oviposition prematurely. As
propranolol blocks beta adrenergic receptors, circulating adrenaline will act on the
uterus via alpha receptors only and so will cause contractions (Crossley, 1980).
Possibly stress associated with the injection procedure causes adrenaline release which
then initiates oviposition by inducing contractions. Indeed, it has been shown that
propranolol induces contractions of the hen uterus in vivo (Verma & Walker, 1974;
Murayama et al., 1980). Propranolol is also reported to terminate pregnancy in
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women by acting as a labour inducing agent (Roy et al., 1985). If this hypothesis is
true then oviposition time may be related to injection time (i.e. oviposition occurs a
short time after injection). Second, propranolol may act to hasten the normal
oviposition mechanisms, in which case oviposition time may be related to expected
oviposition time rather than to injection time. Possibly an inhibitory adrenergic
mechanism modulates oviposition time in unstressed hens and propranolol allows
oviposition to occur earlier than normal by blocking this. Alternatively, the effect of
propranolol on oviposition time in Section 11.2 might not be a real one and may have
occurred through random chance.
The aim of the following experiment was to re-examine the effect of
propranolol on the oviposition times of undisturbed hens. So that any premature
ovipositions could be more easily associated with either the injection time or the
expected oviposition time, hens were injected 2 h before predicted oviposition time.
11.3 Materials and Methods
From 35 stock hens aged 26 weeks, 16 whose next oviposition times could be
predicted were selected and randomly allocated to receive an injection of either 0.9%
saline or 10 mg/kg propranolol (n = 8 each). Propranolol and saline were prepared
and injected as described in Section 11.2.1 with the exception that injections took
place 2.0 h before predicted oviposition time. All hens were replaced in their original
cages immediately after injection.
11.3.2 Results
Mean A oviposition times after injection of either saline or propranolol are
shown in Table 11.1. There was no significant difference between the two treatments
(t-test; t=1.64, 14df, P>0.05).
Table 11.1 Mean (+ SEM) A oviposition time for hens receiving either saline or
10 mg/kg propranolol (n = 8 each).







The major finding from Section 11.2 is that propranolol, a beta adrenergic
receptor antagonist, reduces the duration of oviposition delays induced by social
stress. Indeed, relative to control hens (saline injection and no social stress), no
oviposition delay was evident in hens exposed to social stress and receiving
propranolol. This supports the hypothesis that stress acts via adrenergic pathways to
induce oviposition delays (Weiss & Sturke, 1952; Sykes, 1955; Hughes & Black,
1976; Crossley, 1983). The proportions of alpha and beta adrenergic receptors varies
along the length of the oviduct such that adrenergic stimulation causes relaxation of the
uterus and contraction of the uterovaginal sphincter (Verma et al., 1977, Crossley et
al., 1980; Wechsung & Houvenaghel, 1987). It is therefore possible that adrenaline
released in response to stress delays oviposition both by promoting contractions of the
uterovaginal sphincter (alpha receptors) and by suppressing contractions of the uterus
(beta receptors). Propranolol may prevent these delays by blocking the beta receptor
mediated suppression of uterine contractions.
There are now several lines of evidence supporting the hypothesis that a direct
adrenergic suppression of uterine contractions may be involved in delaying oviposition
during environmental stress. Various stressors cause the release of adrenaline from
the adrenal medulla in hens (Freeman, 1976; Harvey et al., 1984). Oviposition delays
can be induced by exogenous adrenaline (Sykes, 1955; Crossley, 1983; Hughes &
Gilbert, 1984) and these can be prevented by propranolol (Crossley, 1983).
Stimulation of adrenergic receptors cases relaxation of uterine muscle, both in vitro
and in vivo (Verma & Walker, 1974; Verma et al., 1977; Crossley, 1980; Wechsung
& Houvenaghel, 1987). The present study now demonstrates that propranolol can
prevent environmental stress from inducing oviposition delays.
Propranolol acts to reduce anxiety in man (Bowman & Rand, 1980) and
presumably may have similar tranquillising effects in hens and these may contribute
towards the reduction in stress-induced oviposition delay duration observed in the
present study. Thus, relocation from individual to group cages may have been less
stressful for hens receiving propranolol (due to its tranquillising effects), so
shortening oviposition delays, than for hens receiving saline.
Although appropriate control treatments, such as no injection, were not
present, saline injections alone did not appear to induce oviposition delays in either of
the experiments reported here. By contrast, Crossley (1983) found that subcutaneous
injections of saline at 4 ml/hen delayed oviposition for about 4.5 h. Possibly the
larger volume injected and subcutaneous route used in that experiment was more
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stressful than the injection procedure in the present experiments (intramuscular
injection of saline at approximately 1 ml/hen).
In Section 11.2, hens receiving propranolol injection but not social stress laid
earlier than expected and this effect was significant when compared with the control
treatment. Two possible explanations were suggested (see Section 11.2 Introduction).
Briefly, propranolol might initiate the oviposition process prematurely or may allow
oviposition to occur earlier than normal, possibly by blocking an endogenous
adrenergic inhibition of oviposition. In Section 11.3, hens receiving propranolol 2 h
before predicted oviposition time also laid earlier than expected, and by a similar
amount to those in Section 11.2. However, in Section 11.3 this effect was not
significant when compared with the control treatment. As eggs were not expelled
shortly after propranolol injections given 2 h before predicted oviposition time, it
seems unlikely that oviposition is initiated by propranolol. That there was a wide
range of times from propranolol injection until oviposition in Section 11.2 (8-48 min)
is also consistent with the conclusion that this treatment does not induce premature
oviposition. Instead, propranolol presumably allows oviposition to occur slightly
earlier than normal. This effect on oviposition was not reported when propranolol
was included in hens' food (Crossley, 1983).
The mechanism by which propranolol causes oviposition to occur earlier than
expected is not known. When isolated uterine muscle is pre-treated with propranolol
adrenaline is only able to act via alpha receptors and so causes contraction (Crossley et
al., 1980). Perhaps the onset of oviposition is stressful, causing adrenaline release
which, in the presence of propranolol, causes uterine contractions which expel the egg
earlier than normal. Another possibility is that there may be an inhibitory adrenergic
pathway which modulates the oviposition time of undisturbed hens and propranolol
blocks this and so allows oviposition to occur earlier than normal. Propranolol
facilitates electrically stimulated release of oxytocin in lactating rats (Russell et al.,
1993). Perhaps propranolol similarly facilitates AVT release in hens and this
contributes towards its oviposition advancing effect.
In conclusion, propranolol prevented stress-induced oviposition delays,
supporting the hypothesis that adrenergic mechanisms are involved in the causation of
these delays. It is suggested that adrenaline released in response to stress acts directly
to suppress uterine contractions and so to delay oviposition.
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CHAPTER 12: General Discussion
The aim of this thesis was to examine the phenomenon of stress-induced
oviposition delays in laying hens and to investigate the underlying physiological
causation of these delays. The experimental results have been discussed in detail in
previous chapters and so the aim of this concluding chapter is to provide a general
discussion of these findings and their implications.
In Chapter 3 it was found that social stress (relocation from individual to group
cages) caused hens to delay oviposition and this is consistent with the findings of
Hughes et al. (1986) and Watt (1989). Social stress was then used as the standard
environmental stressor in subsequent experiments, where it again induced oviposition
delays (see Chapters 4, 6, 7 and 11 and Appendix 3). Other environmental stressors,
such as obstructed access to regularly used nest sites, are also reported to delay
oviposition (Duncan, 1970; Kite, 1985; Hughes et al., 1986; Cooper & Appleby,
1995). By comparison, oviposition in reptiles and the analogous process in
mammals, parturition, are also disrupted by environmental stress (e.g. Haldar &
Bade, 1981; Leng et al., 1987; Chan & Solomon, 1989; Guillette et al., 1991;
Lawrence et al., 1992).
Several lines of evidence support the assumption that the standard social stress
used in this project, which involves both relocation and contact with unfamiliar con-
specifics, would be stressful for hens. Relocation of hens from individual cages to a
holding crate containing 14 unfamiliar hens is a similar procedure and caused
increased plasma corticosterone concentrations (Beuving & Vonder, 1978). Likewise,
Gross and Siegel (1985) report that various types of social disruption, including
relocation from individual to group cages, increase plasma corticosterone
concentration. The release of corticosterone from the adrenal cortex and into the
circulation is indicative of stress (Freeman, 1976, 1985). Exposing hens to chronic
social disruption (by continuously housing them in groups and regularly changing the
composition of these) increases heterophiklymphocyte ratios and adrenal gland
weights and reduces body weight, changes which indicate that social disruption is
stressful (Siegel, 1971; Gross et al., 1984; Anthony et al., 1988). Contact between
unfamiliar hens is associated with increased levels of aggressive behaviour (Hughes
& Black, 1978; Hughes, 1979). Although systematic recordings of hens' behaviour
during social stress were not made in the present experiments, the level of aggression
at this time was clearly high, relative to that for hens housed in stable groups.
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Although social stress was an effective standard stressor for inducing
oviposition delays, it was not ideal when designing experiments. Ideally, an
independent set of stock hens would be used to make up a stress group for each of the
experimental hens (e.g. Section 7.3). However, this was usually impractical as
numbers of stock hens were limited. There may be factors related to particular
companion hens which influence the severity of the social stress, and so the possibility
of group effects must be considered when placing more than one experimental hen in
the same stress group. Three experimental designs to reduce or account for possible
group effects were used. The first and simplest was to put several experimental hens
into each group cage (e.g. Sections 3.3 and 7.2). As these hens had different
predicted oviposition times, their periods of stress were due to start and finish at
different times. Hence, although the periods when particular hens were exposed to
stress may overlap, two hens were not exposed to exactly the same period of stress
and so the effects of individual hens on the severity of stress experienced by another
should be minimised. The second design was to re-assemble available stock hens into
different groups on each day, in such a way that all hens in a group were strangers,
and to randomly allocate hens from each treatment to separate groups (e.g. Sections
6.3 and 10.3). This design should thus be balanced for possible effects of individual
stock hens. The third design involved pairing experimental hens which had similar
predicted oviposition times, and hence whose stress periods were due to start at
similar times. One hen from each pair was then randomly allocated to each of the two
experimental treatments and both were placed in the same group cage, along with two
stock hens. This pairing of hens could then be accounted for in the statistical analysis,
thus controlling for possible group effects (see Section 7.4).
A standard stressor that did not involve other hens may be more convenient
with respect to experimental design. Although obstructing access to regularly used
nest sites appears to potently induce oviposition delays (Duncan, 1970; Kite, 1985;
Hughes et al., 1986), it is impractical to accurately measure the daily oviposition times
of hens laying in these sites, and so this stressor would not be suitable for experiments
of the type reported in this thesis. Relocation to an unfamiliar environment has been
used as a model for investigating stress-related disruption of parturition and lactation
in mammals (Haldar & Bade, 1981; Leng et al., 1987; Lawrence et al., 1992).
Similarly, an appropriate relocation may prove a useful standard stressor for the
induction of oviposition delays in hens.
Four mechanisms by which stress might act to delay oviposition were
hypothesised in Section 1.5. First, stress may prevent ovarian PG release, so that the
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cascade of events which leads to expulsion of the egg is not initiated. Second, stress
may inhibit neurohypophysial AVT release so that the AVT-related escalation of
uterine contraction frequency does not occur. Third, stress may directly suppress the
rise in uterine contraction frequency required for oviposition. Fourth, stress may
cause contractions of the utero-vaginal sphincter which prevent the egg from leaving
the oviduct. Although the experiments reported in this thesis primarily investigated the
second and third mechanisms, all four possibilities are now discussed.
The first hypothesis is that stress causes oviposition delays by preventing
ovarian PG release. Treatment with an inhibitor of prostaglandin synthesis such as
indomethacin delays oviposition, suggesting that PG release is indeed an essential
component of normal oviposition (Hertelendy & Biellier, 1978; Shimada & Asai,
1979). The mechanism controlling the release of ovarian PGs, and therefore the
initiation of oviposition, has not yet been described, although it may be modulated by
the peak in plasma LH concentration 4-6 h before oviposition (Etches, 1990). At the
level of the ovary it is not clear how stress could act to prevent PG release in the
present experiments
If stress does cause oviposition delays by preventing ovarian PG release, then
plasma PG concentrations are not expected to rise to the levels associated with
oviposition during these delays. Although plasma PGFM concentrations were slightly
higher during oviposition delays than before expected oviposition time, concentrations
at this time were still lower than immediately after oviposition (Chapter 4), and so the
possibility that stress suppresses ovarian PG release cannot be discounted. Although
the finding that PGF2a injection ends stress-induced oviposition delays is consistent
with this hypothesis, the dose administered (0.5 (J-g/kg) may have been sufficient to
overcome alternative oviposition delaying mechanisms (Chapter 6).
In mammals, environmental stress can act via opioidergic mechanisms to
inhibit LH release (e.g. Petraglia et al., 1986; Norman & Smith, 1992). In hens,
exogenous opioids can inhibit LHRH (and hence LH) release (Sakuari et al., 1986;
Stansfield & Cunningham, 1987; Contijoch et al., 1993). Possibly some
environmental stressors could act via opioidergic pathways to inhibit LH release in
laying hens and, as LH release is thought to modulate the mechanisms controlling
oviposition time (Etches, 1990), could delay oviposition. However, such a
mechanism could not have caused the delays observed in the present experiments as
the peak of LH release is 4-6 h before oviposition time (Furr et al., 1973; Wilson &
Sharp, 1973), and exposure to stress did not start until after this.
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The second hypothesis is that stress causes oviposition delays by inhibiting
neurohypophysial AVT release. As stress-related disruptions of parturition and
lactation in mammals are due to an opioidergic inhibition of oxytocin release (e.g.
Haldar & Bade, 1981; Leng et al., 1988; Lawrence et al., 1992), and morphine
inhibits osmotically stimulated AVT release in hens (Xu et al., 1991; Dublecz et al.,
1992), it was hypothesised that endogenous opioids may inhibit AVT release in hens
during stress (see Section 1.7 for a review).
Experiments reported in this thesis investigated plasma AVT concentrations
associated with stress-induced oviposition delays, the ability of exogenous AVT to
end delays, the effect of opioid receptor antagonism on the delay duration, and the
effects of opioid agonists on the oviposition times of undisturbed hens. Plasma AVT
concentration was elevated at the time of ovipositions delayed in response to stress but
not during the delays (Chapter 4). Injection of exogenous AVT rapidly ended stress-
related oviposition delays by expelling the eggs (Chapter 6). Blocking opioid
receptors with the non-specific antagonist nalmefene significantly reduced the delay
duration (Chapter 7). Stimulating opioid receptors with the selective kappa agonist
U50,488 caused oviposition delays, an effect which was prevented by nalmefene and
ended by AVT injection (Chapter 8). U50,488 also increased the time from PGF2a
injection until premature oviposition was induced and reduced the rise in plasma AVT
concentration that is associated with this (Chapter 9). Morphine, a specific mu
agonist, may also delay oviposition in some hens (Chapter 8). These findings support
the hypothesis that stress-related oviposition delays are due to opioidergic inhibition of
neurohypophysial AVT release (see discussions in each chapter).
In mammals, a variety of stressors cause release of endogenous opioids
(Rodgers & Randall, 1988) and it is assumed that this also occurs in hens. The
finding that exposing hens to social stress reduces their frequency of headflicking in
response to alerting stimuli, a putative index of opioid status, is consistent with this
assumption (Chapter 10).
In mammals, opioids can inhibit oxytocin release by acting in either the
hypothalamus or the pituitary (Bicknell, 1985, 1993). In hens, opioid receptors have
not been found on the terminals of AVT neurones (Martin et al., 1992; also see Section
1.6.1), and so opioids presumably act centrally rather than peripherally to inhibit AVT
release. Indeed, peripheral inhibition of neurohypophysial hormone release in
mammals is via kappa receptors (Bicknell, 1985, 1993) and systematically injected
norBNI, a kappa receptor antagonist, did not reduce the duration of stress-induced
oviposition delays in hens (Chapter 8). Thus, it is suggested that endogenous opioids
(during stress) and exogenous opioids act via central opioid receptors to inhibit AVT
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release and so delay oviposition. As endogenous opioids cannot cross the blood brain
barrier, it is suggested that the endogenous opioids which inhibit AVT release are
released centrally.
In mammals, central opioidergic inhibition of oxytocin release involves mu and
kappa but not delta receptors (Bicknell, 1993). In birds, mu, kappa and delta
receptors are present in the hypothalamus and so could be associated with AVT
neurones (Deviche et al., 1993; also see Section 1.6.2). Although experiments with
U50,488 and morphine indicate that delays can be induced by stimulation of kappa
and possibly mu opioid receptors, nalmefene is a relatively unselective antagonist and
so it is not known which receptor types mediate stress-induced oviposition delays.
The disruption of parturition in rats by U50,488, which is thought to involve both
central and peripheral kappa receptors, is prevented by 0.5 mg/kg norBNI
administered i.v. (Douglas et al., 1993). This suggests that this dose of norBNI is
able to antagonise both central and peripheral kappa receptors and so is able to cross
the mammalian blood brain barrier. If a similar dose can also antagonise central kappa
receptors in the hen, the finding that norBNI does not reduce duration of stress-
induced oviposition delays (Chapter 7) would suggest that these are not caused by
opioids acting via kappa receptors. However, as it cannot be assumed that norBNI
can cross the blood brain barrier in hens, this suggestion would be better supported if
it was demonstrated that intracerebroventricular administration of norBNI does not
reduce delay duration.
If inhibition of AVT release is the primary mechanism causing oviposition
delays during stress, then the stimulus for AVT release, a rise in uterine contraction
frequency induced by ovarian PGs, may be expected to occur during the delays. If
this stimulus does not occur, then AVT release may not be triggered and hence
inhibition of AVT release would not be the primary cause of the delays. Instead, the
primary mechanism would be that which prevents the PG induced rise in uterine
contraction frequency. In Chapter 4 it was found that plasma PGFM concentrations
were slightly higher during stress-induced oviposition delays than before expected
oviposition time and this may indicate ovarian PG release. In Chapter 5, SGT
recordings did not show a large rise in uterine contraction frequency during
oviposition delays. This may be because the stimulus for AVT release did not occur or
because it was too short or too small to be detected.
The third hypothesis is that stress-induced oviposition delays are caused by
direct adrenergic suppression of uterine contractions. This is supported by reports that
exogenous adrenaline causes relaxation of uterine muscle, in vivo and in vitro, and
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induces oviposition delays, all in a propranolol reversible manner, (Verma & Walker,
1974; Crossley et al., 1980; Crossley, 1983); and adrenaline is released in response to
stress (Freeman, 1976; Harvey et al., 1984) (see Section 1.7 for a review). The
present finding that propranolol prevents the induction of oviposition delays by social
stress supports this hypothesis (see Chapter 11 for a full discussion, where it was
suggested that propranolol's tranquillising properties may also contribute towards
prevention of oviposition delays).
The fourth hypothesis is that stress-related contractions of the utero-vaginal
sphincter prevent uterine contractions from expelling the egg. Gilbert & Lake (1963)
have described the musculature of this sphincter and it appears suitable for obstructing
the egg's passage. If sphincter contractions are the primary cause of stress-related
oviposition delays, then ovarian PG release, elevated uterine contraction frequency
and AVT release would all be expected to occur as normal during these delays.
Although large rises in plasma AVT concentration and uterine contraction frequency
were not detected during stress-induced oviposition delays (Chapters 4 and 5), a small
rise in plasma PGFM concentration was and this may reflect ovarian PG release
(Chapter 4).
Abdominal muscles and body posture are associated with oviposition and
facilitate expulsion of the egg (Shimada & Saito, 1989). Presumably changes to these
events could contribute towards an oviposition delaying effect of stress. Sturkie et al.
(1962) describe how hens lay at the expected time when they are treated with curare, a
drug which paralyses skeletal muscles but not smooth muscles. The absence of
oviposition delays under this procedure, which is presumably stressful, may suggest
the involvement of skeletal muscles in the causation of oviposition delays.
The experiments reported in this thesis provide evidence that both adrenergic
suppression of uterine contractions and opioidergic inhibition of AVT release are
involved in the causation of oviposition delays when hens are exposed to
environmental stress. The possibility that other stress-related mechanisms contribute
towards causing these delays cannot be excluded. The role of adrenergic and
opioidergic mechanisms in the causation of stress-induced oviposition delays is
summarised in Figure 12.1.
Presumably the adrenergic and opioidergic mechanisms do not act
independently but instead interact to delay oviposition during stress. Possibly the
relative importance of these mechanisms varies during exposure to stress, in particular
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Figure 12.1 A diagrammatic representation of the mechanisms implicated, by the
experiments reported in this thesis, in the causation of stress-induced
oviposition delays. Dashed lines represent pathways involved in stimulating
uterine contractions, and hence oviposition, in undisturbed hens (see Section
1.4.1 for a review). During stress adrenaline, released from the adrenal glands
and into the circulation, directly suppresses uterine contractions and
endogenous opioids (probably released and acting centrally) inhibit
neurohypophysial AVT release (solid lines).
adrenaline is especially important for mediating immediate responses to stress
(Freeman, 1985). As a PG induced rise in uterine contraction frequency is thought to
be the stimulus for AVT release (Saito & Shimada, 1989), adrenergic suppression of
uterine contractions during stress will presumably suppress AVT release.
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Endogenous opioids will also be acting to inhibit AVT release at this time, and so the
cascade of events which culminates in expulsion of the egg will not become
established. Hens exposed to stress and treated with propranolol do not delay
oviposition (Chapter 11), yet AVT release may still be inhibited by endogenous
opioids. It is therefore possible that the rise in plasma AVT concentration associated
with oviposition will be lower in hens treated with propranolol and exposed to stress
than in unstressed hens.
It has been reported that hens continue to lay when they have been either
neurohypophysectomised, lesioned in the supraoptic nucleus, or injected with an AVT
anti serum at a dose considered sufficient to neutralise all AVT released in association
with oviposition (Shirley & Nalbandov, 1956; Ralph, 1960; Opel, 1965; Nakada et
al., 1993, 1994). Consequently, it has been suggested that AVT release may not be
essential for oviposition (Nakada et al., 1994; also see Section 1.4). If AVT release
does not have an important role, then inhibiting its release should not delay
oviposition. However, experiments reported in this thesis suggest that this is not the
case, because both social stress and exogenous opioids appear to delay oviposition by
inhibiting AVT release. The above authors (Shirley & Nalbandov, 1956; Ralph,
1960; Opel, 1965; Nakada et al., 1993, 1994) may, in fact, have missed short
oviposition delays because they did not measure oviposition times as accurately as was
done here. Thus, although neurohypophysial AVT may not be essential for
oviposition to occur, it may be necessary for it to occur at the appropriate time. Sykes
(1953a) reported that severing the spinal cord of hens does not prevent ovipositions,
although they were usually delayed. If release of neurohypophysial AVT is triggered
by a spinal reflex with uterine contractions as the stimulus, a mechanism like that
triggering oxytocin release in mammals (Edqvist & Stabenfeldt, 1993), then Sykes'
(1953a) finding is consistent with the suggestion above that AVT release is necessary
for the appropriate timing of oviposition.
Experiments described in this thesis suggest that endogenous opioids inhibit
AVT release during stress and that stimulation of kappa, and possibly mu, receptors
can inhibit AVT release in undisturbed hens. Further studies investigating the
opioidergic control of AVT release could clarify which receptor types are involved and
where they are located. The apparent lack of opioid receptors on the terminals of AVT
neurones (Martin et al., 1992, and see Section 1.6.2) suggests that opioids act
centrally to inhibit AVT release. In mammals, neurohypophysial hormone release can
be triggered by electrically stimulating the neural stalk and this has been used as a tool
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for investigating peripheral inhibition of hormone release, both in vitro and in vivo
(e.g. Bicknell et al., 1985; Russell et al., 1993) A similar procedure could be used to
investigate the above proposal that opioids do not act peripherally to inhibit AVT
release in hens. Opioids which inhibit neurohypophysial hormone release by acting
centrally do so by suppressing electrical activity of the magnocellular neurones, and
this has been investigated in mammals by directly recording the firing frequency of
these neurones (e.g. Pumford et al., 1993). A similar technique could be used to
investigate which opioid receptor types can mediate central inhibition of AVT release
in hens. In mammals, injection of the peptide CCK causes oxytocin release and this
has been used as a tool for investigating opioidergic control of this hormone's release
(e.g. Leng et al., 1992). As CCK stimulates AVT release in hens (Marks & Koike,
1993), such an approach could also be useful here.
Ovipositions are delayed when hens are given additional food in the 15 min
before expected oviposition time, and this has been interpreted in terms of conflicting
feeding and nesting motivations (Freire, 1994; Appleby & Freire, 1995). The present
study allows further interpretation of these findings. Firstly, presenting food to the
hens may have involved stressful procedures, such as the presence of people, and
perhaps it was these disturbances, rather than the food itself, which induced
oviposition delays. Secondly, feeding in hens may release endogenous opioids
(Savory et al., 1989) and perhaps these cause the delays by inhibiting
neurohypophysial AVT release.
As part of the present project, an experiment investigating the effect of food
presentation on oviposition time, and the mechanisms underlying any delays that were
caused, was attempted. If oviposition delays had been caused by opioidergic
mechanisms (related to either feeding behaviour or stress associated with food
presentation), then treatment with nalmefene should have reduced their duration.
Mature hens of a broiler (meat type) strain were used as these are maintained on a
restricted feeding regime and consequently are highly motivated to feed (Savory et al.,
1993). However, as these hens did not lay sequences of more than about 6 eggs it
was not possible to calculate their expected oviposition times with sufficient accuracy
to be able to assess whether or not ovipositions were delayed.
From a commercial perspective, an effect of feeding on oviposition time may
be important. Hens are usually fed in the morning (B.O.Hughes & C.J.Savory,
personal communication), and this is the time of day when most ovipositions occur
(Etches, 1996). If this food presentation delays oviposition then eggs may become
dusted, or even white banded in extreme cases, abnormalities which would cause egg
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downgrading and possibly compromise the health of embryos (see Section 1.3).
Although daily feeding time is reported to influence the distribution of oviposition
times (Brake, 1985; Wilson & Keeling, 1991), it is not clear if this was because
ovipositions were delayed.
The possibility that oviposition is itself stressful and so stimulates mechanisms
which have an inhibitory influence on the expulsion of the egg must be considered.
Oviposition is associated with increased heart rate (Mills et al., 1985) and elevated
plasma corticosterone concentrations (Beuving & Vonder, 1981; Johnson &
Tienhoven, 1981). Both these changes may reflect stress (Freeman, 1976, 1985) and
hence are consistent with the possibility that oviposition is stressful. It has been
suggested that stress associated with parturition in mammals stimulates adrenergic
mechanisms which prolong labour (Bostedt & Rudolf, 1983; Lederman et al., 1985).
The finding that propranolol advances oviposition time may be consistent with a
similar mechanism occurring in hens (see Chapter 11)
Opioid receptor antagonism reduces inter-birth intervals in rats, suggesting that
endogenous opioids may modulate the duration of labour (Leng et al., 1985). In
hens, guarding behaviour associated with acute ankle joint pain is not shown during
the pre-laying period or at oviposition (Gentle & Corr, 1995), possibly reflecting
release of endogenous opioids at this time. If opioids are released they may have an
inhibitory effect on AVT release and hence on the progress of oviposition. Indeed,
naloxone increases the rise in plasma AVT concentration associated with oviposition
(F.Ellendorff, personal communication), suggesting that an endogenous opioidergic
inhibition of AVT release is present at this time. However, in the present study
nalmefene did not alter oviposition times of unstressed hens (Section 9.6), suggesting
that endogenous opioids were not regulating these oviposition times. However, those
hens had been laying for about 9 weeks. Possibly sensitivity of the AVT system to
opioidergic inhibition declines over successive ovipositions until oviposition is no
longer disrupted. The oviposition times of young hens tend to be quite erratic
(personal observations), and perhaps this reflects disruption caused by mechanisms
related to the stress of oviposition.
The experiments described in Chapter 3 suggest that a threshold of about 3 h
oviposition delay defines an upper limit beyond which oviposition of the delayed egg
no longer occurs, until the subsequent egg arrives in the uterus several hours later.
Before this threshold (i.e. when oviposition delays had not yet reached about 3 h),
ovipositions often occurred during stress and if stress ended they occurred shortly
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(about 15 min) after. These delays were described as short-term. However, once
delays exceeded the 3 h threshold, ovipositions were unlikely to occur during stress or
even if stress ended. Instead the eggs were laid much later, 7-15 h after expected
oviposition time, and these delays were described as long-term. Thus, the threshold
describes the time after expected oviposition time beyond which oviposition no longer
occurs until much later. Four mechanisms to explain this threshold were hypothesised
in Chapter 3, and these are now considered in the light of subsequent experiments.
First, release of ovarian PGs, the initial event in the oviposition process, may
be restricted to a short time period which has an upper limit defined by the threshold.
As the mechanisms controlling ovarian PG release have not been described, this
hypothesis has not been tested.
Second, neurohypophysial AVT and/or ovarian PGs may be released during
stress-induced delays and the threshold is the time beyond which stores of these
hormone(s) are so depleted that oviposition can no longer occur. In Chapter 4 there
was no evidence to suggest that AVT is released during oviposition delays. Indeed,
the findings in subsequent chapters suggest that inhibition of AVT release is one of the
main causes of oviposition delays. Thus, it is unlikely that the threshold reflects
depletion of neurohypophysial AVT stores. Plasma PGFM concentrations were
slightly higher during stress-induced oviposition delays than before expected
oviposition time, possibly reflecting release of ovarian PGs (Chapter 4). Therefore,
the possibility that the threshold reflects a depletion of ovarian PG stores (and
presumably their precursors) cannot be discounted.
Third, the oxytocin (and presumably AVT) degrading enzyme activity in
plasma and uterine tissues is lowest at oviposition time but rises within a few hours
(Gilbert & Lake, 1964; Brzezinska et al., 1967; Brezezinska-Slebodzinska et al.,
1979). Hence, the threshold may reflect the time beyond which any AVT released is
degraded so rapidly that it does not stimulate uterine contractions. Conceivably, a
similar mechanism could also apply to PGs. Injections of either AVT or PGF2a
ended long-term oviposition delays either very slowly or not at all (Section 6.4). By
contrast, similar injections rapidly end short-term delays (Section 6.3). This is
consistent with the hypothesis that reductions in the half-lives of these hormones cause
the threshold.
Fourth, changes in the number and binding characteristics of uterine receptors
for AVT and/or PGs may alter, reducing the ability of these hormones to induce
uterine contractions after the threshold. Such changes have been described for the
AVT receptor and may be under the control of ovarian hormones (Takahashi et al.,
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1992, 1994). This hypothesis is also consistent with the finding that neither AVT nor
PGF2a injections readily end long-term oviposition delays (Section 6.4).
Thus, a single mechanism causing the threshold has not been identified and all
four discussed above could contribute.
In an experiment examining the amenability of oviposition in hens to operant
conditioning, Leuscher and Hurnik (1988) were unable to train hens to lay in the late
afternoon (rather than in the morning as normal) in order to get a food reward. As
hens do not normally feed during the pre-laying period (Savory, 1977; Shimada et al.,
1987b), it was suggested that there may be "associative constraints" between
oviposition as a behaviour and food as a reward. The identification of the 3 h
threshold (Chapter 3) suggests another interpretation of their experiment. Once
oviposition has been delayed beyond this threshold hens no longer lay eggs until the
subsequent egg arrives in the uterus. Thus, the hens in the experiment of Leuscher
and Hurnik (1988) may have been unable to lay at the required time as this was after
the threshold. Possibly oviposition would be more amenable to operant conditioning
if rewarded changes in oviposition time were within the period defined by the 3 h
threshold.
In conclusion, there are several points raised by the present study which merit
further investigation. First, it would be of interest to investigate the underlying cause
of the 3 h threshold, which affects the duration of oviposition delay, and hence the
type of eggshell abnormality. Second, further investigation of opioidergic modulation
of neurohypophysial AVT release could concentrate on identifying the sites of action
of the opioid receptor types. Third, further studies are required to validate the use of
headflick frequency as a behavioural indicator of hens' opioid status. Fourth, the
regulation of ovarian PG release at normal oviposition is still poorly understood
(Shimada & Saito, 1989). Investigation of this and its possible disruption by stress is
needed. Fifth, Some consideration of the possible contribution of stress-related
adrenaline release on contractions of the utero-vaginal sphincter is required. Finally,
investigations with electrodes are required to study uterine contraction patterns in




1. Exposure to social stress (relocation from individual to group cages for periods
of up to 6 h) at expected oviposition time caused many hens to delay oviposition.
These delays often ended during stress, and if exposure to stress ended oviposition
typically ended about 15 min after this. Ovipositions delayed beyond a threshold of
about 3 h were unlikely to occur until they had been delayed for 7-15 h, by which time
the subsequent egg had arrived in the uterus. Delays ending before the threshold were
described as short-term while those ending later were described as long-term.
2. Short-term oviposition delays often resulted in the delayed eggs acquiring a
superficial layer of additional calcification, an abnormality described as "dusting".
When oviposition was delayed long-term the delayed egg became "white-banded" and
the subsequent egg became "slab-sided".
3. Plasma concentrations of both prostaglandin-FM and AVT were elevated at the
times of both normal ovipositions and ovipositions occurring after short-term stress-
induced delays. Prostaglandin-FM, but not AVT, concentrations were slightly
elevated during oviposition delays.
4. Strain gauge transducers were used to record uterine contractions in
association with normal oviposition, oviposition induced prematurely by exogenous
PGF2a, and one oviposition delay induced by stress (relocation). Contraction
frequency rose two-fold (from about 10-12 per min to about 20-25 per min) at each of
these ovipositions. There was no evidence of increased contraction frequency during
the oviposition delay.
5. Social stress did not affect the ability of exogenous PGF2a (0.5 fig/kg, i.v.)
to induce oviposition 2 h prematurely.
6. I.v. injection of either AVT (0.1 |lg/kg) or PGF2a (0.5 fig/kg), but not of
saline, rapidly ended short-term stress-induced oviposition delays.
7. I.v. injection of either AVT (0.1 (lg/kg) or PGF2a (0.5 flg/kg) ended only
some (2/4 and 1/4, respectively) long-term stress-induced oviposition delays, and then
only relatively slowly.
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8. The relatively unselective opioid receptor antagonist nalmefene (0.5 mg/kg,
i.v.) significantly reduced the duration of stress-induced oviposition delays.
9. The preferential kappa and mu receptor antagonist MR2266 (2 mg/kg, i.v.)
reduced the duration of stress-induced oviposition delays, but this effect was not
significant.
10. The selective kappa opioid receptor antagonist norBNI (0.5 mg/kg, i.v.) did
not significantly affect the duration of stress-induced oviposition delays.
11. Treatment with the selective mu receptor agonist morphine (6 mg/kg, i.v.)
induced some hens' ovipositions within 8-13 min and these were 28-101 min
premature. For some other hens this treatment may have delayed oviposition.
12. Treatment with the selective kappa receptor agonist U50,488 (4 mg/kg, i.v.)
caused oviposition delays with a mean duration of 26.4 min. The oviposition delaying
effect of U50,488 was prevented by co-treatment with nalmefene (0.5 mg/kg, i.v) and
ended by exogenous AVT (0.1 (ig/kg, i.v.).
13. Treatment with U50,488 (4 mg/kg, i.v.) delayed the premature induction of
oviposition by exogenous PGF2a (0.5 flg/kg, i.v.) and reduced the rise in plasma
AVT concentration associated with this. These effects were not apparent in hens co-
treated with nalmefene (0.5 mg/kg, i.v.).
14. In one experiment, social stress significantly reduced hens' frequency of
headflicking in response to alerting stimuli. In a second experiment, frequency of
headflicking was significantly increased by nalmefene (0.5 mg/kg, i.m.) but was not
significantly affected by social stress. The i.m. injection procedure (with saline) did
not significantly affect headflick frequency.
15. The (3 adrenergic receptor antagonist propranolol (10 mg/kg, i.m.) prevented
stress-induced oviposition delays. This treatment also caused ovipositions of
unstressed hens to occur on average 25 min earlier than expected.
16. In addition to causing oviposition delays, social stress can induce relatively
short (< 1 h) ovulation delays (see Appendix 3).
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Appendix 1: Validation of Expected and Predicted
Oviposition Times
In many of the experiments reported in this thesis it was important that hens
could be treated a specific time interval before they would normally lay. To enable
this, the time when oviposition would normally occur was predicted using records of
previous days oviposition times. The "predicted oviposition time" is therefore an
estimate of when oviposition would occur (if there was no experimental treatment) and
was a means of determining when experimental procedures should be carried out. The
"expected oviposition time" is a more accurate estimate of when oviposition would
have occurred (had there been no experimental treatment) and is calculated using the
recorded oviposition times on the days before and after treatment. In experiments
expected oviposition time was used in the calculation of oviposition delays.
There were two aims in the present study: first, to assess how accurately
expected oviposition time represents actual (observed) oviposition time in the absence
of any experimental treatments; second, to assess how accurately predicted oviposition
times reflect expected oviposition times.
Al.l Materials and Methods
A stock of hens (n = 37) aged 28 weeks were housed and their oviposition
times recorded as described in Chapter 2. After the third day of recording, the
oviposition time of the egg due on day 4 could be predicted (predicted oviposition
time) for 27 of the hens. Observed oviposition times of these hens were then recorded
for a further 3 days (days 4, 5 and 6) and the occurrence of oviposition on day 7
recorded (to ensure that day 4 was not within three days of the end of an egg
sequence). For each of the 27 hens, the expected oviposition time for day 4 was
calculated twice; once using the observed oviposition times on days 3 and 5 (first day
after day 4) and once using the observed oviposition times on days 3 and 6 (second
day after day 4), as described in Section 2.3. In this project, expected oviposition
time for a day of treatment was only calculated using the second day after treatment
when oviposition time on the first day after treatment was not known, e.g. as a result
of an internal ovulation.
To assess how accurately expected oviposition times reflected observed
oviposition times, the expected oviposition times were deducted from the observed
oviposition times (this was done twice; once for each method of calculating expected
oviposition time). Thus, a value of zero indicates that expected oviposition time
167
equalled observed oviposition time, negative values indicate that expected oviposition
time was later than observed oviposition time and positive values indicate that expected
oviposition time was earlier than observed oviposition time. Note that these values are
equivalent to oviposition delays.
To assess how accurately predicted oviposition time reflected expected
oviposition time, the predicted oviposition times were deducted from the expected
oviposition times. Thus a value of zero indicates that predicted oviposition time
equalled expected oviposition time, negative values indicate that predicted oviposition
time was later than expected oviposition time and positive values indicate that predicted
oviposition time was earlier than expected oviposition time. As most expected
oviposition times for the experiments in this project were calculated using the
oviposition time on the first day after treatment, the accuracy of predicted oviposition
times was assessed here using this calculation (i.e. using day 5).
A1.2 Results and Discussion
One hen laid a soft shelled egg very early and clearly prematurely on day 5 and
so its expected oviposition could only be calculated using day 6. For another hen, the
oviposition time on day 4 was not recorded and so this individual could not be
included in the analysis.
Figure A 1.1 shows the distribution of differences between observed
oviposition times and expected oviposition times (calculated by both methods) for day
4. Both distributions were normally distributed and so confidence intervals could be
calculated. The 95% confidence interval of expected oviposition times calculated
using day 5 (the first day after day 4) was within -29 and +28 min (mean = 0 min) of
observed oviposition time. The 95% confidence interval of expected oviposition times
calculated using day 6 (the second day after day 4) was within -32 and +27 min (mean
= -2 min) of observed oviposition time.
This study demonstrates that calculations of expected oviposition time used in
this project give an accurate approximation of observed oviposition time in the absence
of experimental treatments. Thus, in experiments to investigate the effects of
treatments on oviposition time, expected oviposition times can be used to estimate
when ovipositions would have occurred in the absence of the treatments.
Figure A 1.2 shows the distribution of differences between expected
oviposition times (calculated using day 5) and predicted oviposition times. The data
were normally distributed and so confidence intervals could be calculated. The 95%
168
8l A
-39 -29 -1 9 -9 0 1 0 20 30 40
Observed oviposition time - expected oviposition time
81 B
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Observed oviposition time - expected oviposition time
Figure Al.l Distributions of differences between observed oviposition time and
expected oviposition time, calculated either using day 5 (A; first day after day
4) or day 6 (B; second day after day 4), and observed oviposition time. Data
are grouped in classes of 10 min.
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confidence interval of predicted oviposition times calculated using day 5 was within
-45 and +26 min (mean = -5 min) of expected oviposition time. Thus, expected
oviposition time can be predicted in advance with a level of accuracy sufficient for the
experimental protocols described in this thesis. As a result of the variation in predicted
oviposition time accuracy, it was not possible to treat different birds at exactly the
same time relative to their expected oviposition times, and consequently in all
experiments there is a range of times from the treatments until the expected oviposition
times.
8 -i
-49 -39 -29 -1 9 -9 0 1 0 20 30 40
Expected oviposition time - predicted oviposition time
Figure A1.2 Distributions of differences between expected oviposition time and
predicted oviposition time. Data are grouped in classes of 10 min.
The hens used in this study were of a similar age to those used in most of the
experiments described in the thesis. The proportion of stock birds selected in the
present study is also similar to that in most other experiments. However, it should be
noted that the accuracy of expected oviposition time calculations and of predicted
oviposition times may differ from those recorded here in some experiments, e.g. in
older birds where the lag is longer and egg sequences shorter (Lillpers &
Willhelmson, 1993a).
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Appendix 2: Validation of the Radioimmunoassay
used to Measure AVT in Avian Plasma
A2.1 Introduction
As there was no commercially available assay for the measurement of AVT,
AVP radioimmunoassay kits were used to measure plasma AVT concentrations in this
thesis (Chapters 4 and 9). AVT and mesotocin are the avian equivalents of
mammalian AVP and oxytocin, respectively - all are nonapeptides and are comprised
of a ring and tail component (Acher, 1993). The human AVP assay kit used (RIK-
8103; Peninsula Laboratories, Inc.) was chosen, from a number of oxytocin and AVP
assay kits available, because the peptide antiserum is reported to have 100% cross-
reactivity with AVT (antiserum specifications supplied with kit). This appendix
describes the protocol of this radioimmunoassay and the steps taken to validate its use
for measuring AVT in avian plasma.
Radioimmunoassays are based on the competition between hormone which has
been labelled with a radioisotope and unlabelled hormone (either in a standard or
extracted from a plasma sample) for a limited number of binding sites on specific
antibodies (see Chard (1990) for a review of assay principles). The relationship
between the amount of labelled hormone binding to the antibodies and the amount of
unlabelled hormone is described by a sigmoidal standard curve. The amount of
labelled hormone which binds to the antibodies when in competition with an unknown
amount of unlabelled hormone (e.g. hormone extracted from plasma) is compared
with the standard curve to determine the amount of unlabelled hormone. In the assay
described here, unlabelled AVT (standard or from plasma) competes with a fixed
amount of 125I labelled AVP.
A2.2 Assay Procedure
Assays were conducted according to the instructions supplied with the kits,
with the exception that a modified extraction procedure was used. The modifications
to the extraction procedure were required because plasma from laying hens contains
larger amounts of lipoprotein than human plasma (for which the original extraction
procedure was designed).
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Extraction ofPeptide from Plasma
Plasma (0.5 ml) was mixed with 1 ml buffer A (0.1% Trifloro acetic acid
(anistar grade; Merck) in distilled water), then centrifuged for 20 min at 750 g to pellet
precipitated proteins (the original extraction procedure used 0.5 ml buffer A). With a
Pasteur pipette the supernatant was loaded onto a Sep pac vac C-18 column (vac-3cc,
Waters Associates, Millipore, UK), which had been prepared by washing once with 1
ml buffer B (60% acetonitrile (Rathburn Chemicals) in buffer A) then three times with
buffer A, and then slowly drawn through. The column was then washed twice with 3
ml buffer A and then, to elute the peptide, slowly with 3 ml buffer B. This final eluant
was collected and evaporated to dryness overnight at 35°C in a vacuum oven (pressure
= 780 mm Hg). The peptide was then reconstituted with assay buffer. During the
extraction procedure, solutions were slowly drawn through the C-18 columns, at 2
ml/min, using water pressure to create a vacuum.
Summary ofAssay Protocol
[ARG8]-vasotocin acetate (Sigma) was used as the standard AVT in the
preparation of the standard curves and in the steps taken to validate the assay. Its
structure is identical to that of avian AVT (Acher, 1993).
All standards were replicated and then they and the extracted samples were
assayed in duplicate. Samples of standard peptide and peptide extracted from plasma
were incubated with rabbit anti-AVP serum overnight at 4°C. 125I-AVP was then
added followed by a second overnight incubation at 4°C. Goat anti-rabbit IgG serum
and normal rabbit serum were then added, followed by 1.5 h incubation at room
temperature. After centrifugation at 1700 g for 20 min, the supernatant was removed
from each tube by aspiration and the I125 content of the pellets counted using a gamma
counter (1277 Gammamaster, Wallac). A radioimmunoassay curve fitting programme
(Assay Zap) was used to analyse the assay results.
A2.3 Assay Specifications and Validation
Several steps were taken to demonstrate that the radioimmunoassay kits for
measuring AVP in mammalian plasma could be used for measuring AVT in avian
plasma. Firstly, standard curves of AVP and AVT were prepared. Parallelism
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Figure A2.1 AVT (prepared in phosphate buffered saline) and AVP standard
curves.
20 H '—'—'—■ ■ ■ * ■ i ■—>—' ' ' ■ * ■ i 1—■—
.1 1 10 100
Standard AVT (pg/tube)
Figure A2.2 Standard curve for AVT, as used for measuring AVT from plasma.
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between these indicates that unlabelled AVT can compete with labelled AVP for
specific antibody binding sites. It was also confirmed that the expected plasma AVT
concentrations would fall within the range where the standard curve has an almost
linear slope. Secondly, various known amounts of AVT were added to stock plasma.
These increases in plasma AVT concentration were accurately measured by the assay,
indicating that there is a linear relationship between measured and actual plasma AVT
concentration. This procedure was also used to calculate the efficiency of the
extraction procedure. Finally, the plasma AVT concentrations measured in association
with oviposition were compared with published reports.
AVT and AVP Standard Curves
In a preliminary assay, standard curves for AVP and AVT were prepared by
two-fold serial dilutions of standard AVP and standard AVT. As there was
insufficient assay buffer supplied with the kit for preparing two standard curves, the
serial dilutions of AVT were made using phosphate buffered saline (for subsequent
assays, including the rest of the validation procedures, the AVT standard curve was
prepared with assay buffer). The parallelism between the AVP and AVT standard
curves (Figure A2.1) indicates that AVT can compete with 125I-AVP for binding to the
specific antibodies. The slight displacement of the AVT standard curve to the right of
the AVP standard curve may indicate that AVT binds less competitively with the
antibodies than does AVP. In subsequent assays, the lowest AVT standard was
replaced with a higher one in order to improve the range of AVT determination. Such
an AVT standard curve is shown in Figure A2.2. For this standard curve, ED80 =
3.1 pg/tube, ED50 = 12.6 pg/tube, ED20 = 57.0 pg/tube.
Recovery ofAVTAdded to Plasma
To confirm that the assay could accurately measure the addition of various
amounts of standard AVT added to plasma, and to assess the efficiency of the
extraction procedure, either 0, 20, 40 or 60 pg/ml (n = 4, 2, 2, and 2, respectively) of
standard AVT was added to aliquots of pooled stock plasma. To calculate the amount
of added AVT which was recovered (measured) by the assay, the mean AVT
concentration measured for plasma samples without added AVT (this was 21.1 pg/ml)
was deducted from the mean AVT concentrations measured for plasma samples with
AVT added at 20, 40 or 60 pg/ml. Mean plasma AVT concentration recovered was
directly proportional to the amount of added plasma, i.e. the percentage recovery was
similar for each amount of added AVT (Table A2.1). Thus, the assay can accurately
measure the addition of known amounts of AVT to avian plasma. Mean recovery of
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added standard AVT, an estimate of the efficiency of the extraction procedure, was
86%. In experiments, measurements of AVT from plasma were multiplied by 1.16
(i.e. 100/86) to account for the extraction procedure.
AVT added to stock plasma (pg/ml) 20 40 60
Mean AVT recovered (pg/tube x2) 17.7 31.4 54.7
Recovery of added AVT (%) 88.4 78.4 91.2
Table A2.1 Recovery of standard AVT added to stock plasma. As AVT was
measured in 0.5 ml of plasma, AVT recovered is expressed as pg/tube x 2.
Assay Variation
It was intended that the variation between the 4 replicate measurements of AVT
from stock plasma spiked with no added AVT (0 pg/ml) would be used as an estimate
of intra-assay variation. However the variation between these replicates was clearly
higher than the variation between replicates of other samples (including those
containing added AVT). Therefore, to get a more representative estimate of intra-
assay variation the replicate measurements of AVT in plasmas to which AVT had been
added at either 20, 40 or 60 pg/ml were also used. The difference between each
replicate and the mean for that set of replicates was calculated as a percentage of the
mean. Thus, 10 estimates of variation were calculated and the mean of these, 17.9%,
was taken as an estimate of the intra-assay variation. If the plasmas with no added
AVT are excluded, the estimate of intra-assay variation is 8.6%. It is not clear why
there was high variability in the plasma with no added AVT.
So that an estimate of inter-assay variation could be made, two samples of
stock plasma with no AVT added (0 pg/ml) were included in a subsequent assay. The
mean of the 6 replicate measurements of AVT in this plasma (including the 4 from the
earlier assay) was calculated. The difference between each replicate and the mean was
calculated as a percentage of the mean. The mean of these 6 estimates of variation,
24.4% was taken as an estimate of inter-assay variation. As there was much variation
between the replicates in the earlier assay (see above), the estimate of inter-assay
variation is very high. Within each of the experiments described in this thesis, all
plasma samples were included in the same AVT assay.
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Comparison Between Published andMeasuredAVT Concentrations
Plasma AVT concentration is reported to rise to about 4 or 5 times basal level
at the time of oviposition (Arad & Skadhauge, 1984; Tanaka et al., 1984; Rice et al.,
1985; Shimada et al., 1986; Koike et al., 1988). Using the assay described here, a
five-fold rise in plasma AVT concentration was measured in association with
oviposition (Chapter 5). This supports the conclusion that the present assay does
indeed measure AVT in avian plasma.
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APPENDIX 3: Are Stress-Induced Oviposition
Delays Associated With Delay of the Subsequent
Egg's Ovulation?
A3.1 Introduction
This thesis has confirmed that social stress can delay oviposition in laying
hens. Ovipositions of undisturbed hens are usually followed by ovulation of the
subsequent egg 15-45 min later (Bahr & Johnson, 1991). Although ovulation is
caused by the pre-ovulatory surge in plasma LH concentration which occurs 4-6 h
earlier, the mechanisms underlying this association are not fully understood (see
Etches (1996) for a recent review). In the pre-ovulatory period, proteolytic enzymes
and collegenase weaken the stigma region of the largest pre-ovulatory follicle.
Ovulation then occurs when the stigma ruptures releasing the ovum. With respect to
eggshell quality and number of eggs produced it is of interest to know if ovulation of
the subsequent egg is delayed in association with oviposition delays induced by social
stress. Thus the aim of the following study was to investigate the effect of social
stress on the timing of ovulation.
In both experiments reported here hens were either exposed to social stress, to
induce oviposition delay, or left undisturbed (control), to allow oviposition to occur
normally, and then the state of ovulation was assessed by post-mortem examination.
In Experiment 1, all hens were killed at observed oviposition time to compare effects
of stress and control treatments on state of ovulation at this time. In Experiment 2, all
hens were killed 35 min after predicted oviposition time to compare effects of stress
and control treatments on state of ovulation at this time. From Experiment 2 it was
concluded that social stress can delay both ovulation and oviposition. In Experiment 1
there was no evidence of oviposition delays exceeding 1 h and so it was concluded
that the ovulation delays caused by social stress may be relatively short.
A3.2 Experiment 1: Effect of Stress on the State of Ovulation at
Oviposition Time
The aim of this experiment was to compare the states of ovulation of the
subsequent egg at the times of delayed oviposition and normal oviposition.
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A3.2.1 Materials and Methods
From 39 stock hens aged 40 weeks, 23 whose next oviposition times could be
predicted were selected and allocated randomly to either control (n = 11) or stress (n =
12) treatments. Control hens were left undisturbed in their original cages, while hens
due to be stressed were placed in a plastic holding pen (0.90 m long x 0.65 m wide x
0.58 m high) in an unfamiliar room 30 min before their predicted oviposition times.
The number of hens in this tub was maintained at eight by using unselected stock
birds. All hens in each treatment were killed by injection of sodium pentobarbitone
(sagatal, Rhone Merieux) < 2 min after their observed oviposition or 4 h after
predicted time if they had not laid before this. Within 3 min of death the oviduct was
exposed and the position of the next ovum was classified as either in the ovary (not
ovulated), body cavity (ovulated but not yet taken up by the infundibulum),
infundibulum, magnum, or isthmus.
As expected oviposition times could not be calculated from subsequent
oviposition times (because the hens were dead), oviposition delays were calculated by
deducting the predicted oviposition time from the observed oviposition time.
A3.2.2 Results
Of the 12 hens exposed to the stress treatment, 5 did not lay and were killed 4
h after predicted oviposition time. All 11 control hens laid within 1 h of their predicted
times. When they were killed, only 1 of the control hens had not ovulated while 9 of
those exposed to stress had not. This difference between the treatments was
significant (Fishers exact test, P<0.01), indicating that hens exposed to stress were
more likely to have ovulated before they laid than undisturbed birds.
As the maximum delay of 4 h was reached by 5 hens exposed to stress, the
durations of oviposition delays following each treatment were compared using rank
statistics. The oviposition delays of hens exposed to stress were significantly longer
than those of control hens (Mann-Whitney, w=83, P<0.01).
Figure A3.1 shows the relationship between the duration of oviposition delay
and the position of the egg in the oviduct and indicates that ova ovulated in association
with longer oviposition delays were in a more advanced position in the oviduct than
those associated with short oviposition delays. It is possible that some ova found in
the body cavity may have been dislodged from the infundibulum during the post¬
mortem examination. The positions in the oviduct of all the ova were consistent with
published reports on normal ovulation. The developmental stages of ova were
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appropriate to their positions in the oviduct, with those in the magnum carrying
albumen and those in the isthmus carrying shell membranes as well.
These results suggest that ovulation is not delayed in association with stress-
induced oviposition delays. However, examining the positions of ovum in the oviduct
several hours after ovulation may not be a very accurate method for determining
ovulation time and so it is possible that stress may have induced short ovulation delays
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Figure A3.1 The relationship between the duration of oviposition delay and the
position of the next ovum in the oviduct for hens either exposed to stress (large
open circles) or not disturbed (small solid circles). The five birds with delays
of 4 h had not laid when they were killed. The shaded regions represent the
range of expected positions of the ova at different times after expected
oviposition time (Bahr & Johnson, 1991).
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A3.3 Experiment 2: Effect of Stress on the Stage of Ovulation 35
Minutes After Predicted Oviposition Time
In Experiment 1, ovulation (of the subsequent egg) preceded oviposition more
frequently in hens exposed to social stress than in control hens. Hens exposed to
stress laid after longer oviposition delays than the control hens and the positions of the
recently ovulated ova in the oviduct and their stages of development were compatible
with normal passage in the oviduct, suggesting that ovulation was not delayed in
association with the stress-induced oviposition delays. Experiment 2 tested this
conclusion by investigating the effects of stress and control treatments on the stage of
ovulation 35 min after predicted oviposition time. This should be a more sensitive
way to detect ovulation delays.
A3.3.1 Materials and Methods
From 69 stock hens, aged 34 weeks, 55 whose next oviposition times could
be predicted were selected and allocated randomly to either control (n = 27) or stress
(n = 28) treatments. Control hens were left undisturbed in their original cages while
hens due to be stressed were placed in a plastic tub (as in Experiment 1) 40 min before
their predicted oviposition times. The number of hens in the tub was maintained at 6-
11 using unselected stock birds. All hens were killed by injection of sagatal 35 min
after their predicted oviposition time and the status of the subsequent ova were
classified as ovulated or not ovulated. This time of death was chosen as ovulation
normally occurs 15-45 min after oviposition (Bahr & Johnson, 1991), and it could
therefore be expected that most of the control birds would have ovulated before they
were killed.
Oviposition times were recorded and oviposition delays were calculated by
deducting the predicted oviposition time from the observed oviposition time, as in
Experiment 1.
A3.3.2 Results
On the day of treatment, two hens, one from each treatment, did not carry
hard-shelled eggs and were excluded from the experiment (so, n = 26 for control
treatment and n = 27 for stress treatment).
For stress and control treatments, Table A3.1 shows the numbers of hens
which ovulated or did not ovulate before 35 min after predicted oviposition time.
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Compared with those receiving the control treatment, a significantly greater proportion
of the birds exposed to stress had not ovulated (X2=16.2, 1 df, P<0.001). Thus, the
stress treatment delayed the time of ovulation.
For stress and control treatments, Table A3.2 shows the numbers of hens
which laid or did not lay before 35 min after predicted oviposition time. Compared
with those receiving the control treatment, a significantly greater proportion of the
hens exposed to stress had not laid (X2=45.3, 1 df, P<0.001). Only one hen
allocated to the stress treatment laid and this oviposition occurred before the stress
treatment started (i.e. oviposition was more than 40 min before predicted oviposition
time) and so no hens laid during their exposure to stress. This hen was one of the 4
which ovulated before 35 min after predicted oviposition time. One of the hens
receiving the control treatment also laid more than 40 min before predicted oviposition
time. The median oviposition delay for hens in the control treatment was 0 min, so
these birds laid at around the predicted time. Thus, compared with the control
treatment, the stress treatment delayed the time of oviposition.
Treatment Ovulated Not ovulated
Control 18 8
Stress 4 23
Table A3.1 Numbers of hens which, at 35 min after predicted oviposition time, had
either ovulated or not ovulated.
Treatment Laid Not laid
Control 25 1
Stress 1 26
Table A3.2 Number of hens which, at 35 min after predicted oviposition time, had
either laid or not laid.
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A3.4 Discussion
In Experiment 1, hens exposed to stress were significantly more likely to have
ovulated before laying the egg currently in the uterus and also had significantly longer
oviposition delays than undisturbed hens. The positions of the recently ovulated ova
at the times of ovipositions delayed for various durations suggest that these ovulations
occurred at their normal times, and hence that the stress-induced oviposition delays
were not accompanied by ovulation delays. To use the position of the ova in the
oviduct as an indicator of ovulation time relies on the assumption that the rate of the
ova's passage through the oviduct is not altered by the stress. The stages of
development of the ova recovered from the magnum and the isthmus were similar to
those reported in the literature (Roberts & Brackpool, 1994) and this is consistent with
the assumption that passage through the oviduct was not altered by the stress.
However, examining the position of ovum in the oviduct may not be a very sensitive
method for estimating ovulation time and so the possibility that short (i.e. less than 1
h) ovulation delays are associated with exposure to stress cannot be excluded.
Experiment 2 investigated the stage of ovulation 35 min after predicted
oviposition time as this should give a more sensitive (than Experiment 1) indication of
whether ovulation is delayed by social stress. Relative to the control treatment, social
stress greatly reduced the proportion of hens which had ovulated and the proportion of
hens which had laid before 35 min after predicted oviposition time, indicating that both
ovulations and ovipositions were delayed. From Experiment 2 it is not possible to
estimate the duration of the ovulation delays that were caused. However, as there was
no evidence of long ovulation delays in Experiment 1, it seems likely that the ovulation
delays caused by social stress are relatively short (< 1 h).
The timing of ovipositions of white-banded eggs also suggests that ovulation
delays associated with social stress are likely to be short. When oviposition is delayed
beyond a threshold of about 3 h, the delayed egg is not laid for several more hours,
during which time the next egg ovulates and eventually arrives in the uterus (Chapter
3). Where these eggs touch, the delayed egg acquires a white-band and the recently
ovulated egg acquires a slab-side. Ova ovulating at the normal time do not reach the
uterus until 4-5 h after the previous egg's normal oviposition time (Bahr & Johnson,
1991), yet white-banded eggs may be laid after oviposition delays of as short as 7 h
duration (Chapter 3). Shell material is deposited slowly during the first 3-4 h an egg
spends in the uterus (Talbot & Tyler, 1974; Nys, 1986), and presumably it takes a
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period of contact between the delayed and recently ovulated eggs for them to acquire
their white-bands and slab-sides. Thus, allowing time for the subsequent egg to reach
the uterus and time for the white-band and slab-side shell defects to form, the timing
of ovipositions of eggs with white-bands also suggests that ovulation delays
associated with social stress will be relatively short.
In mammals, opioids can inhibit the release of LH from the anterior pituitary
by acting indirectly to inhibit the release of LHRH from the median eminence (see
Bicknell (1985) for a review). Consequently exposure to stress or treatment with
morphine during the period of LH release suppresses ovulation (e.g. Hulse et al.,
1982; Packmann & Rothchild, 1976). In birds, opioids also suppress LHRH release
(Stansfield & Cunningham, 1987; Contijoch et al., 1993) and so may inhibit
spontaneous ovulation (Sakuari et al., 1986). It is possible that stress could delay
ovulation in hens by inhibiting LH release in an opioidergic manner. However, the
pre-ovulatory peak of LH release is 4 h before oviposition (Furr et al., 1973; Wilson
& Sharp, 1973), yet stress did not start until 30 or 40 min before predicted oviposition
time in the present experiments. Therefore it is unlikely that inhibition of LH release
was the cause of the ovulation delays observed in the present experiments. It is not
clear how stress might act to cause these delays.
That acute environmental stressors can act to disrupt ovulation time of hens has
not been reported previously. As hens were killed in the present experiment, it is not
known if an egg's oviposition is delayed as a consequence of its ovulation being
delayed on the previous day (i.e. the time from ovulation to oviposition is not
reduced), or if its oviposition is at the normal time (i.e. the time from ovulation to
oviposition is shorter than normal). If oviposition time is normal, then the egg may
spend less time in the uterus as a result of the delayed ovulation and this may reduce
eggshell quality. It is also important to know what effect ovulation delays have on the
timing of subsequent ovulations. The ovulations in an egg sequence occur at
progressively later times in the day until the sequence ends with a pause day on which
no egg is laid, and then the next sequence begins with ovulations occurring early in the
day (Etches, 1990). If ovulations subsequent to the delayed ovulation are also
delayed, then the positions of these eggs in the sequence may effectively be advanced
and therefore the egg sequence may end sooner. If stress shortens egg sequences by
delaying ovulation, then this would increase the proportion of days on which no egg
was laid (pause days), and consequently the number of eggs laid per bird per day will
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be reduced. Thus, the finding that acute stress can act to delay ovulation hens may be
important in terms of egg numbers or eggshell quality.
To summarise, Experiment 1 provided no evidence to indicate that ovulation
delays are caused by social stress. However, Experiment 2 indicated that social stress
greatly reduced the proportion of hens which had ovulated before 35 min after
predicted oviposition time, suggesting that ovulation delays were induced. Thus it is
concluded that social stress can induce ovulation delays (Experiment 2) but that these
delays may be relatively short, i.e. less than 1 h (Experiment 1). As this effect of
stress on ovulation has not been reported previously, and it may have consequences
for eggshell quality and egg numbers, it merits further investigation.
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Appendix 4: Published Papers
The following papers relating to experiments described in this thesis have been
published.
Reynard,M. & Savory,C.J. (1995). Experiments on stress-induced delayed
oviposition in hens. In: Proceedings of the 19th International Congress of the
International Society for Applied Ethology (eds. Rutter,S.M., Rushen,J.,
Randle,H.D. & EddisonJ.C). pp.215-216. UFAW, U.K.
Reynard,M. & Savory,C.J. (1995). Duration of stress-induced oviposition
delays in hens, (abstract) British Poultry Science 36(5):863. Also in: Proceedings of
the World's Poultry Science Association United Kingdom Branch Spring Meeting,
Scarborough, 22-23 March 1995. pp.88-89.
Reynard,M. & Savory,C.J. (1996). Social stress can delay both ovulation and
oviposition in laying hens. In: Proceedings of the World's Poultry Science
Association United Kingdom Branch Spring Meeting, Scarborough, 20-22 March
1996. (in press).
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Experiments on Stress-induced Delayed Oviposition in Hens
M.Reynard, C.J.Savory
Roslin Institute (Edinburgh), Roslin, Midlothian, EH25 9PS, UK
Introduction
Exposing laying hens to stressors such as change in group composition can
induce oviposition delays (Hughes 1979). Although the physiological mechanisms
underlying stress-induced oviposition delays are not known it is hypothesised that
opioids released in response to stress inhibit the secretion of arginine vasotocin, the
neurohypophyseal hormone responsible for promoting uterine contractions. This is
analogous to the disruption of parturition and lactation in mammals due to stress-
related opioidergic inhibition of oxytocin release (Leng & Russell 1989).
The aim of these experiments was to investigate how the duration of
oviposition delay is related to the timing of stress (Experiment 1), and to investigate
the role of opioids in this response through the use of an antagonist (Experiment 2)
and an agonist (Experiment 3).
Experiment 1
A pilot experiment suggested that periods of social stress of up to 6 h can
induce oviposition delays, with some birds not laying during this disturbance. These
birds were more likely to lay shortly after the end of the stress period when their
ovipositions were less than 130 min overdue. This, along with the range of
oviposition delays for eggs laid during stress periods, led to the hypothesis that hens
become less able to lay their eggs after delays ofmore than 130 min, even if the stress
is removed. The aim of this experiment was to test this hypothesis by exposing hens
to periods of social stress of various duration, starting 1 h before expected
oviposition.
ISA-Brown laying hens (n=47), 26 weeks old, were housed individually in
cages while oviposition times were recorded automatically. When a hen's next
oviposition time could be predicted from the egg laying records it was exposed to a
period of social stress (relocation to another cage containing 3 unfamiliar hens). Each
bird was exposed to one period of social stress which began 1 h before its predicted
oviposition time and lasted 0.3-6 h.
From the egg laying records on adjacent days, an expected oviposition time for
the day of treatment was calculated. The difference between this and the observed
oviposition time, the delay, was calculated. Nineteen birds did not lay during their
period of stress. These hens were significantly less likely to lay shortly after (<1 h)
the stress ending if oviposition was already more than 130 min overdue (Fisher exact
test, p<0.05). The mean oviposition delay for 5 eggs not laid shortly after the stress
ending was 11.0 h. The range of oviposition delays (max. = 168 min) for eggs laid
during stress also supports the hypothesis that birds become less able to lay following
a delay of around 2-3 h, and then retain their eggs for much longer.
Experiment 2
This experiment investigated the effect of the non-specific opioid antagonist
nalmefene on the duration of stress-induced oviposition delays.
From 36 ISA-Brown hens, 27 weeks old and housed as before, 18 birds with
predictable oviposition times were selected and randomly allocated to receive an
intravenous injection of either nalmefene (0.5 mg/kg, n=9) or saline (0.5 ml/kg, n=9).
Each bird was injected 30 min before its predicted oviposition time and then exposed
to stress by housing it in a new cage with 5 unfamiliar hens. Oviposition times during
stress were recorded and their delays calculated as before.
Oviposition delays were significantly reduced by treatment with nalmefene
compared to saline (p<0.01, by two-tailed Mann-Whitney test, See Fig. 1).
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Experiment 3
The aim of this experiment was to investigate the effect of the selective kappa
agonist U50488 on oviposition time. Previous tests with morphine, a mu receptor
agonist, were inconclusive.
From 35 ISA-Brown hens, 47 weeks old and housed as before, 22 birds with
predictable oviposition times were selected and randomly allocated to receive an
intravenous injection of either U50488 (4 mg/kg, n=10) or saline (0.9 ml/kg, n=12).
Birds were injected 30 min before their predicted oviposition times then left
undisturbed in their usual cages. Oviposition times following the injections were
recorded and their delays calculated as before.
Ovipositions of the U50488 treated birds were delayed significantly longer
than those receiving saline (p<0.05, by two-tailed Mann-Whitney test, See Fig. 2).
Conclusions
Stress-induced oviposition delays fall into two categories, long-term and short-
term (<3h), with the timing of stress relative to the expected oviposition time
influencing which of these occurs.
The non-specific opioid antagonist nalmefene reduced the duration of
oviposition delay in response to social stress. The selective kappa opioid agonist
U50488 induced oviposition delays in unstressed birds. Both these findings support





Fig. 1: Duration of oviposition delay in stressed hens treated with 0.5 mg/kg






Fig. 2: Duration of oviposition delay in unstressed hens treated with 4 mg/kg U50488
(mean + SEM, n=9) or 0.9 ml/kg saline (mean + SEM, n=l 1).
Acknowledgement
The financial support of the British Egg Marketing Board (MR) is gratefuly
acknowledged.
References
Hughes,B-O., 1979. Aggressive behaviour and its relation to oviposition in the
domestic fowl. Applied Animal Ethology, 5:85-93.
Leng,G. & Russell,J.A., 1989. Opioids, oxytocin and parturition. In: Dyer,R.G. &
Bicknell,R.J. (Eds.): Brain Opioid Systems in Reproduction. Oxford
University Press, 231-256.
188
Duration of Stress-Induced Oviposition Delays in Hens
M.REYNARD and C.J.SAVORY
Roslin Institute (Edinburgh), Roslin, Midlothian EH25 9PS, Scotland
It is known that environmental stressors such as change in group composition,
relocation, or removal of access to regularly used nest boxes can cause hens to delay
oviposition, and that this can lead to characteristic eggshell abnormalities such as white
banding, slab-sides and dusting (Hughes, 1979; Hughes et al., 1986). As the type of
eggshell defect may be related to the duration of oviposition delay, this study was
carried out to investigate the effect of the timing of a period of social stress on the
duration of egg over-retention.
It was found that exposing birds to social stress (relocation from individual
cages to larger cages with 3 unfamiliar companions) for periods of 4-5 h spanning the
expected oviposition time potently induced oviposition delays, with many birds
retaining their eggs until they were returned to their home cages. In these birds,
oviposition occurred soon after (8-22 min) the end of the stress period only when the
egg was still less than about 3 h overdue. In contrast, when the stress period did not
end until after this 3 h-threshold, the egg was not laid until much later, after a delay of
10-19 h. Thus the durations of oviposition delays depend on the timing of the stress,
and can be classified as being either short- or long-term.
When they were eventually laid all of the eggs delayed long-term carried a
white band of extraneous calcification, while the subsequent egg was slab-sided in
each case (because of contact with the delayed egg in the uterus) and was often laid
prematurely with a soft or thin shell. Short-term oviposition delays typically resulted
in the eggshells acquiring a superficial layer of calcium carbonate on top of the cuticle,
visible as a white chalky coating or dusting on the surface of brown eggs.
As a long-term oviposition delay results in a banded and a slab-sided egg
which are both downgraded, while a short-term delay causes only minor eggshell
dusting, the 3 h-threshold may be a commercially important finding.
HUGHES,B.O., GILBERT,A.B., & BROWN,M.F.(1986) Categorisation and
causes of abnormal egg shells: relationship with stress. British Poultry Science, 27:
325-337.
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Social Stress can Delay both Ovulation and Oviposition
in Laying Hens
M.REYNARD, C.J.SAVORY and J.S.MANN
Roslin Institute (Edinburgh). Roslin, Midlothian EH25 9PS, Scotland
Oviposition is usually followed by ovulation of the subsequent egg 15-45 min
later, and both processes are associated with ovarian hormonal changes (Bahr &
Johnson, 1991). A variety of environmental stressors can cause hens to delay
oviposition (e.g. Hughes et al., 1986). The aim of this study was to see if the
subsequent egg's ovulation is also delayed. Social stress (relocation of hens from
individual battery cages to a 0.6 holding pen where group size was 6-11) was used
to induce oviposition delays.
The first experiment compared the position of the ovum at normal and delayed
oviposition times. ISA Brown hens whose next oviposition times could be predicted
were randomly allocated to either control (n = 11) or social stress (n = 12) treatments.
Social stress started 30 min before predicted oviposition time. Hens from both
treatments were killed by sodium pentobarbitone injection immediately after
oviposition (or 4 h after predicted time if oviposition did not occur), and their oviducts
examined. Ovipositions were delayed significantly longer (Mann-Whitney, W=83,
P<0.01) by stress treatment (median = 104 min) than by control treatment (median = 4
min). Ovulation was significantly more likely to occur before oviposition in hens
exposed to stress (Fishers exact test, P<0.01). From the positions of the subsequent
eggs in the oviduct and their stages of development it was concluded any ovulation
delays could not have exceeded 1 h.
The second experiment examined the effects of control and stress treatments on
ovulation 35 min after predicted oviposition time; this should indicate whether stress
can delay ovulation more precisely than Experiment 1. ISA Brown hens whose next
oviposition times could be predicted were randomly allocated to either control (n = 26)
or social stress (n = 27) treatments. Stress started 40 min before predicted oviposition
time, and all hens were killed 35 min after predicted oviposition time. Compared with
the control treatment, both oviposition (X^=45.3, ldf, p<0.001) and ovulation
(X2=16.2, ldf, p<0.001) were significantly less likely to have occurred before death
with the stress treatment (see Table).
From the second experiment it was concluded that social stress can delay both
oviposition and ovulation. From the first experiment there was no evidence of












Table. Effects of control and social stress treatments on the number of hens laying
and the number of hens ovulating before 35 min after predicted oviposition time.
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